
<html lang="en"     class="pb-page"  data-request-id="c82ab6e6-74ed-4286-84bf-8d0bb95ffd35"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b00566;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors" /></meta><meta name="dc.Creator" content="Arik J.  Hone" /></meta><meta name="dc.Creator" content="Fernando  Fisher" /></meta><meta name="dc.Creator" content="Sean  Christensen" /></meta><meta name="dc.Creator" content="Joanna  Gajewiak" /></meta><meta name="dc.Creator" content="David  Larkin" /></meta><meta name="dc.Creator" content="Paul  Whiteaker" /></meta><meta name="dc.Creator" content="J. Michael  McIntosh" /></meta><meta name="dc.Description" content="Pharmacologically distinguishing α3β2 nicotinic acetylcholine receptors (nAChRs) from closely related subtypes, particularly α6β2, has been challenging due to the lack of subtype-selective ligands...." /></meta><meta name="Description" content="Pharmacologically distinguishing α3β2 nicotinic acetylcholine receptors (nAChRs) from closely related subtypes, particularly α6β2, has been challenging due to the lack of subtype-selective ligands...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 13, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00566" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00566" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00566" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00566" /></link>
        
    
    

<title>PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00566" /></meta><meta property="og:title" content="PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0010.jpeg" /></meta><meta property="og:description" content="Pharmacologically distinguishing α3β2 nicotinic acetylcholine receptors (nAChRs) from closely related subtypes, particularly α6β2, has been challenging due to the lack of subtype-selective ligands. We created analogs of α-conotoxin (α-Ctx) PeIA to identify ligand–receptor interactions that could be exploited to selectively increase potency and selectivity for α3β2 nAChRs. A series of PeIA analogs were synthesized by replacing amino acid residues in the second disulfide loop with standard or nonstandard residues and assessing their activity on α3β2 and α6/α3β2β3 nAChRs heterologously expressed in Xenopus laevis oocytes. Asparagine11 was found to occupy a pivotal position, and when replaced with negatively charged amino acids, selectivity for α3β2 over α6/α3β2β3 nAChRs was substantially increased. Second generation peptides were then designed to further improve both potency and selectivity. One peptide, PeIA-5466, was ∼300-fold more potent on α3β2 than α6/α3β2β3 and is the most α3β2-selective antagonist heretofore reported." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00566"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00566">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00566&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00566&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00566&amp;href=/doi/10.1021/acs.jmedchem.9b00566" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6262-6275</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00525" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00657" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Arik J. Hone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arik J. Hone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Sciences, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arik+J.++Hone">Arik J. Hone</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9912-0955" title="Orcid link">http://orcid.org/0000-0002-9912-0955</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fernando Fisher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fernando Fisher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Sciences, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Fisher">Fernando Fisher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sean Christensen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean Christensen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Sciences, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Christensen">Sean Christensen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joanna Gajewiak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joanna Gajewiak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Sciences, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joanna++Gajewiak">Joanna Gajewiak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Larkin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Larkin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Sciences, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Larkin">David Larkin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Whiteaker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Whiteaker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Psychiatry, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Whiteaker">Paul Whiteaker</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">J. Michael McIntosh</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. Michael McIntosh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Sciences,  Department of Psychiatry, University of Utah, Salt Lake City, Utah 84112, United States</div><div class="loa-info-affiliations-info">George E. Whalen Veterans Affairs Medical Center, Salt Lake City, Utah 84148, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#86ebe5efe8f2e9f5eea8ebefede3c6e1ebe7efeaa8e5e9eb"><span class="__cf_email__" data-cfemail="f9949a90978d968a91d79490929cb99e94989095d79a9694">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+Michael++McIntosh">J. Michael McIntosh</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00566&amp;href=/doi/10.1021%2Facs.jmedchem.9b00566" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6262–6275</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 13, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 April 2019</li><li><span class="item_label"><b>Published</b> online</span>13 June 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 July 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00566" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00566</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6262%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DArik%2BJ.%2BHone%252C%2BFernando%2BFisher%252C%2BSean%2BChristensen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D13%26contentID%3Dacs.jmedchem.9b00566%26title%3DPeIA-5466%253A%2BA%2BNovel%2BPeptide%2BAntagonist%2BContaining%2BNon-natural%2BAmino%2BAcids%2BThat%2BSelectively%2BTargets%2B%25CE%25B13%25CE%25B22%2BNicotinic%2BAcetylcholine%2BReceptors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6275%26publicationDate%3DJuly%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00566"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">739</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00566" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Arik&quot;,&quot;last_name&quot;:&quot;J. Hone&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Fisher&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Christensen&quot;},{&quot;first_name&quot;:&quot;Joanna&quot;,&quot;last_name&quot;:&quot;Gajewiak&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Larkin&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Whiteaker&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Michael McIntosh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6262-6275&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00566&quot;},&quot;abstract&quot;:&quot;Pharmacologically distinguishing α3β2 nicotinic acetylcholine receptors (nAChRs) from closely related subtypes, particularly α6β2, has been challenging due to the lack of subtype-selective ligands. We created analogs of α-conotoxin (α-Ctx) PeIA to identify ligand–receptor interactions that could be exploited to selectively increase potency and selectivity for α3β2 nAChRs. A series of PeIA analogs were synthesized by replacing amino acid residues in the second disulfide loop with standard or nonstandard residues and assessing their activity on α3β2 and α6/α3β2β3 nAChRs heterologously expressed in Xenopus laevis oocytes. Asparagine11 was found to occupy a pivotal position, and when replaced with negatively charged amino acids, selectivity for α3β2 over α6/α3β2β3 nAChRs was substantially increased. Second generation peptides were then designed to further improve both potency and selectivity. One peptide, PeIA-5466, was ∼300-fold more potent on α3β2 than α6/α3β2β3 and is the most α3β2-selective antagonist heretof&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00566&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00566" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00566&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00566" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00566&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00566" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00566&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00566&amp;href=/doi/10.1021/acs.jmedchem.9b00566" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00566" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00566" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00566%26sid%3Dliteratum%253Aachs%26pmid%3D31194549%26genre%3Darticle%26aulast%3DHone%26date%3D2019%26atitle%3DPeIA-5466%253A%2BA%2BNovel%2BPeptide%2BAntagonist%2BContaining%2BNon-natural%2BAmino%2BAcids%2BThat%2BSelectively%2BTargets%2B%25CE%25B13%25CE%25B22%2BNicotinic%2BAcetylcholine%2BReceptors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D13%26spage%3D6262%26epage%3D6275%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/jmcmar.2019.62.issue-13/20190711/jmcmar.2019.62.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pharmacologically distinguishing α3β2 nicotinic acetylcholine receptors (nAChRs) from closely related subtypes, particularly α6β2, has been challenging due to the lack of subtype-selective ligands. We created analogs of α-conotoxin (α-Ctx) PeIA to identify ligand–receptor interactions that could be exploited to selectively increase potency and selectivity for α3β2 nAChRs. A series of PeIA analogs were synthesized by replacing amino acid residues in the second disulfide loop with standard or nonstandard residues and assessing their activity on α3β2 and α6/α3β2β3 nAChRs heterologously expressed in <i>Xenopus laevis</i> oocytes. Asparagine<sup>11</sup> was found to occupy a pivotal position, and when replaced with negatively charged amino acids, selectivity for α3β2 over α6/α3β2β3 nAChRs was substantially increased. Second generation peptides were then designed to further improve both potency and selectivity. One peptide, PeIA-5466, was ∼300-fold more potent on α3β2 than α6/α3β2β3 and is the most α3β2-selective antagonist heretofore reported.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nonmuscle nicotinic acetylcholine receptors (nAChRs) are an extended branch of the Cys-loop superfamily of pentameric ligand-gated ion channels, formed from combinations of α (α2−α10) and β (β2−β4) subunits. These subtypes are important in normal physiology and in a wide range of disease states.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Their pharmacological and functional profiles, as well as expression patterns, frequently overlap, making them difficult to distinguish definitive physiological roles for each nAChR subtype that is expressed in any given location. Because of this, antagonists, which selectively inhibit particular nAChR subtypes, are essential tools for reliably defining causal relationships between receptor function and physiology/behavior. Selective pharmacological tools are also valuable complements to genetically modified animal models.</div><div class="NLM_p">Within the central nervous system (CNS), nAChRs containing the β2 subunit β2* nAChR (the asterisk denotes the possible or known presence of other subunits in native nAChR complexes<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a>) comprise the majority. Most CNS β2* nAChRs are of the α4β2* subtype, which is expressed across almost all brain regions and frequently at high densities. However, other subtypes are expressed in subsets of brain regions, where they can be very influential.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Autoradiography studies of mouse brain have indicated that the presence of α3β2* nAChRs is most prominent in the medial habenula–fasciculus retroflexus–interpeduncular tract. Other regions likely to express α3β2* nAChRs are the dopaminergic cell bodies of the substantia nigra (SN) and ventral tegmental area (VTA), dorsal cortex of the inferior colliculus, and the medial vestibular and prepositus hypoglossal nuclei.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Peripherally, α3β2* nAChR subtypes have been shown by immunoprecipitation and gene-knock out studies to be expressed by neurons of autonomic ganglia including those found in superior cervical, nodose, and intracardiac ganglia<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> as well as in the retina.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, pharmacological and functional studies of α3β2 nAChRs have been hampered due to the lack of ligands capable of selectively inhibiting α3β2 over other nAChRs subtypes, particularly α6β2.</div><div class="NLM_p">α-Conotoxins (α-Ctxs) are small, disulfide-rich peptides produced in the venom glands of carnivorous marine snails of the genus <i>Conus</i>. These snails use the peptides to capture and immobilize their prey and to defend against predators.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Their small size, usually 13–30 amino acids, ease of de novo synthesis, and amenability to modification make them attractive candidates for the development of novel peptide ligands for drug discovery. One such peptide, PeIA, was isolated from the piscivorous species <i>Conus pergrandis</i>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The fully folded peptide is 16 amino acids in length and has two disulfide bonds connecting Cys<sup>2</sup> to Cys<sup>8</sup> and Cys<sup>3</sup> to Cys<sup>16</sup>, which serve to keep the peptide in its stable and biologically active conformation (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Amino acid sequence and structure of PeIA and RP-HPLC of analogs containing non-natural amino acid residues. (A) The linear sequence of PeIA shown with the disulfide connectivity and Asn<sup>11</sup> as the line structure. (B) Cartoon rendition of the crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JME">5JME</a>, chain H)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(41)</a> of PeIA highlighting the position of Asn<sup>11</sup> (blue). (C) Side-chain structures of the non-natural amino acids Aad, Api, and Asu used in analog synthesis and corresponding RP-HPLC traces of the fully folded peptides. [Aad<sup>11</sup>]PeIA, [Api<sup>11</sup>]PeIA, and [Asu<sup>11</sup>]PeIA eluted at 37.5, 39.0, and 42.4% solvent B, respectively, using an ACN gradient of 10–50% in 40 min and a C18 analytical column.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previous structure–function studies of PeIA identified residues Ser<sup>9</sup> and Val<sup>10</sup> that when substituted with His and Ala, respectively, increase potency for rat α3β2 nAChRs expressed in <i>Xenopus laevis</i> oocytes.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, these changes also substantially increase PeIA activity on rat α6/α3β2β3 nAChRs. A second study identified substitutions that selectively decreased activity on α3β2 but preserved activity on α6/α3β2β3 nAChRs.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> An Asn<sup>11</sup> to Arg substitution was found to be critical for exploiting a nonconserved Lys<sup>152</sup>–Glu<sup>152</sup> difference between α3 and α6 subunits, respectively. These two studies provided the basis for using PeIA to interrogate ligand–receptor interactions and to inform the design and synthesis of selective antagonists of α3β2 nAChRs.</div><div class="NLM_p">Although some α-Ctxs show minor preferences for α3β2 over α6β2 nAChRs (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), there are currently no ligands that can be used to selectively inhibit the α3β2 subtype. Thus, one aim of this study was to develop a potent ligand that can distinguish between these two subtypes. To this end, we synthesized a number of PeIA analogs with single-residue substitutions to identify interactions that increased potency and/or selectivity for α3β2 nAChRs expressed in <i>X. laevis</i> oocytes. Novel peptides were then designed containing these identified amino acids and then assessed for α3β2 over α6/α3β2β3 nAChR selectivity. One peptide, PeIA-5466 (see <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), was ∼300-fold selective and displayed low nM potency for α3β2 nAChRs. The results of these studies demonstrate that ligands can be developed that are selective for α3β2 over α6β2 nAChRs. The novel peptides described herein may be useful for selectively identifying α3β2* in cells that express multiple nAChR subtypes, and particularly those that express α6β2* nAChRs. This is especially an issue in the MH-IPN tract and VTA dopaminergic projection neurons. In both cases, function within these tracts significantly influences addiction/dependence on nicotine (and other abused drugs), and α3β2* expression is found alongside that of α6β2* nAChRs.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Amino Acid Sequences and Potencies of Select α-Ctxs that Target α3β2 and α6/α3β2β3 nAChRs<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0009.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Residues highlighted in yellow are conserved among these α-Ctxs. IC<sub>50</sub> values are from electrophysiology experiments using <i>X. laevis</i> oocytes heterologously expressing cloned rat nAChRs; values in parentheses indicate the 95% confidence interval; selectivity was calculated as the IC50 ratio of (α6/α3β2β3)/(α3β2).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">This work.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis of PeIA Analogs Containing Non-natural Amino Acid Residues</h3><div class="NLM_p">Nonconserved residues of α3 and α6 subunits, including residue 152, have been shown to influence the potencies of certain α-conopeptides for α3β2 and α6/α3β2β3 nAChRs.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> In the α3 subunit, residue 152 is a Lys, whereas in α6, a Glu is present. Substituting Asn<sup>11</sup> with the positively charged amino acids Lys or Arg substantially reduced PeIA potency on α3β2, probably by creating an unfavorable charge–charge interaction between the ligand and the receptor. Thus, substituting Asn<sup>11</sup> with negatively charged amino acid was hypothesized to produce a favorable interaction with Lys<sup>152</sup> of the α3 subunit and an unfavorable interaction with Glu<sup>152</sup> of the α6 subunit. Therefore, we synthesized a series of PeIA analogs where Asn<sup>11</sup> was replaced with amino acids with negatively charged side chains. In addition to Asp and Glu, we also synthesized analogs with non-natural amino acids with longer, negatively charged side chains. These amino acids include α-aminoadipic acid (Aad), α-aminopimelic acid (Api), and α-aminosuberic acid (Asu). The side chains of these amino acids are one, two, and three carbons longer than Glu, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A–C). The linear peptides were synthesized using standard solid-phase peptide chemistry and Fmoc amino acids. To ensure that the disulfide bonds were formed correctly, Cys<sup>2</sup> and Cys<sup>8</sup> side chains were orthogonally protected by trityl and Cys<sup>3</sup> and Cys<sup>16</sup> by acetamidomethyl groups. The peptides were folded by removing the trityl groups with 20 mM potassium ferricyanide and 0.1 M Tris-HCl, forming the first disulfide bridge (Cys<sup>2</sup>–Cys<sup>8</sup>). Closure of the second disulfide bridge (Cys<sup>3</sup>–Cys<sup>16</sup>) was accomplished by iodine oxidation. The folded peptides were purified using reverse-phase high-performance liquid chromatography (RP-HPLC) and the masses determined using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) or electrospray ionization (ESI) mass spectrometry (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Yield, Purity, and Mass Spectrometry for Synthetic Peptides<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center" char=".">yield (nmol)</th><th class="colsep0 rowsep0" align="center">% purity</th><th class="colsep0 rowsep0" align="center" char=".">calculated M<sup>+</sup> Da</th><th class="colsep0 rowsep0" align="center" char=".">observed M<sup>+</sup> Da</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asn<sup>9</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">5569</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1678.63</td><td class="colsep0 rowsep0" align="char" char=".">1678.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Tyr<sup>9</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">3714</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1727.65</td><td class="colsep0 rowsep0" align="char" char=".">1727.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Thr<sup>9</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">3541</td><td class="colsep0 rowsep0" align="left">>97</td><td class="colsep0 rowsep0" align="char" char=".">1665.64</td><td class="colsep0 rowsep0" align="char" char=".">1665.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Ile<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2714</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1665.54</td><td class="colsep0 rowsep0" align="char" char=".">1665.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Nle<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">3643</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1665.54</td><td class="colsep0 rowsep0" align="char" char=".">1665.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Thr<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2742</td><td class="colsep0 rowsep0" align="left">>99</td><td class="colsep0 rowsep0" align="char" char=".">1653.60</td><td class="colsep0 rowsep0" align="char" char=".">1653.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asp<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">5311</td><td class="colsep0 rowsep0" align="left">>97</td><td class="colsep0 rowsep0" align="char" char=".">1652.61</td><td class="colsep0 rowsep0" align="char" char=".">1652.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Aad<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2591</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1680.63</td><td class="colsep0 rowsep0" align="char" char=".">1680.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Api<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">1637</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1694.63</td><td class="colsep0 rowsep0" align="char" char=".">1694.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asu<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">3957</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1708.63</td><td class="colsep0 rowsep0" align="char" char=".">1708.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Gla<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2014</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1695.61</td><td class="colsep0 rowsep0" align="char" char=".">1695.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asp<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">3440</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1637.61</td><td class="colsep0 rowsep0" align="char" char=".">1637.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Adi<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2244</td><td class="colsep0 rowsep0" align="left">>97</td><td class="colsep0 rowsep0" align="char" char=".">1665.63</td><td class="colsep0 rowsep0" align="char" char=".">1665.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asu<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">1809</td><td class="colsep0 rowsep0" align="left">>97</td><td class="colsep0 rowsep0" align="char" char=".">1693.63</td><td class="colsep0 rowsep0" align="char" char=".">1693.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Gln<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2571</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1650.64</td><td class="colsep0 rowsep0" align="char" char=".">1650.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Arg<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">1650</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1678.68</td><td class="colsep0 rowsep0" align="char" char=".">1678.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Arg<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2027</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1694.64</td><td class="colsep0 rowsep0" align="char" char=".">1694.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Val<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">1951</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1637.61</td><td class="colsep0 rowsep0" align="char" char=".">1637.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Ile<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">3749</td><td class="colsep0 rowsep0" align="left">>99</td><td class="colsep0 rowsep0" align="char" char=".">1651.62</td><td class="colsep0 rowsep0" align="char" char=".">1651.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Nle<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char=".">2774</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1651.62</td><td class="colsep0 rowsep0" align="char" char=".">1651.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-4769</td><td class="colsep0 rowsep0" align="char" char=".">5289</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1715.67</td><td class="colsep0 rowsep0" align="char" char=".">1715.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5106</td><td class="colsep0 rowsep0" align="char" char=".">5493</td><td class="colsep0 rowsep0" align="left">>96</td><td class="colsep0 rowsep0" align="char" char=".">1715.67</td><td class="colsep0 rowsep0" align="char" char=".">1715.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5115</td><td class="colsep0 rowsep0" align="char" char=".">7226</td><td class="colsep0 rowsep0" align="left">>97</td><td class="colsep0 rowsep0" align="char" char=".">1716.65</td><td class="colsep0 rowsep0" align="char" char=".">1716.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5080</td><td class="colsep0 rowsep0" align="char" char=".">1145</td><td class="colsep0 rowsep0" align="left">>96</td><td class="colsep0 rowsep0" align="char" char=".">1730.67</td><td class="colsep0 rowsep0" align="char" char=".">1730.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5415</td><td class="colsep0 rowsep0" align="char" char=".">2842</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1744.67</td><td class="colsep0 rowsep0" align="char" char=".">1744.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5355</td><td class="colsep0 rowsep0" align="char" char=".">1292</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1758.67</td><td class="colsep0 rowsep0" align="char" char=".">1758.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5587</td><td class="colsep0 rowsep0" align="char" char=".">3644</td><td class="colsep0 rowsep0" align="left">>97</td><td class="colsep0 rowsep0" align="char" char=".">1772.67</td><td class="colsep0 rowsep0" align="char" char=".">1772.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5413</td><td class="colsep0 rowsep0" align="char" char=".">3753</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1758.67</td><td class="colsep0 rowsep0" align="char" char=".">1758.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5416</td><td class="colsep0 rowsep0" align="char" char=".">2523</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1758.67</td><td class="colsep0 rowsep0" align="char" char=".">1758.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5466</td><td class="colsep0 rowsep0" align="char" char=".">2603</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="char" char=".">1758.67</td><td class="colsep0 rowsep0" align="char" char=".">1758.84</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">MALDI-TOF mass spectrometry was used to determine the masses of all peptides except for [Gla<sup>14</sup>]PeIA, which was determined using ESI mass spectrometry. RP-HPLC chromatograms for each of the peptides showing the purity are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00566/suppl_file/jm9b00566_si_001.pdf" class="ext-link">SI</a> Figure 2.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Function Studies Identify Ligand–Receptor Interactions That Are Critical for Activity on α3β2 nAChRs</h3><div class="NLM_p">To determine if PeIA analogs containing non-natural amino acid residues were active, we tested them on <i>X. laevis</i> oocytes heterologously expressing rat α3β2 or α6/α3β2β3 nAChRs. First, we tested analogs with N11D and N11E substitutions. [Asp<sup>11</sup>]PeIA showed a ∼3-fold loss of activity on α3β2, whereas [Glu<sup>11</sup>]PeIA retained activity compared to native PeIA (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). [Asp<sup>11</sup>]PeIA showed a similar loss of activity on α6/α3β2β3 receptors, but a more substantial loss of ∼7-fold was observed with [Glu<sup>11</sup>]PeIA (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Next, we evaluated PeIA analogs containing Aad, Api, or Asu in the 11th position. These substitutions systematically extend the length of the side chain bearing the carboxylic acid group, one carbon at a time. When tested on α3β2 receptors, [Aad<sup>11</sup>]PeIA, [Api<sup>11</sup>]PeIA, and [Asu<sup>11</sup>]PeIA all retained antagonist activity on α3β2 nAChRs but displayed different potencies. [Aad<sup>11</sup>]PeIA and [Asu<sup>11</sup>]PeIA showed minor losses of potency, whereas [Api<sup>11</sup>]PeIA retained the potency of native PeIA (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). By contrast, all three analogs showed substantially reduced activity on α6/α3β2β3 receptors and of them, [Aad<sup>11</sup>]PeIA showed the greatest loss of potency (∼500-fold) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PeIA analogs with negatively charged amino acid residues in position 11 show increased selectivity for α3β2 nAChRs. Analogs with substitutions of Asn<sup>11</sup> were synthesized and a concentration–response analysis was performed for each to determine the IC<sub>50</sub> values. The value obtained for each analog was compared to that of the native peptide (red dashed curves) to assess the effects of the substitution. (A) Analogs with Asp, Glu, or Api substitutions showed <3-fold change in potency for α3β2 nAChRs. Aad, with a one-carbon longer side chain than Glu and one-carbon shorter than Api, reduced PeIA potency by 6-fold. (B) By contrast, all analogs showed substantially reduced potency (6- to 274-fold) for α6/α3β2β3 nAChRs. The most α3β2-selective of these analogs was determined to be [Api<sup>11</sup>]PeIA (blue curve), which showed a 300-fold preference for the α3β2 subtype. A minimum of four oocytes was used for each IC<sub>50</sub> determination, and the error bars indicate the SD. The analogs are listed in rank order of potency from top (most potent) to bottom (least potent); values are presented in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values for PeIA and Analogs with Negatively Charged Amino Acid Substitutions of Asn<sup>11</sup><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="(">α3β2 nAChR</th><th class="rowsep1 colsep0" colspan="3" align="center">α6/α3β2β3 nAChR</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">log change in IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">log change in IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">selectivity ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA</td><td class="colsep0 rowsep0" align="char" char="(">19.4 (15.3–24.6)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">19.8 (17.9–21.8)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asp<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">54.0 (45.7–64.5)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">362 (215–611)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Glu<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">31.1 (27.0–36.0)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">114 (92.7–140)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Aad<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">123 (96.9–157)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">>2.7</td><td class="colsep0 rowsep0" align="char" char=".">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Api<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">18.1 (14.8–22.2)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.1</td><td class="colsep0 rowsep0" align="left">5432 (2809–10 500)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="char" char=".">300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asu<sup>11</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">44.4 (40.2–49.0)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">2605 (1628–4168)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="char" char=".">59</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values in parentheses indicate the 95% CI of the IC<sub>50</sub> values. Changes in potency were calculated as the log(analog IC<sub>50</sub>)/(PeIA IC<sub>50</sub>), negative values indicate increased potency and positive values indicate decreased potency. Selectivity was calculated as the IC<sub>50</sub> ratio of (α6/α3β2β3)/(α3β2).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> PeIA Analogs with Substitutions of Ser<sup>9</sup>, Val<sup>10</sup>, or Leu<sup>15</sup> Show Increased Potency for Inhibition of α3β2 nAChRs</h3><div class="NLM_p">The 300-fold selectivity of [Api<sup>11</sup>]PeIA greatly exceeds that of α-Ctx OmIA, the most α3β2-selective ligand reported to date.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The sequences of OmIA and PeIA differ by four residues in positions 9, 12, 14, and 15. In OmIA, these residues are Asn, Asn, His, and Ile. Another α3β2-selective α-Ctx, LvIA, also has Asn in the 9th position and Ile in the 15th position but shares with PeIA an Asn in the 11th position and a Glu in the 14th position. One or more of these amino acid differences probably contribute to the α3β2-selectivity of OmIA and LvIA. A second series of PeIA analogs was synthesized with various substitutions of Ser<sup>9</sup>, Val<sup>10</sup>, Glu<sup>14</sup>, and Leu<sup>15</sup> to determine if they might enhance selectivity for α3β2 over α6β2. First, analogs with substitutions of Ser<sup>9</sup> including [Thr<sup>9</sup>]PeIA, [Tyr<sup>9</sup>]PeIA, and [Asn<sup>9</sup>]PeIA were synthesized, and their potencies compared to that of the native peptide as well as the previously described analog [His<sup>9</sup>]PeIA.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> All three of these newly synthesized analogs showed a 2–3-fold change in potency for α3β2 nAChRs, substantially less than the 15-fold change observed for [His<sup>9</sup>]PeIA (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Next, we evaluated a number of Val<sup>10</sup>-substituted analogs incorporating amino acids with different hydrophobic side-chain lengths or charges. Analogs having amino acid residues with hydrophobic side chains all showed lower IC<sub>50</sub> values (3–6-fold) on α3β2 nAChRs, whereas substitution of Val<sup>10</sup> with Thr had very little effect (<3-fold change) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Next, Glu<sup>14</sup> was substituted with six natural and non-natural amino acids having different chemical properties to evaluate the effects of charge and side-chain length on PeIA potency. All amino acids with negatively charged side chains, except for γ-carboxyglutamic acid, produced a substantial loss of potency including Asp, Aad, Api, and Asu (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Similar losses of potencies were observed with E14Q and E14R substitutions. These results suggest that Glu<sup>14</sup> of PeIA is critical for the activity on α3β2 nAChRs. Finally, we evaluated analogs where Leu<sup>15</sup> was substituted with other hydrophobic amino acids or Arg. Both losses and increases in potency were observed with these substitutions. Isoleucine lowered the IC<sub>50</sub> value for the inhibition of α3β2 nAChRs by ∼3-fold, whereas Val and norleucine (Nle) had little or no effect (<3-fold change) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Alanine or Arg substitution, on the other hand, resulted in ∼8- and ∼40-fold increases, respectively, in the IC<sub>50</sub> value of PeIA. These results suggest that an Ile in position 15 is the most favorable hydrophobic amino acid for activity on α3β2 nAChRs.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure–function analysis of PeIA identifies amino acid substitutions that increase potency for α3β2 nAChRs. PeIA analogs with substitutions of Ser<sup>9</sup>, Val<sup>10</sup>, Glu<sup>14</sup>, or Leu<sup>15</sup> were synthesized and a concentration–response analysis was performed for each to determine the IC<sub>50</sub> values. The value for each analog was compared to that of the native peptide to evaluate the interaction between the substituted positions and α3β2 nAChRs. (A) Analogs with Asn, Tyr, or Thr substitutions of Ser<sup>9</sup> showed a <3-fold change in potency for α3β2 nAChRs. Substitution of Ser<sup>9</sup> with His increased the potency of PeIA by 15-fold. (B) Substitution of Val<sup>10</sup> with Ala increased (6-fold) PeIA potency, whereas other hydrophobic amino acids showed a <3-fold change but trended toward increased potency. Substitution with Thr also showed a <3-fold change. (C) Substitutions of Glu<sup>14</sup> revealed the importance of a Glu in this position for PeIA potency on α3β2 nAChRs. Substitution with any other negatively charged amino acid reduced potency by 3- to 10-fold. A <3-fold change in potency was observed by changing Glu to Gla. Substitution of Glu<sup>14</sup> with Gln or Arg reduced PeIA potency by 4- and 6-fold, respectively. (D) Varying effects on PeIA potency were observed when Leu<sup>15</sup> was substituted with other hydrophobic amino acids, whereas Ile increased PeIA potency by 3-fold, Ala reduced potency by 38-fold; Nle and Val produced a <3-fold change. Arg reduced PeIA potency by 8-fold. A minimum of four oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD. The analogs are listed in rank order of potency from top (most potent) to bottom (least potent); values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Data for PeIA (red dashed curves) were previously presented in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and shown for the ease of comparison to the curves of the analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub> Values for PeIA Analogs with Single Substitutions of His<sup>9</sup>, Val<sup>10</sup>, Glu<sup>14</sup>, and Leu<sup>15 </sup><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="(">α3β2 nAChR</th><th class="rowsep1 colsep0" colspan="3" align="center" char="(">α6/α3β2β3 nAChR</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">log change in IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">log change in IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">selectivity ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA</td><td class="colsep0 rowsep0" align="char" char="(">19.4 (15.3–24.6)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="(">19.8 (17.9–21.8)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[His<sup>9</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">1.30 (1.19–1.41)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–1.2</td><td class="colsep0 rowsep0" align="char" char="(">0.99 (0.93–1.05)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–1.3</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asn<sup>9</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">9.32 (8.32–10.4)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">–0.3</td><td class="colsep0 rowsep0" align="char" char="(">16.0 (12.8–20.0)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.1</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Tyr<sup>9</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">9.18 (7.67–11.0)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">–0.3</td><td class="colsep0 rowsep0" align="char" char="(">13.0 (9.0–18.9)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.2</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Thr<sup>9</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">7.10 (5.78–8.72)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">–0.4</td><td class="colsep0 rowsep0" align="char" char="(">5.12 (4.51–5.81)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.6</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Ala<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">3.37 (3.05–3.72)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.8</td><td class="colsep0 rowsep0" align="char" char="(">2.4 (2.0–2.7)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">–0.9</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Ile<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">11.8 (10.2–13.6)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.2</td><td class="colsep0 rowsep0" align="char" char="(">13.4 (10.9–16.6)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">–0.2</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Leu<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">10.6 (9.2–12.2)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.3</td><td class="colsep0 rowsep0" align="char" char="(">18.8 (16.0–22.1)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Nle<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">9.29 (7.99–10.8)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">–0.3</td><td class="colsep0 rowsep0" align="char" char="(">19.9 (17.3–23.0)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Thr<sup>10</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">24.5 (21.7–27.8)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="char" char="(">29.0 (23.7–36.2)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Gla<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">16.6 (15.1–18.4)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.1</td><td class="colsep0 rowsep0" align="char" char="(">28.5 (25.7–31.6)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asp<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">65.1 (44.9–94.4)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char="(">21.0 (16.6–26.5)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Adi<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">115 (88.9–148)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="char" char="(">29.2 (24.3–35.2)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Asu<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">155 (123–196)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="char" char="(">135 (107–171)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Gln<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">77.1 (57.8–1028)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="char" char="(">14.4 (11.7–17.6)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">–0.1</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Arg<sup>14</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">109 (83.9–141)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="char" char="(">7.40 (6.06–9.04)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.4</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Arg<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">161 (133–196)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="char" char="(">54.0 (33.1–88.1)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Ala<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">733 (522–1028)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="char" char="(">82.5 (63.5–107)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Val<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">40.9 (32.8–50.9)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="char" char="(">5.20 (4.40–6.14)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.6</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Ile<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">6.41 (5.51–7.46)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">–0.5</td><td class="colsep0 rowsep0" align="char" char="(">12.8 (10.5–15.5)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">–0.2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[Nle<sup>15</sup>]PeIA</td><td class="colsep0 rowsep0" align="char" char="(">21.1 (18.5–24.1)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="char" char="(">13.2 (10.9–15.9)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">–0.2</td><td class="colsep0 rowsep0" align="left">0.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Values in parentheses indicate the 95% CI of the IC<sub>50</sub> values. Changes in potency were calculated as the log(analog IC<sub>50</sub>)/(PeIA IC<sub>50</sub>), negative values indicate increased potency and positive values indicate decreased potency. Selectivity was calculated as the IC<sub>50</sub> ratio of (α6/α3β2β3)/(α3β2).</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> PeIA Analogs with Substitutions of Ser<sup>9</sup>, Val<sup>10</sup>, Glu<sup>14</sup>, or Leu<sup>15</sup> Show Decreased Potency for Inhibition of α6/α3β2β3 nAChRs</h3><div class="NLM_p">To determine if the PeIA analogs described above might produce a favorable change in the ability of PeIA to discriminate between the α3β2 and α6β2 subtypes, we determined the IC<sub>50</sub> values for the inhibition of α6/α3β2β3 and compared the changes to those observed for the α3β2 subtype. Changes in α6/α3β2β3 potency for analogs with substitutions of Ser<sup>9</sup> showed patterns similar to those for the α3β2 subtype. The IC<sub>50</sub> values of [Asn<sup>9</sup>]PeIA and [Tyr<sup>9</sup>]PeIA for α6/α3β2β3 nAChRs were similar to that of the native peptide (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Only [Thr<sup>9</sup>]PeIA showed a substantial change in potency (4-fold increase), relative to PeIA. A lack of change in PeIA potency was observed when analogs with substitutions of Val<sup>10</sup> were tested on α6/α3β2β3 nAChRs. The IC<sub>50</sub> values for [Leu<sup>10</sup>]PeIA, [Nle<sup>10</sup>]PeIA, [Ile<sup>10</sup>]PeIA, and [Thr<sup>10</sup>]PeIA were similar to that of native PeIA (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Similarly, analogs with substitutions of Glu<sup>14</sup> displayed equal potencies with native PeIA with the exception of [Asu<sup>14</sup>]PeIA, which produced a ∼7-fold loss of potency (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Analogs where Leu<sup>15</sup> was replaced with Val or Ile showed differential changes in potencies for α6/α3β2β3 relative to those for the α3β2 subtype, whereas the L15I substitution increased PeIA potency on α3β2, very little change (<3-fold) was observed for α6/α3β2β3 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The L15V substitution decreased the IC<sub>50</sub> value of PeIA for α6/α3β2β3 by 4-fold, whereas an increase was observed for the α3β2 subtype. Finally, like α3β2, α6/α3β2β3 nAChRs were substantially less sensitive to [Arg<sup>15</sup>]PeIA than the native peptide.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure–function analysis of PeIA identifies amino acid substitutions that decrease potency for α6/α3β2β3 nAChRs. A concentration–response analysis was performed for the newly synthesized PeIA analogs, and the IC<sub>50</sub> values compared to that of the native peptide and the IC<sub>50</sub> values for α3β2 nAChRs. (A) Analogs with substitutions of Ser<sup>9</sup> displayed changes in potencies similar to those for α3β2 nAChRs. [Thr<sup>9</sup>]PeIA displayed increased (4-fold) potency for α6/α3β2β3 nAChRs, whereas all others showed <3-fold change. Note that none of the Ser<sup>9</sup> substitutions changed α3β2-α6/α3β2β3 selectivity. (B) Very little change in potency was observed for the newly synthesized analogs with substitutions of Val<sup>10</sup>. (C) In contrast to the results obtained for α3β2 nAChRs, α6/α3β2β3 nAChRs were less sensitive to perturbations of the interaction between PeIA position 14 and the receptor. Of the analogs with other negatively charged amino acids, only [Asu<sup>14</sup>]PeIA showed a change in potency (7-fold loss). Substitution of Glu<sup>14</sup> with Gln showed a very little effect (<3-fold) on PeIA potency for α6/α3β2β3 nAChRs, whereas Arg reduced the IC<sub>50</sub> value by 3-fold. (D) Like α3β2, varying effects on PeIA potency were also observed for α6/α3β2β3 nAChRs when Leu<sup>15</sup> was substituted with other hydrophobic amino acids. Whereas the L15I substitutions increased the IC<sub>50</sub> value for α3β2, a <3-fold change was observed for α6/α3β2β3 nAChRs. The L15Nle substitution resulted in a <3-fold change in the IC<sub>50</sub>, whereas L15V decreased the IC<sub>50</sub> for α6/α3β2β3 nAChRs by 4-fold. A minimum of four oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD. The analogs are listed in rank order of potency from top (most potent) to bottom (least potent); values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Data for PeIA (red dashed curves) were previously presented in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and shown for the ease of comparison to the curves of the analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Novel Peptides Containing Substitutions of Ser<sup>9</sup>, Val<sup>10</sup>, Asn<sup>14</sup>, or Leu<sup>15</sup> Show Increased Potency and Selectivity for α3β2 nAChRs</h3><div class="NLM_p">The results obtained from the single-amino-acid-substituted analogs identified several residue substitutions that were favorable for α3β2 potency and selectivity. When combined, these favorable substitutions might generate peptides with enhanced selectivity for α3β2 over α6β2 nAChRs while maintaining high potency for the α3β2 subtype. Initially, we combined S9H and V10L substitutions to generate the peptide PeIA-4769. These two combined substitutions produced a peptide that was 68-fold more potent than PeIA on α3β2 nAChRs but only 19-fold more potent on α6/α3β2β3 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). PeIA-4769 was, therefore, used as the initial high potency peptide to incorporate negatively charged amino acids in the 11th position to confer selectivity for α3β2 over α6/α3β2β3 nAChRs. Five derivatives of PeIA-4769 were synthesized containing Asp, Glu, Aad, Api, or Asu in the 11th position and of them, PeIA-5355, containing Api<sup>11</sup>, showed the most substantial separation (∼59-fold) between the IC<sub>50</sub> values for α3β2 and α6/α3β2β3 nAChRs (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). PeIA-5415 and PeIA-5587, containing Asu<sup>11</sup> and Aad<sup>11</sup>, respectively, were also substantially more potent on α3β2 nAChRs by 52- and 39-fold, respectively. Next, a 6th PeIA-4769-based peptide was synthesized containing an Ile in the 15th position and evaluated for α3β2-selectivity. The resulting peptide, PeIA-5106, displayed pM potency on both α3β2 and α6/α3β2β3 subtypes (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), but no additional increase in selectivity for α3β2 was found over PeIA-4769. However, when Ile<sup>15</sup> was combined with Api<sup>11</sup> to produce PeIA-5413, a ∼100-fold increase in selectivity for α3β2 over α6/α3β2β3 was obtained, relative to PeIA-5106 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). These somewhat surprising results with Ile<sup>15</sup> in combination with His<sup>9</sup>, Leu<sup>10</sup>, and Api<sup>11</sup> prompted us to synthesize a final pair of peptides by incorporating a Nle in the 10th position of PeIA-5355. The first Nle<sup>10</sup>-containing peptide, PeIA-5416, displayed a ∼160-fold increase in the selectivity for α3β2 over PeIA-5355. Finally, PeIA-5466 was synthesized containing His<sup>9</sup>, Nle<sup>10</sup>, Api<sup>11</sup>, and Ile<sup>15</sup> residues and was found to be ∼300-fold more potent on α3β2 than α6/α3β2β3 nAChRs. Furthermore, the peptide displayed high potency for inhibition of α3β2 with an IC<sub>50</sub> value of 1.34 (1.13–1.60) nM.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Novel peptides containing the non-natural amino acids Aad, Api, or Asu show enhanced selectivity for α3β2 over α6/α3β2β3 nAChRs. Based on the structure–activity results with PeIA, a series of peptides were synthesized and a concentration–response analysis was performed for each to determine the IC<sub>50</sub> values for the inhibition of α3β2 and α6/α3β2β3 nAChRs as well as the selectivity ratio. (A) The first peptide synthesized, PeIA-4769, shares many of the residues found in PeIA (see <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) but has His and Leu residues in positions 9 and 10, respectively. PeIA-4769 was 68-fold more potent (blue curve) than PeIA on α3β2 nAChRs. Five additional peptides, based on PeIA-4769, were synthesized containing non-natural amino acid residues in position 11 and of them PeIA-5355, with Api in position 11, was the most potent (pM IC<sub>50</sub> value) on α3β2 nAChRs. (B) The IC<sub>50</sub> values for the peptides in (A) were determined for the inhibition of α6/α3β2β3 nAChRs and the α3β2-α6/α3β2β3 selectivity ratios calculated. PeIA-4769 was also potent (nM IC<sub>50</sub> value, blue curve) α6/α3β2β3 nAChRs. PeIA-5355 displayed the highest selectivity ratio (59-fold) for α3β2 and α6/α3β2β3 nAChRs. Selectivity ratios of 52- and 39-fold were also observed with PeIA-5415 and PeIA-5587, respectively. A minimum of four oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD; values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PeIA-5466 is potent and highly selective for α3β2 over α6/α3β2β3 nAChRs. Peptides based on PeIA-4769 and PeIA-5355 were synthesized with different residues in the 10th and 15th positions and a concentration–response analysis was performed for each. The IC<sub>50</sub> values for inhibition of α3β2 and α6/α3β2β3 nAChRs for each peptide were compared to those of PeIA and the α3β2-α6/α3β2β3 selectivity ratio calculated. (A, B) PeIA-5106 and PeIA-5416 were synthesized to evaluate the effects of Nle<sup>10</sup> and Ile<sup>15</sup>, respectively, on α3β2-α6/α3β2β3 nAChR selectivity. PeIA-5106 was 69-fold more potent than PeIA on α3β2 nAChRs, but only a minor increase (3-fold) in α3β2-α6/α3β2β3 selectivity, over PeIA-4769, was found. PeIA-5416 with Ile<sup>15</sup>, was 220-fold selective for α3β2 nAChRs. An additional 70-fold enhancement of selectivity was obtained with PeIA-5466 (red curves). A minimum of 4 oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD; values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. IC<sub>50</sub> Values for α3β2-Selective Peptides<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="(">α3β2 nAChR</th><th class="rowsep1 colsep0" colspan="2" align="center" char="(">α6/α3β2β3 nAChR</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">residue differences with PeIA</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-4769</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup></td><td class="colsep0 rowsep0" align="char" char="(">0.29 (0.25– 0.34)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">1.04 (0.921–1.18)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5115</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup>,Asp<sup>11</sup></td><td class="colsep0 rowsep0" align="char" char="(">1.67 (1.44–1.95)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">19.9 (17.8–22.3)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5080</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup>,Glu<sup>11</sup></td><td class="colsep0 rowsep0" align="char" char="(">1.22 (1.06–1.40)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">16.2 (13.3–19.8)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5415</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup>,Aad<sup>11</sup></td><td class="colsep0 rowsep0" align="char" char="(">3.01 (2.40–3.78)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="(">155 (122–197)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5355</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup>,Api<sup>11</sup></td><td class="colsep0 rowsep0" align="char" char="(">0.38 (0.36–0.44)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">22.3 (19.9–24.9)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5587</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup>,Asu<sup>11</sup></td><td class="colsep0 rowsep0" align="char" char="(">1.28 (1.06–1.54)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">50.3 (40.4–62.7)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5106</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup>,Ile<sup>15</sup></td><td class="colsep0 rowsep0" align="char" char="(">0.28 (0.23–0.33)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="(">0.86 (0.77–0.96)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5413</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Leu<sup>10</sup>,Api<sup>11</sup>,Ile<sup>15</sup></td><td class="colsep0 rowsep0" align="char" char="(">0.57 (0.44–0.74)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">58.2 (51.4–65.8)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">102</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5416</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Nle<sup>10</sup>,Api<sup>11</sup></td><td class="colsep0 rowsep0" align="char" char="(">1.33 (1.17–1.53)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="(">286 (220–373)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">220</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5466</td><td class="colsep0 rowsep0" align="left">His<sup>9</sup>,Nle<sup>10</sup>,Api<sup>11</sup>,Ile<sup>15</sup></td><td class="colsep0 rowsep0" align="char" char="(">1.34 (1.13–1.60)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">377 (275–508)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">290</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Values in parentheses indicate the 95% CI of the IC<sub>50</sub> values. IC<sub>50</sub> ratio calculated as (α6/α3β2β3)/(α3β2).</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub> Values for α3β2-Selective Peptides on Other nAChRs Subtypes<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="(">α3β4</th><th class="rowsep1 colsep0" colspan="3" align="center" char="(">α4β2</th><th class="rowsep1 colsep0" colspan="3" align="center" char="(">α6/α3β4</th><th class="rowsep1 colsep0" colspan="3" align="center" char="(">α7</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ratio</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ratio</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ratio</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5355</td><td class="colsep0 rowsep0" align="char" char="(">501 (425–592)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1329</td><td class="colsep0 rowsep0" align="char" char="(">280 (251–313)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">742</td><td class="colsep0 rowsep0" align="char" char="(">43.1 (37.5–49.6)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">114</td><td class="colsep0 rowsep0" align="char" char="(">31.6 (29.2–34.3)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5413</td><td class="colsep0 rowsep0" align="char" char="(">341 (317–366)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">595</td><td class="colsep0 rowsep0" align="char" char="(">572 (501–652)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">998</td><td class="colsep0 rowsep0" align="char" char="(">77.3 (57.3–104)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="char" char="(">34.5 (28.8–41.4)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5416</td><td class="colsep0 rowsep0" align="char" char="(">168 (155–201)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">129</td><td class="colsep0 rowsep0" align="char" char="(">1930 (1520–2451)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1461</td><td class="colsep0 rowsep0" align="char" char="(">120 (102–141)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char="(">18.7 (14.5–24.2)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PeIA-5466</td><td class="colsep0 rowsep0" align="char" char="(">380 (344–419)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">292</td><td class="colsep0 rowsep0" align="char" char="(">2066 (1666–2563)</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">1615</td><td class="colsep0 rowsep0" align="char" char="(">205 (164–257)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">158</td><td class="colsep0 rowsep0" align="char" char="(">15.0 (12.1–18.5)</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Values in parentheses indicate the 95% CI of the IC<sub>50</sub> values. IC<sub>50</sub> ratio calculated as (nAChR subtype)/(α3β2).</p></div></div></div><div class="NLM_p">We also examined the kinetics of PeIA-5466 for the inhibition of the ACh responses and their recovery. Oocytes expressing α3β2 or α6/α3β2β3 nAChRs were continuously perfused with 10 nM PeIA-5466 until a steady-state level of inhibition was observed (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B). The data were analyzed to determine the observed inhibitory rate-constant (<i>k</i><sub>obs</sub>) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). The <i>k</i><sub>obs</sub> for α3β2 nAChRs was 0.617 ± 0.023 min<sup>–1</sup>. The kinetics for the inhibition of α6/α3β2β3 nAChRs was more rapid such that <i>k</i><sub>obs</sub> could not be determined under the conditions used in this study. The ACh responses in oocytes expressing α3β2 or α6/α3β2β3 nAChRs in the presence of 10 nM PeIA-5466 were inhibited to 8 ± 1% (<i>n</i> = 5) and 90 ± 4% (<i>n</i> = 6) of control values, respectively (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). To determine the kinetics for the recovery of the ACh responses, in a separate set of experiments oocytes expressing α3β2 nAChRs were perfused with 100 nM PeIA-5466 until a steady-state level of inhibition was achieved, then the peptide was washed out, and the responses monitored for recovery (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>E). The off-rate constant (<i>k</i><sub>off</sub>) was determined to be 0.065 ± 0.001 min<sup>–1</sup>, and the <i>t</i><sub>1/2</sub> for recovery was 10.6 (10.2–11.0) min (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>F).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Kinetic analysis of PeIA-5466 for α3β2 and α6/α3β2β3 nAChRs. <i>Xenopus</i> oocytes expressing α3β2 or α6/α3β2β3 nAChRs were subjected to TEVC electrophysiology as described in <a class="ref internalNav" href="#sec4_1" aria-label="Methods">Methods</a>. (A) Representative current traces from an oocytes expressing α3β2 nAChRs before, during, and after exposure to 10 nM PeIA-5466. (B) Representative current traces from an oocyte expressing α6/α3β2β3 nAChRs before, during, and after exposure to 10 nM PeIA-5466. (C) The exponential fit of the data for the inhibition of α3β2 nAChRs yielded a <i>k</i><sub>obs</sub> of 0.617 ± 0.023 min<sup>–1</sup> and a <i>t</i><sub>1/2</sub> of 1.1 (1.0–1.2) min. (C, D) The current amplitudes in the presence of 10 nM PeIA-5466 were inhibited to 8 ± 1% (<i>n</i> = 5, SD) of control values for α3β2 nAChRs and to 90 ± 4% (<i>n</i> = 6, SD) of control values for α6/α3β2β3 nAChRs. (E) Representative current traces from an oocyte expressing α3β2 nAChRs showing the inhibition and recovery kinetics during and after exposure to 100 nM PeIA-5466. The current amplitudes in the presence of 100 nM peptide were inhibited to 2 ± 1% (<i>n</i> = 4, SD) of control values. (F) The exponential fit of the data for recovery from inhibition yielded an observed off-rate constant (<i>k</i><sub>off</sub>) of 0.065 ± 0.001 min<sup>–1</sup> and a <i>t</i><sub>1/2</sub> for recovery of 10.6 (10.2–11.0) min. The <i>K</i><sub>d</sub> was determined to be 1.18 ± 0.47 nM. The 30 s traces in A, B, and E are shown concatenated omitting the 30 s intersweep interval for brevity. The error bars in (C, D, and F) indicate the SD. The <i>K</i><sub>d</sub> was calculated from <i>K</i><sub>d</sub> = <i>k</i><sub>off</sub>/<i>k</i><sub>on</sub> where <i>k</i><sub>on</sub> = (<i>k</i><sub>obs</sub> – <i>k</i><sub>off</sub>)/[ligand].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Selectivity Profiles of PeIA-5466 and Related Peptides for Other nAChR Subtypes</h3><div class="NLM_p">To determine if PeIA-5466 and the related Api-containing peptides interacted with other nAChR subtypes, we tested the peptides on a panel of nAChRs subtypes including α3β4, α4β2, α6/α3β4, and α7 nAChRs. The α3β4 and α6β4 subtypes may potentially be expressed with α3β2 in neurons of the PNS and have overlapping sensitivities to ligands, whereas α4β2 and α7 are widely expressed in both the CNS and periphery. All four (PeIA-5355, −5413, −5416, and −5466) of the Api-containing peptides displayed IC<sub>50</sub> values for α3β4 that were >100-fold higher than those for α3β2 nAChRs (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A–D; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The potency of PeIA-5355, in particular, was 1329-fold lower for α3β4 nAChRs. Similarly, all peptides were substantially less potent on α4β2 nAChRs with PeIA-5466 being the least potent (IC<sub>50</sub> 1600 higher for α4β2 than that for α3β2 nAChRs). Moderate potency was observed for α6/α3β4 with the least potent being PeIA-5466 (IC<sub>50</sub> value ∼160-fold higher than for α3β2). Finally, α7 nAChRs displayed varying sensitivities to the four analogs. PeIA-5355 and PeIA-5466 were the least and most potent, respectively.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Selectivity profiles of peptides containing non-natural amino acid residues. (A–D) The IC<sub>50</sub> values of PeIA-5106, PeIA-5413, PeIA-5416, and PeIA-5466 were determined for a panel of nAChR subtypes including α3β4, α4β2, α6/α3β4, and α7. PeIA-5355 displayed the largest selectivity ratio for α3β2 and α3β4 subtypes (1329-fold). PeIA-5466 displayed the largest selectivity ratio between α3β2 nAChRs and both α4β2 and α6/α3β4 subtypes. A minimum of four oocytes was used for each IC<sub>50</sub> curve with the exception of those for α3β4 where three oocytes were used. The exceptionally slow on-rate kinetics of all peptides for α3β4 nAChRs required 45–60 min to reach equilibrium using a concentration of 1 μM (data not shown). Two successive applications of 10 μM were then applied immediately after the equilibrium was achieved with 1 μM. The long perfusion time required for concentrations <300 nM exceeded practical recording times and only a few data points were obtained (<3). The error bars indicate the SD; values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. Data for α3β2 nAChRs (dashed red curves) were previously presented in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and shown for the ease of comparison to the curves for other subtypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The α3β2 nAChR subtype has been challenging to study pharmacologically. To date, no ligands have been reported, either agonists or antagonists, that interact with α3β2 with a sufficient margin of selectivity to allow distinguishing α3β2 from α6β2 nAChRs. In fact, naturally occurring ligands that inhibit α3β2 almost invariably interact with α6β2 nAChRs with similar affinity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This lack of α3β2-selective ligands has hampered the investigation of the functional role of this receptor in regions of the CNS where α6β2* subtypes are prominently expressed. To give one example, α-Ctx MII-sensitive nAChRs located on the terminals of SN/VTA dopamine projection neurons are thought to be mostly α6β2* nAChR.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> Because of this relative simplicity, the relevance of α6β2*-nAChR in these dopaminergic projections to nicotine (and other drug) use, salience, and movement disorders has been well established using MII in both rodents and non-human primate models.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> By contrast, α3β2* nAChR expression overlaps with that of α6β2* nAChR in VTA dopaminergic cell bodies, and the relative roles and/or importance of each subtype in VTA-driven behaviors is not known. To give a second example with relevance to nicotine dependence/drug addiction, the MH-IPN pathway contains the highest density of α3β2* nAChRs within the brain,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> but this compact tract contains a bewildering variety of other nAChR subtypes, including closely related α3β4* and α6* nAChR subtypes. Distinguishing the roles of α3β2* and other nAChR subtypes, and the circuits through which they exert their influence, within the MH, IPN, and the network of regions with which they communicate will require the use of highly selective ligands such as those developed in this study. As a third example, in the PNS superior cervical ganglion neurons have been shown, through gene-knock out and immunoprecipitation studies, to express a number of α3-containing subtypes including α3β4*, α3β4α5, and α3β2β4* subtypes,<a onclick="showRef(event, 'ref7 ref23'); return false;" href="javascript:void(0);" class="ref ref7 ref23">(7,23)</a> but a pharmacological dissection of the role each subtype plays in the physiology of these neurons has been challenging.</div><div class="NLM_p">α-Conotoxins OmIA and LvIA show some preference for α3β2 over α6/α3β2β3 nAChRs, but the most α3β2-selective of the two, OmIA, shows only an 18-fold preference and, therefore, does not possess a selectivity ratio sufficiently large to permit unequivocal pharmacological identification; an IC<sub>50</sub> concentration for α3β2 would be expected to inhibit 10–20% of the response from α6β2 nAChRs.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> OmIA does, however, distinguish well between α3β2 and α3β4 nAChRs. LvIA, on the other hand, does not distinguish α3β2 from α3β4, α6β2, or α6β4 subtypes (selectivity ratios <20).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Additionally, most pharmacological characterizations of ligands are performed using heterologous receptor expression systems, but the IC<sub>50</sub> values for heterologously vs natively expressed nAChRs can differ by 3–5-fold potentially narrowing the selectivity ratio.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Thus, ligands with selectivity ratios of at least 100-fold are desirable and 300-fold preferred.</div><div class="NLM_p">Native PeIA is a moderately potent antagonist of α3β2 and α6/α3β2β3 nAChRs (IC<sub>50</sub> ∼ 20 nM for both) as well as the α9α10 subtype (IC<sub>50</sub> ∼ 30 nM)<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> but also inhibits α6β4 and α3β4 subtypes at higher concentrations (IC<sub>50</sub> ∼ 130 nM and ∼ 1.6 μM, respectively).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Like OmIA, PeIA shows some preferences for α3 and α6 subtypes containing β2 subunits over those with β4 subunits, but again the overlapping potencies make it difficult to distinguish α3β2 nAChRs from these other subtypes using PeIA. Previous structure–function analyses of PeIA identified residues that are important for activity, and that can be substituted to enhance potency and selectivity for α3β2 and α6β2 over the closely related α3β4 and α6β4 subtypes.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> A peptide was synthesized containing His<sup>9</sup>, Ala<sup>10</sup>, and Asn<sup>14</sup> residues that showed a ∼65-fold increase in potency for α3β2 and α6/α3β2β3 and a ∼230- and ∼1600-fold decrease in potency for α6/α3β4 and α3β4 nAChRs, respectively. Subsequent analyses demonstrated that A7V, N11R, and E14A substitutions substantially decreased PeIA activity on α3β2 receptors but had minimal or no impact on α6/α3β2β3 potency.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Iterative substitution of native α-Ctx sequences has been a successful strategy for generating a number of nAChR subtype-selective peptides<a onclick="showRef(event, 'ref12 ref13 ref14 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36">(12−14,27−36)</a> and could potentially be effective for developing the first α3β2-selective antagonist.</div><div class="NLM_p">Position 11 of PeIA has been shown to be important for conferring selectivity for α6/α3β2β3 over α3β2 when a positively charged residue is present probably, because this position interacts with a key Lys vs Glu residue difference between α3 and α6 subunits, respectively.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> The chemical characteristics (side-chain length and charge) of the non-natural amino acids used in this study have been critically important in allowing us to exploit this α3−α6 subunit difference. Although it is true that the use of non-natural amino acids can allow the introduction of completely different functional groups, this particular study illustrates that the major advantage afforded by this approach is the ability to systematically “fine tune” ligand–receptor interactions at critical positions by incorporating residues with minor differences in chemical properties. In this example, the non-natural amino acids, Adi, Api, and Asu, employed at position 11 differ, by units of one, in the number of carbon atoms in their side chains (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). When we replaced Asn<sup>11</sup> with negatively charged amino acids, the resulting analogs showed minor reductions in potency for α3β2 with the exception of [Glu<sup>11</sup>]PeIA and [Api<sup>11</sup>]PeIA, which retained potency of the native peptide (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). By contrast, all showed substantially less activity on α6/α3β2β3 nAChRs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The most favorable change in selectivity was observed with the analog [Api<sup>11</sup>]PeIA, which showed a ∼300-fold preference for α3β2 over α6/α3β2β3 nAChRs. We note that [Api<sup>11</sup>]PeIA is substantially more selective than the most α3β2-selective α-Ctxs previously reported (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). These results show definitively that the side-chain length of the residue found in position 11 of PeIA is a critical factor for optimizing charge–charge interaction with Lys<sup>152</sup> of the α3 subunit.</div><div class="NLM_p">Further insights were found from the use of amino acids with minor differences in chemical properties when we substituted residues in the 9th, 10th, 14th, and 15th positions. We found that when Ser<sup>9</sup> was substituted with Tyr, Asn, or Thr, favorable effects on PeIA potency for α3β2 were observed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). However, only Thr increased potency for α6/α3β2β3 nAChRs (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). When PeIA Val<sup>10</sup> was substituted with other hydrophobic amino acids, small changes, that trended toward increased potency, for α3β2 were observed with [Ala<sup>10</sup>]PeIA, [Ile<sup>10</sup>]PeIA, [Leu<sup>10</sup>]PeIA, and [Nle<sup>10</sup>]PeIA (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). None of these analogs substantially changed the IC<sub>50</sub> value for α6/α3β2β3 nAChRs (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) except for Ala, as previously reported.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In the case of position 14, the substitution of Glu with any other negatively charged amino acid, with the exception of γ-carboxyglutamic acid, resulted in a 3- to 10-fold loss of potency for α3β2 nAChRs. Replacement of Glu<sup>14</sup> with Gln and Arg was also detrimental for PeIA potency (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). These results suggest a critical role for Glu<sup>14</sup> in the activity of PeIA on α3β2 nAChRs. By contrast, Glu<sup>14</sup> appears to be less important for α6/α3β2β3 nAChRs, which tolerated all amino acid substitutions except Asu (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The interaction between PeIA and α3β2 was also more sensitive to perturbation than α6/α3β2β3 nAChRs when Leu<sup>15</sup> was replaced with other hydrophobic amino acids. The substitution of Leu<sup>15</sup> with Ala resulted in a ∼36-fold loss of PeIA potency for α3β2 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) but only a ∼4-fold loss for α6/α3β2β3 nAChRs (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The L15V substitution resulted in a 3-fold loss of potency for α3β2 but a ∼4-fold increase for α6/α3β2β3 nAChRs. Finally, the L15I substitution selectively decreased the IC<sub>50</sub> value for α3β2, whereas L15Nle had no effect on potency for either subtype. The importance of a hydrophobic residue in position 15 was assessed by replacing Leu with Arg, which substantially reduced PeIA potency for both subtypes. These results suggest that the side-chain length as well as hydrophobicity are important determinants of the interaction between position 15 of PeIA and its nAChR targets. In summary, the ability to access expanded chemical spaces using natural and non-natural amino acids allowed us to further identify interactions that could be exploited to improve α3β2* nAChR selectivity of PeIA and related peptides. However, the advantage was (perhaps unsurprisingly) not as substantial in these other positions as at the absolutely critical position 11.</div><div class="NLM_p">From the substitutions listed in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, we selected those that displayed the most favorable changes in potency or selectivity for α3β2 nAChRs to combine with negatively charged amino acid substitution of Asn<sup>11</sup>. Two amino acid residues, namely, His<sup>9</sup> and Val<sup>10</sup>, produced the peptide PeIA-4769 that was 68-fold more potent on α3β2 than PeIA (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). PeIA-4769 was also highly potent on the α6/α3β2β3 subtype (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Given the high potency of PeIA-4769, we used the sequence of this peptide as a platform to design novel ligands with non-natural amino acid residues to enhance selectivity for the α3β2 subtype. Substantial gains in selectivity were achieved with each of the PeIA-4769-derived peptides containing non-natural amino acid residues in position 11 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Of them, PeIA-5355 displayed the greatest preference (∼59-fold) for α3β2 over the α6/α3β2β3 nAChRs. PeIA-5415 and PeIA-5587 also showed ∼52- and ∼39-fold preferences, respectively, for the α3β2 subtype.</div><div class="NLM_p">Small differences in the side chains of residues in certain positions can affect the potency of PeIA for α3β2 and α6/α3β2β3 nAChRs. Speculatively, this may suggest that the additional substitutions allow for further fine tuning of the critical interaction between the residue in position 11 and the competitive binding pocket of the α3β2 nAChR. Guided by this principle, we synthesized four additional peptides containing different combinations of His<sup>9</sup>, Nle<sup>10</sup>, Api<sup>11</sup>, and Ile<sup>15</sup> residues to gain a more complete picture of the interaction between peptide ligands and α3β2 nAChRs. Interestingly, in contrast to the lower IC<sub>50</sub> value of [Ile<sup>15</sup>]PeIA for α3β2 nAChRs, compared to native PeIA, PeIA-5106, also with Ile<sup>15</sup>, showed no difference in potency compared to PeIA-4769. However, when we combined His<sup>9</sup>, Leu<sup>10</sup>, and Api<sup>11</sup> with Ile<sup>15</sup>, the resulting peptide, PeIA-5413, displayed a ∼100-fold increase in the selectivity for α3β2 over α6/α3β2β3 nAChRs, compared to PeIA-4769 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Furthermore, PeIA-5413 retained pM potency for α3β2 nAChRs. Therefore, we next reassessed the effects of introducing a Nle in position 10 by synthesizing PeIA-5416. Strikingly, this peptide displayed a ∼220-fold preference for α3β2 over α6/α3β2β3 nAChRs, which represents a 100-fold increase in α3β2-selectivity over PeIA-5413. Finally, PeIA-5466 was synthesized containing His<sup>9</sup>, Nle<sup>10</sup>, Api<sup>11</sup>, and Ile<sup>15</sup> residues and displayed an IC<sub>50</sub> of 1.34 nM for α3β2 nAChRs. This value is ∼300-fold lower than that for α6/α3β2β3 nAChRs. These results, obtained by fine tuning the interactions at positions 10 and 15, again demonstrate that minor differences in the chemical properties of residue side chains in key positions can have substantial effects on the ligand activity. Kinetic studies were also performed to examine the binding affinity of PeIA-5466 for α3β2 nAChRs, and a <i>K</i><sub>d</sub> value in the 700–1600 pM range was obtained (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Thus, to our knowledge, PeIA-5466 is the most potent and selective α3β2 antagonist heretofore reported.</div><div class="NLM_p">The pharmacological profiles of the most highly optimized α3β2 nAChR selective peptides are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. One significant advantage of examining multiple, closely related, peptides is that it is possible to select those with optimal properties for specific applications. For example, PeIA-5355 is exceptionally selective for α3β2 over α3β4 nAChRs, displaying and IC<sub>50</sub> value 1329-fold lower for α3β2 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). This peptide may be particularly useful for distinguishing α3β2 from α3β4 nAChRs in the PNS where both subtypes are prominently expressed. The same is true in, for example, the MH-IPN tract. In addition to these properties, PeIA-5355 shows the highest selectivity of the final set of peptides against α7 nAChRs (84-fold). This all-round selectivity profile is likely to make it particularly valuable in, for example, in vivo infusion experiments where additional pharmacological manipulations may be difficult or impossible to apply. By contrast, PeIA-5466 has better absolute selectivity for α3β2 over α6/α3β2β3 nAChRs than does PeIA-5355 while retaining nearly 300-fold selectivity against α3β4 nAChR. Although this performance comes at the expense of poor selectivity (only 12-fold) against α7-nAChR, this would be less important in an in vitro assay context where α7 nAChRs can be selectively inhibited by a number of available antagonist including analogs of α-Ctx ArIB<a onclick="showRef(event, 'ref31 ref37'); return false;" href="javascript:void(0);" class="ref ref31 ref37">(31,37)</a> or the three-fingered serpent toxins from <i>Bungurus multicinctus</i> or <i>Naja</i> cobra species.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> As a further example, for distinguishing α3β2 from α4β2 nAChRs, PeIA-5466 is the best ligand, displaying a 1615-fold preference for the α3β2 subtype (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). A high selectivity ratio may be critical for identifying α3β2* nAChRs in the CNS where a significant majority of the nAChR population is of the α4β2* subtype.</div><div class="NLM_p last">In this report, we describe the synthesis and characterization of a series of peptide antagonists with high selectivity for rat α3β2 over α6/α3β2β3 nAChRs. Although some previously identified α-Ctxs show minor preferences for α3β2 nAChRs (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), none of them possesses a selectivity margin sufficiently large enough to facilitate distinguishing α3β2 from α6β2 nAChRs pharmacologically. The development of PeIA-5466 and related peptides represents the first set of ligands, to our knowledge, which display such capabilities and may enable the selective study of α3β2 nAChRs. Importantly, these antagonists and other α3β2-selective ligands such as positive allosteric modulators<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> may be useful for defining the functional roles of α3β2* in CNS circuitry involved in nicotine/tobacco dependence where closely related α3β4* and α6β2* subtypes are also present.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Materials</h3><div class="NLM_p last">Acetylcholine chloride (Cat# A6625), potassium chloride (Cat# P3911), and bovine serum albumin (Cat# A2153) were purchased from Sigma Aldrich (St. Louis, MO). Sodium chloride (Cat# S271), calcium chloride dihydrate (Cat# C79), magnesium chloride hexahydrate (Cat# M33), sodium hydroxide (Cat# S313), and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Cat# BP310) were purchased from Fisher Scientific (Pittsburg, PA).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Peptide Synthesis</h3><div class="NLM_p last">Solid-phase Fmoc peptide chemistry and an Apex 396 automated peptide synthesizer (AAPPTec, Louisville, KY) were used to synthesize all peptides. The peptides were initially constructed on a preloaded Fmoc-Rink Amide MBHA resin (substitution: 0.4 mmol/g; Peptides International Inc.; Louisville, KY). All standard amino acids were purchased from AAPPTec except for <i>N</i>-Fmoc-<span class="smallcaps smallerCapital">l</span>-γ-carboxyglutamic acid, γ-di-<i>t</i>-butyl ester (γ; Gla; Advanced ChemTech, Louisville, KY), Fmoc-<span class="smallcaps smallerCapital">l</span>- and norleucine (Nle) were purchased from EMD Millipore (Burlington, MA). Fmoc-<span class="smallcaps smallerCapital">l</span>-2-aminohexanedioic acid δ-<i>tert</i>-butyl ester (Aad) and (<i>S</i>)-Fmoc-2-aminopimelic acid-7-<i>tert</i>-butyl ester (Api) were purchased from Chem-Impex International, Inc. (Wood Dale, IL), (2<i>S</i>)-2-[[(9<i>H</i>-fluoren-9-ylmethoxy)carbonyl]amino]-octanedioic acid-8-(<i>tert</i>-butyl) ester (Asu) was purchased from W&J PharmaChem, Inc. (Silver Spring, MD). Side-chain protection for the following amino acids was as follows: Arg, 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl; Lys, <i>tert-</i>butyloxycarbonyl Hyp; Asn, Gln, and His, trityl; Ser, Gla, Aad, Api, Asu, Asp, and Glu <i>tert</i>-butyl. Cys residues were orthogonally protected by trityl for Cys<sup>2</sup> and Cys<sup>8</sup> and acetamidomethyl for Cys<sup>3</sup> and Cys<sup>16</sup>. The peptides were synthesized at 50 μmol scale. Coupling activation was achieved with 1 equiv of 0.4 M benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate and 2 equiv of 2 M <i>N</i>,<i>N</i>-diisopropylethylamine in <i>N</i>-methyl-2-pyrrolidone as the solvent. For standard amino acid coupling reactions, a 10-fold molar excess of amino acid was used, and the reaction was carried out for 60 min at room temperature. For nonstandard amino acids, including Asu, Api, and Aad, a 3-fold molar excess was used and a 5-fold excess for Gla and Nle. Coupling reactions for the nonstandard amino acids were extended to 90 min. The Fmoc-deprotection step was performed twice with 20% (v/v) piperidine in dimethylformamide for 5 and then 15 min.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cleavage and Purification of PeIA-5466</h3><div class="NLM_p last">The following protocol was used for all newly synthesized peptides. PeIA-5466 resin (100 mg) was placed in a 15 mL tube and treated with 2 mL of Reagent K, composed of trifluoroacetic acid (TFA)/phenol/ethanedithiol/thioanisol/H<sub>2</sub>O (9:0.75:0.25:0.5:0.5 (v/v)). The reaction was gently mixed for 1.5 h at room temperature (for [Arg<sup>15</sup>]PeIA, the reaction time was extended to 2 h). Next, the cleavage mixture was filtered and precipitated with 100 mL of cold methyl-<i>tert</i>-butyl ether (MTBE). The crude peptide was separated into four 50 mL conical tubes, then precipitated by centrifugation at 7000<i>g</i> for 7 min and washed 2 more times with 30 mL of cold MTBE. The crude peptide pellet was then dissolved in 40 mL of solvent B, and the crude linear peptides were purified by preparative RP-HPLC using a reverse-phase C18-column (Vydac, 5 μM, 250 × 22 mm<sup>2</sup>) and a gradient of 10–50% solvent B in 40 min (solvent A: 0.1% TFA in water; solvent B: 60% acetonitrile (ACN) 0.092% TFA, 40% water). The purity of linear PeIA-5466 was assessed by RP-HPLC on an analytical C18-column (Vydac, 5 μM, 250 × 4.6 mm<sup>2</sup>) using the 10–50% solvent B gradient earlier described. Out of 100 mg of resin, 3300 nmol of linear PeIA-5466 were obtained with 76% purity (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00566/suppl_file/jm9b00566_si_001.pdf" class="ext-link">SI</a> Figure 1 for RP-HPLC chromatograms).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Two-Step Oxidative Folding of PeIA-5466</h3><div class="NLM_p last">The following protocol was used to selectively fold the peptides into the correct disulfide configuration for all peptides.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> First Disulfide Bond Formation (Cys<sup>2</sup>–Cys<sup>8</sup>)</h3><div class="NLM_p last">In a solution consisting of 20 mM potassium ferricyanide (0.659 g; 2 mmol) and 0.1 M Tris base (1.21 g; 10 mmol), dissolved in 100 mL of nanopure water, 3300 nmol of linear PeIA-5466, diluted with solvent A to a total volume of 100 mL, was added drop-wise (the peptide final concentration was approximately 20 μM, and the pH was 7.5). The reaction was carried out for 45 min at room temperature, then terminated by dilution with 300 mL of solvent A to lower the pH. The reaction mixture was then passed through a disposable C18 cartridge (Grace Davison Discovery Sciences, Extract Clean C18-HF 1000 mg/8 mL), and the peptide eluted using solvent B. The efficiency of the reaction as well as the purity of the peptide were analyzed by analytical RP-HPLC, as described for the linear peptide. Out of 3300 nmol of the linear peptide, 3150 nmol of monocyclic PeIA-5466 were obtained (95% yield, 84% purity).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Second Disulfide Bond Formation (Cys<sup>3</sup>–Cys<sup>16</sup>)</h3><div class="NLM_p last">Simultaneous removal of the acetamidomethyl groups and closure of the second disulfide bridge were accomplished by iodine oxidation. Iodine (76 mg, 2 mmols) was added to 15 mL of acetonitrile and stirred until completely dissolved. Then, 45 mL of nanopure water was added followed by 0.18 mL of TFA. The monocyclic PeIA-5466 solution (3150 nmol), diluted with 90 mL with solvent A, was dripped into 60 mL of the 10 mM iodine solution (prepared as described above) and allowed to react for 10 min at room temperature. The peptide final concentration was approximately 20 μM. The reaction was quenched by adding 5–10 drops of 1 M freshly prepared ascorbic acid (0.176 g, 1 mmol) solution in water (1 mL) until the reaction mixture became transparent. The reaction was then diluted 5-fold with solvent A and subsequently purified by RP-HPLC using a preparative C18-column, as described for the linear peptide. The obtained yield was 2603 nmol of the fully folded PeIA-5466. Purity and final yield of PeIA-5466 were determined by RP-HPLC using analytical C18-column using the gradients described earlier for linear peptides and were determined to be >98 and 78% (based on the starting amount of the linear peptide), respectively. The purity of all fully folded peptides was also determined to be >95% (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; <a href="/doi/suppl/10.1021/acs.jmedchem.9b00566/suppl_file/jm9b00566_si_001.pdf" class="ext-link">SI</a>, Figure 2). The calculated mass of PeIA-5466 was [MH]<sup>+1</sup> = 1758.67 and the observed mass was [M + H]<sup>+1</sup> = 1758.84, as determined by MALDI-TOF mass spectrometry at the Mass Spectrometry and Proteomics Core Facility at the University of Utah (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Two-electrode voltage-clamp electrophysiology of <i>X. laevis</i> oocytes</h3><div class="NLM_p">Protocols for the isolation of oocytes from female <i>X. laevis</i> frogs were approved by the University of Utah Institutional Animal Care and Use Committee and were strictly adhered to for this study. Methods describing the preparation of cRNA encoding rat nAChR subunits for the expression of nAChRs in oocytes have been previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Stage IV–V oocytes were injected with equal ratios of cRNA encoding cloned rat α3, α4, α6/α3, α7, β2, β3, or β4 subunits to generate the nAChR subtype of interest and used 1–5 days after injection. The α6/α3 construct was generated by replacing the extracellular ligand-binding domain of the α3 subunit with that of the α6 subunit, as previously described.<a onclick="showRef(event, 'ref12 ref30'); return false;" href="javascript:void(0);" class="ref ref12 ref30">(12,30)</a> This construct was used, because the injection of oocytes with cRNAs encoding α6, β2, and β3 subunits results in few or no functionally expressed receptors.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p last">To initiate electrophysiology experiments, the oocytes were placed in a 30 μL perfusion chamber constructed from Sylgard 184 (DowDuPont, Midland, MI) and continuously gravity-perfused with saline containing 96 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl<sub>2</sub>, and 1.0 mM MgCl<sub>2</sub>. The saline solution was buffered with 5 mM HEPES and had a pH of 7.4. The oocytes were impaled with electrodes pulled from glass capillaries (Cat. # TW100F-4, World Precision Instruments, Sarasota FL), filled with 3 M KCl, and had resistances of 1–10 MΩ. The oocyte membranes were clamped at a holding potential of −70 mV using an Oocyte Clamp OC-725C voltage-clamp amplifier (Warner Instrument Corp., Hamden, CT) and stimulated with 1 s pulses of ACh once every 60 s. The resulting ACh-gated currents were filtered through a 5 Hz low-pass Bessel filter (model F1B1; Frequency Devices, Ottawa, IL) and digitized at 50 Hz using a National Instruments USB-6009 DAQ (National Instruments, Austin, TX). The concentrations of ACh used were 100 μM for receptor subtypes containing β2 subunits and 300 μM for α7 and subtypes containing β4 subunits. The ACh concentrations and brief exposure times were chosen to avoid open-channel block and long-term desensitization of the receptors. The solution changes were controlled through a series of three-way solenoid valves interfaced with a computer via a CoolDrive valve driver (Neptune Research & Development, West Caldwell, NJ) and controlled by the National Instruments LabVIEW 2010 software. The peptides were suspended in saline containing 1 mg/mL of bovine serum albumin, to reduce nonspecific adsorption and either perfusion applied (for concentrations ≤1 μM) or applied in a static bath for 5 min (for concentrations ≥10 μM).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Data Analysis</h3><div class="NLM_p last">Concentration–response data were obtained from a minimum of four oocytes, unless otherwise indicated. The ACh responses in the presence of the peptide were normalized to the average of at least three control responses in the case of perfusion-applied peptides. For peptides applied in a static bath, the current amplitudes in the presence of the peptide were normalized to a single control response in the absence of the peptide. The variance of the data is represented as the ± standard deviation of the mean (SD) and shown with error bars. Peptides were routinely retested on oocytes from different donors to ensure data reproducibility. To estimate the IC<sub>50</sub> value for inhibition of the ACh responses by a given peptide, the normalized data were analyzed by nonlinear regression and fit using a four-parameter logistic equation using the Prism statistical analysis software (GraphPad, La Jolla, CA). The IC<sub>50</sub> values are presented with corresponding 95% confidence intervals to indicate the precision of the IC<sub>50</sub> estimate and displayed in parentheses. For the purposes of this study, changes in IC<sub>50</sub> values were considered meaningful if ≥3-fold.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00566" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00566" class="ext-link">10.1021/acs.jmedchem.9b00566</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">RP-HPLC chromatograms of PeIA-5466 showing the crude linear, purified linear, first- and second-step oxidation products, and the fully folded/purified peptide; RP-HPLC chromatograms of the fully folded peptides (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00566/suppl_file/jm9b00566_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00566/suppl_file/jm9b00566_si_001.pdf">jm9b00566_si_001.pdf (476.44 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00566" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Michael McIntosh</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Sciences, 
    Department of Psychiatry, 
     and , University of Utah, Salt Lake
City, Utah 84112, United States</span>; 
    <span class="hlFld-Affiliation affiliation">George
E. Whalen Veterans Affairs Medical Center, Salt Lake City, Utah 84148, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c4a9a7adaab0abb7aceaa9adafa184a3a9a5ada8eaa7aba9"><span class="__cf_email__" data-cfemail="f499979d9a809b879cda999d9f91b49399959d98da979b99">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arik J. Hone</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Sciences and , University of Utah, Salt Lake
City, Utah 84112, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9912-0955" title="Orcid link">http://orcid.org/0000-0002-9912-0955</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Fisher</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Sciences and , University of Utah, Salt Lake
City, Utah 84112, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Christensen</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Sciences and , University of Utah, Salt Lake
City, Utah 84112, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanna Gajewiak</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Sciences and , University of Utah, Salt Lake
City, Utah 84112, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Larkin</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Sciences and , University of Utah, Salt Lake
City, Utah 84112, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Whiteaker</span> - <span class="hlFld-Affiliation affiliation">Department of Psychiatry and , University of Utah, Salt Lake
City, Utah 84112, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4149-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by NIH grants R01 GM103801 and P01 GM48677 to J.M.M. and R01 DA042749 to P.W.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">nAChR</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChBP</td><td class="NLM_def"><p class="first last">acetylcholine-binding protein</p></td></tr><tr><td class="NLM_term">α-Ctx</td><td class="NLM_def"><p class="first last">α-conotoxin</p></td></tr><tr><td class="NLM_term">Nle</td><td class="NLM_def"><p class="first last">norleucine</p></td></tr><tr><td class="NLM_term">Aad</td><td class="NLM_def"><p class="first last">adipic acid</p></td></tr><tr><td class="NLM_term">Api</td><td class="NLM_def"><p class="first last">pimelic acid</p></td></tr><tr><td class="NLM_term">Asu</td><td class="NLM_def"><p class="first last">suberic acid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">PNS</td><td class="NLM_def"><p class="first last">peripheral nervous system</p></td></tr><tr><td class="NLM_term">MH</td><td class="NLM_def"><p class="first last">medial habenula</p></td></tr><tr><td class="NLM_term">IPN</td><td class="NLM_def"><p class="first last">interpeduncular nucleus</p></td></tr><tr><td class="NLM_term">SN</td><td class="NLM_def"><p class="first last">substantia nigra</p></td></tr><tr><td class="NLM_term">MALDI-TOF</td><td class="NLM_def"><p class="first last">matrix-assisted laser desorption/ionization time-of-flight mass spectrometry</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span> <span> </span><span class="NLM_article-title">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.tips.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16876883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=482-491&author=C.+Gottiauthor=M.+Zoliauthor=F.+Clementi&title=Brain+nicotinic+acetylcholine+receptors%3A+native+subtypes+and+their+relevance&doi=10.1016%2Fj.tips.2006.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span></div><div class="casAuthors">Gotti, Cecilia; Zoli, Michele; Clementi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors comprise a heterogeneous class of cationic channels that is present throughout the nervous system.  These channels are involved both in physiol. functions (including cognition, reward, motor activity and analgesia) and in pathol. conditions such as Alzheimer's disease, Parkinson's disease, some forms of epilepsy, depression, autism and schizophrenia.  They are also the targets of tobacco-smoking effects and addiction.  Neuronal nicotinic acetylcholine receptors are pentamers of homomeric or heteromeric combinations of α (α2-α10) and β (β2-β4) subunits, which have different pharmacol. and biophys. properties and locations in the brain.  The lack of subtype-specific ligands and the fact that many neuronal cells express multiple subtypes initially hampered the identification of the different native nicotinic acetylcholine receptor subtypes, but the increasing knowledge of subtype compn. and roles will be of considerable interest for the development of new and clin. useful nicotinic acetylcholine receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEGpOWmD0nkrVg90H21EOLACvtfcHk0lg9wrvop224PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D&md5=3c913a4e614585b2f3f52fdfb523d28f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DBrain%2520nicotinic%2520acetylcholine%2520receptors%253A%2520native%2520subtypes%2520and%2520their%2520relevance%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D482%26epage%3D491%26doi%3D10.1016%2Fj.tips.2006.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors in neuropathic and inflammatory pain</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>592</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.12884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1002%2F1873-3468.12884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=29030971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslansr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=592&publication_year=2018&pages=1045-1062&author=A.+J.+Honeauthor=J.+M.+McIntosh&title=Nicotinic+acetylcholine+receptors+in+neuropathic+and+inflammatory+pain&doi=10.1002%2F1873-3468.12884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors in neuropathic and inflammatory pain</span></div><div class="casAuthors">Hone, Arik J.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">592</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1045-1062</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) are actively being investigated as therapeutic targets for the treatment of pain and inflammation, but despite more than 30 years of research, there are currently no FDA-approved analgesics that are specific for these receptors.  Much of the initial research effort focused on the α4β2 nAChR subtype, but more recently, addnl. subtypes have been identified as promising new leads and include α6β4, α7, and α9-contg. nAChRs.  This Review will focus on the distribution of these nAChRs in the cell types involved in neuropathic pain and inflammation and the activity of currently available nicotinic ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2oGGynDFQerVg90H21EOLACvtfcHk0lg9wrvop224PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslansr%252FI&md5=f69f8999c25ad12272d2108c9b9cd6ae</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.12884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.12884%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%2520in%2520neuropathic%2520and%2520inflammatory%2520pain%26jtitle%3DFEBS%2520Lett.%26date%3D2018%26volume%3D592%26spage%3D1045%26epage%3D1062%26doi%3D10.1002%2F1873-3468.12884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunzell, D. H.</span></span> <span> </span><span class="NLM_article-title">Preclinical evidence that activation of mesolimbic alpha6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype</span>. <i>Nicotine Tob. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1258</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1093/ntr/nts089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1093%2Fntr%2Fnts089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=22492084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Srur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=1258-1269&author=D.+H.+Brunzell&title=Preclinical+evidence+that+activation+of+mesolimbic+alpha6+subunit+containing+nicotinic+acetylcholine+receptors+supports+nicotine+addiction+phenotype&doi=10.1093%2Fntr%2Fnts089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype</span></div><div class="casAuthors">Brunzell, Darlene H.</div><div class="citationInfo"><span class="NLM_cas:title">Nicotine & Tobacco Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1258-1269</span>CODEN:
                <span class="NLM_cas:coden">NTREF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-2203</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Introduction: Nicotine is a major psychoactive ingredient in tobacco yet very few individuals quit smoking with the aid of nicotine replacement therapy.  Targeted therapies with more selective action at nicotinic acetylcholine receptors (nAChRs) that contain a β2 subunit (β2*nAChRs; *denotes assembly with other subunits) have enjoyed significantly greater success, but exhibit potential for unwanted cardiac, gastrointestinal, and emotive side effects.  Discussion: This literature review focuses on the preclin. evidence that suggests that subclasses of β2*nAChRs that assemble with the α6 subunit may provide an effective target for tobacco cessation. α6β2*nAChRs have a highly selective pattern of neuroanatomical expression in catecholaminergic nuclei including the ventral tegmental area and its projection regions. α6β2*nAChRs promote dopamine (DA) neuron activity and DA release in the mesolimbic dopamine system, a brain circuitry that is well-studied for its contributions to addiction behavior.  A combination of genetic and pharmacol. studies indicates that activation of α6β2*nAChRs is necessary and sufficient for nicotine psychostimulant effects and nicotine self-administration. α6β2*nAChRs support maintenance of nicotine use, support the conditioned reinforcing effects of drug-assocd. cues, and regulate nicotine withdrawal.  Conclusions: These data suggest that α6β2*nAChRs represent a crit. pool of high affinity β2*nAChRs that regulates nicotine dependence phenotype and suggest that inhibition of these receptors may provide an effective strategy for tobacco cessation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomGwdGfeDdyLVg90H21EOLACvtfcHk0lisuMjrxLnyeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Srur3P&md5=56014398337b177ef892e209462a2f68</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fntr%2Fnts089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fntr%252Fnts089%26sid%3Dliteratum%253Aachs%26aulast%3DBrunzell%26aufirst%3DD.%2BH.%26atitle%3DPreclinical%2520evidence%2520that%2520activation%2520of%2520mesolimbic%2520alpha6%2520subunit%2520containing%2520nicotinic%2520acetylcholine%2520receptors%2520supports%2520nicotine%2520addiction%2520phenotype%26jtitle%3DNicotine%2520Tob.%2520Res.%26date%3D2012%26volume%3D14%26spage%3D1258%26epage%3D1269%26doi%3D10.1093%2Fntr%2Fnts089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrion, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccenda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. A.</span></span> <span> </span><span class="NLM_article-title">CGTP Collaborators. The concise guide to PHARMACOLOGY 2015/16: ligand-gated ion channels</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">5870</span>– <span class="NLM_lpage">5903</span>, <span class="refDoi"> DOI: 10.1111/bph.13350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1111%2Fbph.13350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=26650440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKqtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=5870-5903&author=S.%0AP.+Alexanderauthor=J.+A.+Petersauthor=E.+Kellyauthor=N.+Marrionauthor=H.+E.+Bensonauthor=E.+Faccendaauthor=A.+J.+Pawsonauthor=J.+L.+Sharmanauthor=C.+Southanauthor=J.+A.+Davies&title=CGTP+Collaborators.+The+concise+guide+to+PHARMACOLOGY+2015%2F16%3A+ligand-gated+ion+channels&doi=10.1111%2Fbph.13350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels</span></div><div class="casAuthors">Alexander, Stephen P. H.; Peters, John A.; Kelly, Eamonn; Marrion, Neil; Benson, Helen E.; Faccenda, Elena; Pawson, Adam J.; Sharman, Joanna L.; Southan, Christopher; Davies, Jamie A.; CGTP Collaborators</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5870-5903</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The Concise Guide to PHARMACOl. 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacol., plus links to an open access knowledge base of drug targets and their ligands (www.guidetopharmacol.org), which provides more detailed views of target and ligand properties.  The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13349/full.  Ligand-gated ion channels are one of the eight major pharmacol. targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters.  These are presented with nomenclature guidance and summary information on the best available pharmacol. tools, alongside key refs. and suggestions for further reading.  The Concise Guide is published in landscape format in order to facilitate comparison of related targets.  It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacol.org, superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOl. 2013/14.  It is produced in conjunction with NC-IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate.  It consolidates information previously curated and displayed sep. in IUPHAR-DB and GRAC and provides a permanent, citable, point-in-time record that will survive database updates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT4dRlIqrJpLVg90H21EOLACvtfcHk0lisuMjrxLnyeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKqtrnO&md5=91b1d9a402109b312e0be1eab89b5ca6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fbph.13350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13350%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DS.%2BP.%26aulast%3DPeters%26aufirst%3DJ.%2BA.%26aulast%3DKelly%26aufirst%3DE.%26aulast%3DMarrion%26aufirst%3DN.%26aulast%3DBenson%26aufirst%3DH.%2BE.%26aulast%3DFaccenda%26aufirst%3DE.%26aulast%3DPawson%26aufirst%3DA.%2BJ.%26aulast%3DSharman%26aufirst%3DJ.%2BL.%26aulast%3DSouthan%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DJ.%2BA.%26atitle%3DCGTP%2520Collaborators.%2520The%2520concise%2520guide%2520to%2520PHARMACOLOGY%25202015%252F16%253A%2520ligand-gated%2520ion%2520channels%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D5870%26epage%3D5903%26doi%3D10.1111%2Fbph.13350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baddick, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span> <span> </span><span class="NLM_article-title">An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.bcp.2011.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=21575611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKksLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=828-841&author=C.+G.+Baddickauthor=M.+J.+Marks&title=An+autoradiographic+survey+of+mouse+brain+nicotinic+acetylcholine+receptors+defined+by+null+mutants&doi=10.1016%2Fj.bcp.2011.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants</span></div><div class="casAuthors">Baddick, Christopher G.; Marks, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nine nicotinic receptor subunits are expressed in the central nervous system indicating that a variety of nicotinic acetylcholine receptors (nAChR) may be assembled.  A useful method with which to identify putative nAChR is radioligand binding.  In the current study the binding of [125I]α-bungarotoxin, [125I]α-conotoxinMII, 5[125I]-3-((2S)-azetidinylmethoxy)pyridine (A-85380), and [125I]epibatidine has been measured autoradiog. to provide data on many nAChR binding sites.  Each binding site was evaluated semi-quant. for samples prepd. from wild-type and α2, α4, α6, α7, β2, β4, α5 and β3 null mutant mice.  Deletion of the α7 subunit completely and selectively eliminated [125I]α-bungarotoxin binding.  The binding of [125I]α-conotoxinMII was eliminated in most brain regions by deletion of either the α6 or β2 subunit and is reduced by deletion of either the α4 or β3 subunit.  The binding of 5[125I]A-85380 was completely eliminated by deletion of the β2 subunit and significantly reduced by deletion of the α4 subunit.  Most, but not all, α4-independent sites require expression of the α6 subunit.  The effect of gene deletion on total [125I]epibatidine binding was very similar to that on [125I]A-85380 binding. [125I]Epibatidine also labels β4* nAChR, which was readily apparent for incubations conducted in the presence of 100 nM cytisine.  The effects of α3 gene deletion could not be evaluated, but persistence of residual sites implies the expression of α3* nAChR.  Taken together these results confirm and extend previously published evaluations of the effect of nAChR gene deletion and help to define the nAChR subtypes measurable by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfbL6hRbAVfbVg90H21EOLACvtfcHk0lisuMjrxLnyeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKksLjL&md5=8ed112053333147a42745dfa31b9959d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DBaddick%26aufirst%3DC.%2BG.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26atitle%3DAn%2520autoradiographic%2520survey%2520of%2520mouse%2520brain%2520nicotinic%2520acetylcholine%2520receptors%2520defined%2520by%2520null%2520mutants%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D828%26epage%3D841%26doi%3D10.1016%2Fj.bcp.2011.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span> <span> </span><span class="NLM_article-title">Involvement of the alpha3 subunit in central nicotinic binding populations</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2522</span>– <span class="NLM_lpage">2529</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-07-02522.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.22-07-02522.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11923417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XisF2gurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2522-2529&author=P.+Whiteakerauthor=C.+G.+Petersonauthor=W.+Xuauthor=J.+M.+McIntoshauthor=R.+Paylorauthor=A.+L.+Beaudetauthor=A.+C.+Collinsauthor=M.+J.+Marks&title=Involvement+of+the+alpha3+subunit+in+central+nicotinic+binding+populations&doi=10.1523%2FJNEUROSCI.22-07-02522.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the α3 subunit in central nicotinic binding populations</span></div><div class="casAuthors">Whiteaker, Paul; Peterson, Cyrus G.; Xu, Wei; McIntosh, J. Michael; Paylor, Richard; Beaudet, Arthur L.; Collins, Allan C.; Marks, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2522-2529</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The α3 subunit gene was one of the first neuronal nicotinic acetylcholine receptor (nAChR) subunits to be cloned (Boulter et al., 1986), but direct evidence of α3 subunit contributions to mammalian central nAChR populations has not been presented.  The studies reported here used mice engineered to contain a null mutation in the α3 nAChR subunit gene (Xu et al., 1999) to examine the involvement of the α3 subunit in central nAChR populations.  Heterologously expressed αββ2 and αββ4 nAChRs are pharmacol. similar to native [125I]α-conotoxin MII (α-CtxMII)-binding and A 85380-resistant [125I]epibatidine-binding nAChR subtypes nAChRs was tested using quant. autoradiog. in α3-null mutant mice.  Somewhat surprisingly, deletion of the α3 nAChR subunit gene did not affect expression of the great majority of [125I]α-CtxMII-binding sites, indicating that they do not correspond to heterologously expressed α3β2 nAChRs.  The only exception to this was obsd. in the habenulointerpeduncular tract, where α3-dependent [125l]α-CtxMII binding was obsd.  This finding may suggest the presence of an addnl., minor nicotinic population in this pathway.  In contrast, most A 85380-resistant [125I]epibatidine-binding nAChRs were dependent on α3 gene expression, suggesting that they do indeed correspond to an α3 nAChR subtype.  However, widespread but lower levels of α3-independent A 85380-resistant [125I]epibatidine binding were also seen.  Again, this may indicate the existence of an addnl., minor population of non-α3 A 85380-resistant sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbSs2pQ4bQVrVg90H21EOLACvtfcHk0liHeX0abiHk8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisF2gurg%253D&md5=fdfac6437aaa0b0f849a50d02ff3aad5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-07-02522.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-07-02522.2002%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DPaylor%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DA.%2BL.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26atitle%3DInvolvement%2520of%2520the%2520alpha3%2520subunit%2520in%2520central%2520nicotinic%2520binding%2520populations%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D2522%26epage%3D2529%26doi%3D10.1523%2FJNEUROSCI.22-07-02522.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">David, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuraszkiewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr-Urtreger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papke, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholze, P.</span></span> <span> </span><span class="NLM_article-title">Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">978</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.2010.07133.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1111%2Fj.1460-9568.2010.07133.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=20377613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A280%3ADC%252BC3c3kvVKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=978-993&author=R.+Davidauthor=A.+Ciuraszkiewiczauthor=X.+Simeoneauthor=A.+Orr-Urtregerauthor=R.+L.+Papkeauthor=J.+M.+McIntoshauthor=S.+Huckauthor=P.+Scholze&title=Biochemical+and+functional+properties+of+distinct+nicotinic+acetylcholine+receptors+in+the+superior+cervical+ganglion+of+mice+with+targeted+deletions+of+nAChR+subunit+genes&doi=10.1111%2Fj.1460-9568.2010.07133.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes</span></div><div class="casAuthors">David Reinhard; Ciuraszkiewicz Anna; Simeone Xenia; Orr-Urtreger Avi; Papke Roger L; McIntosh J M; Huck Sigismund; Scholze Petra</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">978-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) mediate fast synaptic transmission in ganglia of the autonomic nervous system.  Here, we determined the subunit composition of hetero-pentameric nAChRs in the mouse superior cervical ganglion (SCG), the function of distinct receptors (obtained by deletions of nAChR subunit genes) and mechanisms at the level of nAChRs that might compensate for the loss of subunits.  As shown by immunoprecipitation and Western blots, wild-type (WT) mice expressed: alpha 3 beta 4 (55%), alpha 3 beta 4 alpha 5 (24%) and alpha 3 beta 4 beta 2 (21%) nAChRs. nAChRs in beta 4 knockout (KO) mice were reduced to < 15% of controls and no longer contained the alpha 5 subunit.  Compound action potentials, recorded from the postganglionic (internal carotid) nerve and induced by preganglionic nerve stimulation, did not differ between alpha 5 beta 4 KO and WT mice, suggesting that the reduced number of receptors in the KO mice did not impair transganglionic transmission.  Deletions of alpha 5 or beta2 did not affect the overall number of receptors and we found no evidence that the two subunits substitute for each other.  In addition, dual KOs allowed us to study the functional properties of distinct alpha 3 beta4 and alpha 3 beta 2 receptors that have previously only been investigated in heterologous expression systems.  The two receptors strikingly differed in the decay of macroscopic currents, the efficacy of cytisine, and their responses to the alpha-conotoxins AuIB and MII.  Our data, based on biochemical and functional experiments and several mouse KO models, clarify and significantly extend previous observations on the function of nAChRs in heterologous systems and the SCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUSUN5ZuqB2cKL0FlyGHDofW6udTcc2eY5LoJx8AbteLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3kvVKhuw%253D%253D&md5=e3e60e56e35d6489042efd44ef8b19af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2010.07133.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2010.07133.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DR.%26aulast%3DCiuraszkiewicz%26aufirst%3DA.%26aulast%3DSimeone%26aufirst%3DX.%26aulast%3DOrr-Urtreger%26aufirst%3DA.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DHuck%26aufirst%3DS.%26aulast%3DScholze%26aufirst%3DP.%26atitle%3DBiochemical%2520and%2520functional%2520properties%2520of%2520distinct%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520the%2520superior%2520cervical%2520ganglion%2520of%2520mice%2520with%2520targeted%2520deletions%2520of%2520nAChR%2520subunit%2520genes%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2010%26volume%3D31%26spage%3D978%26epage%3D993%26doi%3D10.1111%2Fj.1460-9568.2010.07133.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellar, K. J.</span></span> <span> </span><span class="NLM_article-title">Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose ganglia</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1699</span>, <span class="refDoi"> DOI: 10.1124/mol.106.027458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.106.027458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16882879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFygsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1693-1699&author=D.+Maoauthor=R.+P.+Yasudaauthor=H.+Fanauthor=B.+B.+Wolfeauthor=K.+J.+Kellar&title=Heterogeneity+of+nicotinic+cholinergic+receptors+in+rat+superior+cervical+and+nodose+ganglia&doi=10.1124%2Fmol.106.027458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose ganglia</span></div><div class="casAuthors">Mao, Danyan; Yasuda, Robert P.; Fan, Hong; Wolfe, Barry B.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1693-1699</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic cholinergic receptors (nAChRs) are present in ganglia in the peripheral nervous system.  In autonomic ganglia, they are responsible for fast synaptic transmission, whereas in the sensory ganglia and sensory neurons, they may be involved in modulation of neurotransmission.  The present study measured nAChRs in several rat autonomic ganglia: the superior cervical ganglia (SCG), sensory nodose ganglia, stellate ganglia, and pelvic ganglia.  The densities of the heteromeric nAChRs detd. by receptor binding assay in those four ganglia are 481, 45, 9, and 11 fmol/mg protein, resp.  Immunopptn. studies with subunit-specific antibodies showed that a majority of the nAChRs in the SCG and nodose ganglia contain the α3 and β4 subunits, but a significant percentage of the nAChRs in these ganglia also contain α5 and β2 subunits.  A small percentage of the nAChRs in nodose ganglia also contain α2 and α4 subunits.  Sequential immunopptn. assays indicated that in the SCG, all α5 subunits are assocd. with α3 and β4 subunits, forming the mixed heteromeric α3β4α5 subtype.  A receptor composed of α3, β2, and β4 subunits in the SCG was also detected.  In rat SCG, we found the following distribution of nAChRs subtypes: 55 to 60% simple α3β4 subtype, 25 to 30% α3β4α5 subtype, and 10 to 15% α3β4β2 subtype.  These findings indicate that the nAChRs in SCG and nodose ganglia are heterogeneous, which suggests that different receptor subtypes may play different roles in these ganglia or may be activated under different conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnjpJGg1ir7Vg90H21EOLACvtfcHk0liHeX0abiHk8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFygsbbL&md5=4822eabbd069389ba81972fe75b0a0a9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.027458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.027458%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DD.%26aulast%3DYasuda%26aufirst%3DR.%2BP.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DHeterogeneity%2520of%2520nicotinic%2520cholinergic%2520receptors%2520in%2520rat%2520superior%2520cervical%2520and%2520nodose%2520ganglia%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1693%26epage%3D1699%26doi%3D10.1124%2Fmol.106.027458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marritt, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellar, K. J.</span></span> <span> </span><span class="NLM_article-title">Nicotinic cholinergic receptors in the rat retina: simple and mixed heteromeric subtypes</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1656</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1124/mol.105.012369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.105.012369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16129735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yksbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1656-1668&author=A.+M.+Marrittauthor=B.+C.+Coxauthor=R.+P.+Yasudaauthor=J.+M.+McIntoshauthor=Y.+Xiaoauthor=B.+B.+Wolfeauthor=K.+J.+Kellar&title=Nicotinic+cholinergic+receptors+in+the+rat+retina%3A+simple+and+mixed+heteromeric+subtypes&doi=10.1124%2Fmol.105.012369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic cholinergic receptors in the rat retina: Simple and mixed heteromeric subtypes</span></div><div class="casAuthors">Marritt, Andrea M.; Cox, Brandon C.; Yasuda, Robert P.; McIntosh, J. Michael; Xiao, Yingxian; Wolfe, Barry B.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1656-1668</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic acetylcholine receptors (nAChRs) were measured in the rat retina to det. the heteromeric subtypes.  The authors detected seven nicotinic receptor subunit mRNA transcripts, α2-α4, α6, and β2-β4, with RNase protection assays.  The d. of heteromeric nAChR binding sites is ∼3 times higher in the retina than in the cerebral cortex.  Moreover, the d. of the sites in the retina measured with [3H]epibatidine ([3H]EB) is ∼30% higher than with 125I-3-(2(S)-azetidinylmethoxy)pyridine (A-85380) and more than twice that measured with [3H]cytisine or [3H](-)nicotine.  These data suggest that the retina expresses multiple subtypes of nAChRs, including a large fraction of receptors contg. the β2 subunit and a smaller fraction contg. the β4 subunit.  Consistent with this, in binding competition studies, nicotinic ligands fit a model for two affinity classes of binding sites, with the higher affinity sites representing 70 to 80% of the nAChRs in the retina.  To det. the specific subtypes of nAChRs in the rat retina, the authors used subunit-specific antibodies in immunopptn. assays.  Immunopptn. of [3H]EB-labeled nAChRs with antibodies specific to the β2 and β4 subunits indicated that ∼80% of the receptors contained β2 subunits and ∼25% contained β4 receptors, consistent with the binding pharmacol. results.  Sequential immunopptn. assays indicated that the rat retina contains multiple subtypes of nAChRs.  The majority of the receptors measured seemed to be simple heteromeric subtypes, composed of a single type of α and a single type of β subunit; but a significant fraction are mixed heteromeric subtypes, composed of two or more α and/or β subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf3diaS65kBLVg90H21EOLACvtfcHk0lh__xk6-3ckJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yksbbJ&md5=5e81aa65a247d9cbab6e57991f7f86fd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.012369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.012369%26sid%3Dliteratum%253Aachs%26aulast%3DMarritt%26aufirst%3DA.%2BM.%26aulast%3DCox%26aufirst%3DB.%2BC.%26aulast%3DYasuda%26aufirst%3DR.%2BP.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DNicotinic%2520cholinergic%2520receptors%2520in%2520the%2520rat%2520retina%253A%2520simple%2520and%2520mixed%2520heteromeric%2520subtypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1656%26epage%3D1668%26doi%3D10.1124%2Fmol.105.012369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prashanth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of predatory and defensive venom peptides in cone snails</span>. <i>Mol. Biosyst.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2453</span>– <span class="NLM_lpage">2465</span>, <span class="refDoi"> DOI: 10.1039/C7MB00511C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1039%2FC7MB00511C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=29090697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGgsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=2453-2465&author=J.+R.+Prashanthauthor=S.+Dutertreauthor=R.+J.+Lewis&title=Pharmacology+of+predatory+and+defensive+venom+peptides+in+cone+snails&doi=10.1039%2FC7MB00511C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of predatory and defensive venom peptides in cone snails</span></div><div class="casAuthors">Prashanth, Jutty Rajan; Dutertre, Sebastien; Lewis, Richard James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2453-2465</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cone snails are predatory gastropods whose neurotoxic venom peptides (conotoxins) have been extensively studied for pharmacol. probes, venom evolution mechanisms and potential therapeutics.  Conotoxins have a wide range of structural and functional classes that continue to undergo accelerated evolution that underlies the rapid expansion of the genus over their short evolutionary history.  A no. of pharmacol. classes, driven by sep. evolved defensive and predatory venoms, have been hypothesised to facilitate shifts in prey that exemplify the adaptability of cone snails.  Here we provide an overview of these pharmacol. families and discuss their ecol. roles and evolutionary impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxcPA_aaO_t7Vg90H21EOLACvtfcHk0lh__xk6-3ckJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGgsL3O&md5=289c17b0ba0357aa94a6069952187387</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC7MB00511C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MB00511C%26sid%3Dliteratum%253Aachs%26aulast%3DPrashanth%26aufirst%3DJ.%2BR.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26atitle%3DPharmacology%2520of%2520predatory%2520and%2520defensive%2520venom%2520peptides%2520in%2520cone%2520snails%26jtitle%3DMol.%2520Biosyst.%26date%3D2017%26volume%3D13%26spage%3D2453%26epage%3D2465%26doi%3D10.1039%2FC7MB00511C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plazas, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Casati, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgoyhen, A. B.</span></span> <span> </span><span class="NLM_article-title">A novel alpha-conotoxin, PeIA, cloned from <i>Conus pergrandis</i>, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">30107</span>– <span class="NLM_lpage">30112</span>, <span class="refDoi"> DOI: 10.1074/jbc.M504102200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M504102200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15983035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1CrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30107-30112&author=J.+M.+McIntoshauthor=P.+V.+Plazasauthor=M.+Watkinsauthor=M.+E.+Gomez-Casatiauthor=B.+M.+Oliveraauthor=A.+B.+Elgoyhen&title=A+novel+alpha-conotoxin%2C+PeIA%2C+cloned+from+Conus+pergrandis%2C+discriminates+between+rat+alpha9alpha10+and+alpha7+nicotinic+cholinergic+receptors&doi=10.1074%2Fjbc.M504102200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel α-Conotoxin, PeIA, Cloned from Conus pergrandis, Discriminates between Rat α9α10 and α7 Nicotinic Cholinergic Receptors</span></div><div class="casAuthors">McIntosh, J. Michael; Plazas, Paola V.; Watkins, Maren; Gomez-Casati, Maria E.; Olivera, Baldomero M.; Elgoyhen, A. Belen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">30107-30112</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The α9 and α10 nicotinic cholinergic subunits assemble to form the receptor believed to mediate synaptic transmission between efferent olivocochlear fibers and hair cells of the cochlea, one of the few examples of postsynaptic function for a non-muscle nicotinic acetylcholine receptor (nAChR).  However, it has been suggested that the expression profile of α9 and α10 overlaps with that of α7 in the cochlea and in sites such as dorsal root ganglion neurons, peripheral blood lymphocytes, developing thymocytes, and skin.  We now report the cloning, total synthesis, and characterization of a novel toxin α-conotoxin PeIA that discriminates between α9α10 and α7 nAChRs.  This is the first toxin to be identified from Conus pergrandis, a species found in deep waters of the Western Pacific.  α-Conotoxin PeIA displayed a 260-fold higher selectivity for α-bungarotoxin-sensitive α9α10 nAChRs compared with α-bungarotoxin-sensitive α7 receptors.  The IC50 of the toxin was 6.9±0.5 nM and 4.4±0.5 nM for recombinant α9α10 and wild-type hair cell nAChRs, resp.  α-Conotoxin PeIA bears high resemblance to α-conotoxins MII and GIC isolated from Conus magus and Conus geographus, resp.  However, neither α-conotoxin MII nor α-conotoxin GIC at concns. of 10 μM blocked acetylcholine responses elicited in Xenopus oocytes injected with the α9 and α10 subunits.  Among neuronal non-α-bungarotoxin-sensitive receptors, α-conotoxin PeIA was also active at α3β2 receptors and chimeric α6/α3β2β3 receptors.  α-Conotoxin PeIA represents a novel probe to differentiate responses mediated either through α9α10 or α7 nAChRs in those tissues where both receptors are expressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryUnClGrq7DrVg90H21EOLACvtfcHk0lh__xk6-3ckJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1CrsLw%253D&md5=95d518d0f5c06356d47d021092c3a6af</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504102200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504102200%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DPlazas%26aufirst%3DP.%2BV.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DGomez-Casati%26aufirst%3DM.%2BE.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DElgoyhen%26aufirst%3DA.%2BB.%26atitle%3DA%2520novel%2520alpha-conotoxin%252C%2520PeIA%252C%2520cloned%2520from%2520Conus%2520pergrandis%252C%2520discriminates%2520between%2520rat%2520alpha9alpha10%2520and%2520alpha7%2520nicotinic%2520cholinergic%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30107%26epage%3D30112%26doi%3D10.1074%2Fjbc.M504102200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scadden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks alpha6beta2beta3 versus alpha6beta4 nicotinic acetylcholine receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">982</span>, <span class="refDoi"> DOI: 10.1124/mol.112.080853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.112.080853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=22914547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=972-982&author=A.+J.+Honeauthor=M.+Scaddenauthor=J.+Gajewiakauthor=S.+Christensenauthor=J.+Lindstromauthor=J.+M.+McIntosh&title=alpha-Conotoxin+PeIA%5BS9H%2CV10A%2CE14N%5D+potently+and+selectively+blocks+alpha6beta2beta3+versus+alpha6beta4+nicotinic+acetylcholine+receptors&doi=10.1124%2Fmol.112.080853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin PeIA[S9H, V10A, E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Hone, Arik J.; Scadden, Mick'l; Gajewiak, Joanna; Christensen, Sean; Lindstrom, Jon; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">972-982</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) contg. α6 and β2 subunits modulate dopamine release in the basal ganglia and are therapeutically relevant targets for treatment of neurol. and psychiatric disorders including Parkinson's disease and nicotine dependence.  However, the expression profile of β2 and β4 subunits overlap in a variety of tissues including locus ceruleus, retina, hippocampus, dorsal root ganglia, and adrenal chromaffin cells.  Ligands that bind α6β2 nAChRs also potently bind the closely related α6β4 subtype.  To distinguish between these two subtypes, we synthesized novel analogs of a recently described α-conotoxin, PeIA.  PeIA is a peptide antagonist that blocks several nAChR subtypes, including α6/α3β2β3 and α6/α3β4 nAChRs, with low nanomolar potency.  We systematically mutated PeIA and evaluated the resulting analogs for enhanced potency and/or selectivity for α6/α3β2β3 nAChRs expressed in Xenopus oocytes (α6/α3 is a subunit chimera that contains the N-terminal ligand-binding domain of the α6 subunit).  On the basis of these results, second-generation analogs were then synthesized.  The final analog, PeIA[S9H,V10A,E14N], potently blocked acetylcholine-gated currents mediated by α6/α3β2β3 and α6/α3β4 nAChRs with IC50 values of 223 pM and 65 nM, resp., yielding a >290-fold sepn. between the two subtypes.  Kinetic studies of ligand binding to α6/α3β2β3 nAChRs yielded a koff of 0.096±0.001 min-1 and a kon of 0.23±0.019 min-1 M-9.  The synthesis of PeIA[S9H,V10A,E14N] demonstrates that ligands can be developed to discriminate between α6β2 and α6β4 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK4nivcsuLRbVg90H21EOLACvtfcHk0liAINWZ9Azncw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktLjF&md5=31cd7b436adad233ea33f7ff3c480579</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.080853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.080853%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DScadden%26aufirst%3DM.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3Dalpha-Conotoxin%2520PeIA%255BS9H%252CV10A%252CE14N%255D%2520potently%2520and%2520selectively%2520blocks%2520alpha6beta2beta3%2520versus%2520alpha6beta4%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D972%26epage%3D982%26doi%3D10.1124%2Fmol.112.080853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scadden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Positional scanning mutagenesis of alpha-conotoxin PeIA identifies critical residues that confer potency and selectivity for alpha6/alpha3beta2beta3 and alpha3beta2 nicotinic acetylcholine receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">25428</span>– <span class="NLM_lpage">25439</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.482059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M113.482059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=23846688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyisbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=25428-25439&author=A.+J.+Honeauthor=M.+Ruizauthor=M.+Scaddenauthor=S.+Christensenauthor=J.+Gajewiakauthor=L.+Azamauthor=J.+M.+McIntosh&title=Positional+scanning+mutagenesis+of+alpha-conotoxin+PeIA+identifies+critical+residues+that+confer+potency+and+selectivity+for+alpha6%2Falpha3beta2beta3+and+alpha3beta2+nicotinic+acetylcholine+receptors&doi=10.1074%2Fjbc.M113.482059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Positional Scanning Mutagenesis of α-Conotoxin PeIA Identifies Critical Residues That Confer Potency and Selectivity for α6/α3β2β3 and α3β2 Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Hone, Arik J.; Ruiz, Miguel; Scadden, Mick'l; Christensen, Sean; Gajewiak, Joanna; Azam, Layla; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">25428-25439</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The nicotinic acetylcholine receptor (nAChR) subtype α6β2* (the asterisk denotes the possible presence of addnl. subunits) has been identified as an important mol. target for the pharmacotherapy of Parkinson disease and nicotine dependence.  The α6 subunit is closely related to the α3 subunit, and this presents a problem in designing ligands that discriminate between α6β2* and α3β2* nAChRs.  The authors used positional scanning mutagenesis of α-conotoxin PeIA, which targets both α6β2* and α3β2*, in combination with mutagenesis of the α6 and α3 subunits, to gain mol. insights into the interaction of PeIA with heterologously expressed α6/α3β2β3 and α3β2 receptors.  Mutagenesis of PeIA revealed that Asn11 was located in an important position that interacts with the α6 and α3 subunits.  Substitution of Asn11 with a pos. charged amino acid essentially abolished the activity of PeIA for α3β2 but not for α6/α3β2β3 receptors.  These results were used to synthesize a PeIA analog that was >15,000-fold more potent on α6/α3β2β3 than α3β2 receptors.  Analogs with an N11R substitution were then used to show a crit. interaction between the 11th position of PeIA and Glu152 of the α6 subunit and Lys152 of the α3 subunit.  The results of these studies provide mol. insights into designing ligands that selectively target α6β2* nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa4UrcdUyLH7Vg90H21EOLACvtfcHk0liAINWZ9Azncw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyisbvN&md5=f07548e4b525c3f67d19c283dc4bf720</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.482059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.482059%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DRuiz%26aufirst%3DM.%26aulast%3DScadden%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DPositional%2520scanning%2520mutagenesis%2520of%2520alpha-conotoxin%2520PeIA%2520identifies%2520critical%2520residues%2520that%2520confer%2520potency%2520and%2520selectivity%2520for%2520alpha6%252Falpha3beta2beta3%2520and%2520alpha3beta2%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D25428%26epage%3D25439%26doi%3D10.1074%2Fjbc.M113.482059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Amino acid residues that confer high selectivity of the alpha6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A,E11A,L15A]</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">11625</span>– <span class="NLM_lpage">11632</span>, <span class="refDoi"> DOI: 10.1074/jbc.M710288200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M710288200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=18299323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=11625-11632&author=L.+Azamauthor=D.+Yoshikamiauthor=J.+M.+McIntosh&title=Amino+acid+residues+that+confer+high+selectivity+of+the+alpha6+nicotinic+acetylcholine+receptor+subunit+to+alpha-conotoxin+MII%5BS4A%2CE11A%2CL15A%5D&doi=10.1074%2Fjbc.M710288200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Residues That Confer High Selectivity of the α6 Nicotinic Acetylcholine Receptor Subunit to α-Conotoxin MII[S4A,E11A,L15A]</span></div><div class="casAuthors">Azam, Layla; Yoshikami, Doju; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11625-11632</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) contg. α3 and β2 subunits are found in autonomic ganglia and mediate ganglionic transmission.  The closely related α6 nAChR subtype is found in the central nervous system where changes in its level of expression are obsd. in Parkinson's disease.  To obtain a ligand that discriminates between these two receptors, the authors designed and synthesized a novel analog of α-conotoxin MII, MII[S4A,E11A,L15A], and tested it on nAChRs expressed in Xenopus oocytes.  The peptide blocked chimeric α6/α3β2β3 nAChRs with an IC50 of 1.2 nM; in contrast, its IC50 on the closely related α3β2 as well as non-α6 nAChRs was three orders of magnitude higher.  The authors identified the residues in the receptors that are responsible for their differential sensitivity to the peptide.  The authors constructed chimeras with increasingly longer fragments of the N-terminal ligand binding domain of the α3 subunit inserted into the homologous positions of the α6 subunit, and these were used to det. that the region downstream of the first 140 amino acids was involved.  Further mutagenesis of this region revealed that the α6 subunit residues Glu 152, Asp 184, and Thr 195 were crit., and replacement of these three residues with their homologs from the α3 subunit increased the IC50 of the peptide by >1000-fold.  Conversely, when these key residues in α3 were replaced with those from α6, the IC50 decreased by almost 150-fold.  Similar effects were seen with other α6-selective conotoxins, suggesting the general importance of these α6 residues in conferring selective binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKOAKc153j1rVg90H21EOLACvtfcHk0liAINWZ9Azncw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSgtb0%253D&md5=a1abf4d7afff19417b0eb22507aaa978</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M710288200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M710288200%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DAmino%2520acid%2520residues%2520that%2520confer%2520high%2520selectivity%2520of%2520the%2520alpha6%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520to%2520alpha-conotoxin%2520MII%255BS4A%252CE11A%252CL15A%255D%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D11625%26epage%3D11632%26doi%3D10.1074%2Fjbc.M710288200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talley, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsigelny, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">24678</span>– <span class="NLM_lpage">24686</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602969200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M602969200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16803900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1eqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=24678-24686&author=T.+T.+Talleyauthor=B.+M.+Oliveraauthor=K.+H.+Hanauthor=S.+B.+Christensenauthor=C.+Dowellauthor=I.+Tsigelnyauthor=K.+Y.+Hoauthor=P.+Taylorauthor=J.+M.+McIntosh&title=Alpha-conotoxin+OmIA+is+a+potent+ligand+for+the+acetylcholine-binding+protein+as+well+as+alpha3beta2+and+alpha7+nicotinic+acetylcholine+receptors&doi=10.1074%2Fjbc.M602969200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin OmIA Is a Potent Ligand for the Acetylcholine-binding Protein as Well as α3β2 and α7 Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Talley, Todd T.; Olivera, Baldomero M.; Han, Kyou-Hoon; Christensen, Sean B.; Dowell, Cheryl; Tsigelny, Igor; Ho, Kwok-Yiu; Taylor, Palmer; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">24678-24686</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The molluskan acetylcholine-binding protein (AChBP) is a homolog of the extracellular binding domain of the pentameric ligand-gated ion channel family.  AChBP most closely resembles the α-subunit of nicotinic acetylcholine receptors and in particular the homomeric α7 nicotinic receptor.  We report the isolation and characterization of an α-conotoxin that has the highest known affinity for the Lymnaea AChBP and also potently blocks the α7 nAChR subtype when expressed in Xenopus oocytes.  Remarkably, the peptide also has high affinity for the α3β2 nAChR indicating that α-conotoxin OmIA in combination with the AChBP may serve as a model system for understanding the binding determinants of α3β2 nAChRs.  α-Conotoxin OmIA was purified from the venom of Conus omaria.  It is a 17-amino-acid, two-disulfide bridge peptide.  The ligand is the first α-conotoxin with higher affinity for the closely related receptor subtypes, α3β2 vs. α6β2, and selectively blocks these two subtypes when compared with α2β2, α4β2, and α1β1δε nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGk7LsNVTHLVg90H21EOLACvtfcHk0ljhl9s-MinTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1eqtL4%253D&md5=fb284ad12ed0d254efeea3b6e0605804</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602969200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602969200%26sid%3Dliteratum%253Aachs%26aulast%3DTalley%26aufirst%3DT.%2BT.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DHan%26aufirst%3DK.%2BH.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DTsigelny%26aufirst%3DI.%26aulast%3DHo%26aufirst%3DK.%2BY.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DAlpha-conotoxin%2520OmIA%2520is%2520a%2520potent%2520ligand%2520for%2520the%2520acetylcholine-binding%2520protein%2520as%2520well%2520as%2520alpha3beta2%2520and%2520alpha7%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D24678%26epage%3D24686%26doi%3D10.1074%2Fjbc.M602969200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span> <span> </span><span class="NLM_article-title">Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">8785</span>– <span class="NLM_lpage">8789</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-20-08785.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.22-20-08785.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=12388584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XosV2jurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=8785-8789&author=M.+Zoliauthor=M.+Morettiauthor=A.+Zanardiauthor=J.+M.+McIntoshauthor=F.+Clementiauthor=C.+Gotti&title=Identification+of+the+nicotinic+receptor+subtypes+expressed+on+dopaminergic+terminals+in+the+rat+striatum&doi=10.1523%2FJNEUROSCI.22-20-08785.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum</span></div><div class="casAuthors">Zoli, Michele; Moretti, Milena; Zanardi, Alessio; McIntosh, J. Michael; Clementi, Francesco; Gotti, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8785-8789</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal nicotinic acetylcholine receptors (nAChRs) expressed on mesostriatal dopaminergic neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement.  Using immunopptn. and ligand-binding techniques, the authors have shown that both α6β2* and α4(nonα6)β2* nAChRs are expressed in the caudate-putamen and that only α6* nAChRs can bind α-conotoxin MII and methyllycaconitine with affinities of 1.3 and 40 nM, resp.  Further studies performed on 6-hydroxydopamine-lesioned striatum led to the identification of nAChR subtypes selectively expressed on dopaminergic terminals [α4α5β2, α4α6β2(β3), and α6β2(β3)], nondopaminergic neuronal structures (α2α4β2), or both structures (α4β2).  The identification of the nAChRs expressed on striatal dopaminergic terminals opens up the possibility of developing selective nAChR ligands active on dopaminergic systems and assocd. diseases, such as Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohdPx-pMamHrVg90H21EOLACvtfcHk0ljhl9s-MinTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosV2jurw%253D&md5=3e65f80387d6cec795ce85a3f9284caa</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-20-08785.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-20-08785.2002%26sid%3Dliteratum%253Aachs%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DGotti%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520the%2520nicotinic%2520receptor%2520subtypes%2520expressed%2520on%2520dopaminergic%2520terminals%2520in%2520the%2520rat%2520striatum%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D8785%26epage%3D8789%26doi%3D10.1523%2FJNEUROSCI.22-20-08785.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champtiaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marubio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span> <span> </span><span class="NLM_article-title">Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1208</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-04-01208.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.22-04-01208.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11850448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFeksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=1208-1217&author=N.+Champtiauxauthor=Z.+Y.+Hanauthor=A.+Bessisauthor=F.+M.+Rossiauthor=M.+Zoliauthor=L.+Marubioauthor=J.+M.+McIntoshauthor=J.+P.+Changeux&title=Distribution+and+pharmacology+of+alpha+6-containing+nicotinic+acetylcholine+receptors+analyzed+with+mutant+mice&doi=10.1523%2FJNEUROSCI.22-04-01208.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice</span></div><div class="casAuthors">Champtiaux, Nicolas; Han, Zhi-Yan; Bessis, Alain; Rossi, Francesco Mattia; Zoli, Michele; Marubio, Lisa; McIntosh, J. Michael; Changeux, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1208-1217</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The α6 subunit of the nicotinic acetylcholine receptor (nAChR) is expressed at very high levels in dopaminergic (DA) neurons.  However, because of the lack of pharmacol. tools selective for α6-contg. nAChRs, the role of this subunit in the etiol. of nicotine addiction remains unknown.  To provide new tools to investigate this issue, the authors generated an α6 nAChR knock-out mouse.  Homozygous null mutants (α6-/-) did not exhibit any gross neurol. or behavioral deficits.  A careful anat. and mol. examn. of α6-/- mouse brains demonstrated the absence of developmental alterations in these animals, esp. in the visual and dopaminergic pathways, where the α6 subunit is normally expressed at the highest levels.  On the other hand, receptor autoradiog. revealed a decrease in [3H]nicotine, [3H]epibatidine, and [3H]cytisine high-affinity binding in the terminal fields of retinal ganglion cells of α6-/- animals, whereas high-affinity [125I]α-conotoxinMII (αCtxMII) binding completely disappeared in the brain.  Moreover, inhibition of [3H]epibatidine binding on striatal membranes, using unlabeled αCtxMII or cytisine, revealed the absence of αCtxMII-sensitive and cytisine-resistant [3H]epibatidine binding sites in α6-/- mice, although the total amt. of binding was unchanged.  Because αCtxMII, a toxin formerly thought to be specific for α3β2-contg. nAChRs, is known to partially inhibit nicotine-induced dopamine release, these results support the conclusion that α6 rather than α3 is the partner of β2 in the nicotinic modulation of DA neurons.  They further show that α6-/- mice might be useful tools to understand the mechanisms of nicotine addiction, although some developmental compensation might occur in these mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIjWbQ1jwkLVg90H21EOLACvtfcHk0ljhl9s-MinTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFeksr4%253D&md5=1c980791f21ea6863b8d31628ee16447</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-04-01208.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-04-01208.2002%26sid%3Dliteratum%253Aachs%26aulast%3DChamptiaux%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DZ.%2BY.%26aulast%3DBessis%26aufirst%3DA.%26aulast%3DRossi%26aufirst%3DF.%2BM.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DMarubio%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DDistribution%2520and%2520pharmacology%2520of%2520alpha%25206-containing%2520nicotinic%2520acetylcholine%2520receptors%2520analyzed%2520with%2520mutant%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D1208%26epage%3D1217%26doi%3D10.1523%2FJNEUROSCI.22-04-01208.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span> <span> </span><span class="NLM_article-title">The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.neuropharm.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15814104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1KhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=696-705&author=O.+Salminenauthor=P.+Whiteakerauthor=S.+R.+Gradyauthor=A.+C.+Collinsauthor=J.+M.+McIntoshauthor=M.+J.+Marks&title=The+subunit+composition+and+pharmacology+of+alpha-Conotoxin+MII-binding+nicotinic+acetylcholine+receptors+studied+by+a+novel+membrane-binding+assay&doi=10.1016%2Fj.neuropharm.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The subunit composition and pharmacology of α-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay</span></div><div class="casAuthors">Salminen, Outi; Whiteaker, Paul; Grady, Sharon R.; Collins, Allan C.; McIntosh, J. Michael; Marks, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">696-705</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The subunit compn. and pharmacol. of α-Conotoxin MII-binding (α-CtxMII) nicotinic acetylcholine receptors (nAChR) was studied by an improved [125I]-α-CtxMII membrane binding method.  This binding method facilitates pharmacol. studies that have been difficult to accomplish with [125I]-α-CtxMII autoradiog. or α-CtxMII inhibition of [125I]-epibatidine binding.  Binding densities and Kd-values obtained by this [125I]-α-CtxMII membrane binding were similar to the values obtained by autoradiog. or α-CtxMII inhibition of [125I]-epibatidine binding, verifying that each of these approaches measures the same nAChR population.  Binding results with nAChR subunit-null mutant mice confirm and extend observations from earlier studies: [125I]-α-CtxMII binding measures two sets of α6β2* nAChR (α4α6β2β3 or α6β2β3).  Most nicotinic agonists and antagonists show monophasic inhibition of [125I]-α-CtxMII binding, indicating that α4α6β2β3 and α6β2β3 have similar binding properties.  Comparison of the binding and activation profiles of α6β2* nAChR to those of other nAChR subtypes (α4β2* and β4*) indicates that these receptors have distinctly different pharmacol. indicating that it may be possible to target α6β2* nAChR selectively to develop compds. that might be therapeutically useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-j_xt2Pmj7LVg90H21EOLACvtfcHk0lhqoXr3h6vLlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1KhtLk%253D&md5=0d0cb2418f06d4e5c37aa03eb13a7a64</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DO.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520subunit%2520composition%2520and%2520pharmacology%2520of%2520alpha-Conotoxin%2520MII-binding%2520nicotinic%2520acetylcholine%2520receptors%2520studied%2520by%2520a%2520novel%2520membrane-binding%2520assay%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D48%26spage%3D696%26epage%3D705%26doi%3D10.1016%2Fj.neuropharm.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vailati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span> <span> </span><span class="NLM_article-title">Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1124/mol.104.006015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.104.006015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15470079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt12ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=32-41&author=M.+Quikauthor=S.+Vailatiauthor=T.+Bordiaauthor=J.+M.+Kulakauthor=H.+Fanauthor=J.+M.+McIntoshauthor=F.+Clementiauthor=C.+Gotti&title=Subunit+composition+of+nicotinic+receptors+in+monkey+striatum%3A+effect+of+treatments+with+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+or+L-DOPA&doi=10.1124%2Fmol.104.006015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit composition of nicotinic receptors in monkey striatum: Effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA</span></div><div class="casAuthors">Quik, Maryka; Vailati, Silvia; Bordia, Tanuja; Kulak, Jennifer M.; Fan, Hong; McIntosh, J. Michael; Clementi, Francesco; Gotti, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) represent an important modulator of striatal function both under normal conditions and in pathol. states such as Parkinson's disease.  Because different nAChR subtypes may have unique functions, immunopptn. and ligand binding studies were done to identify their subunit compn.  As in the rodent, α2, α4, α6, β2, and β3 nAChR subunit immunoreactivity was identified in monkey striatum.  However, distinct from the rodent, the present results also revealed the novel presence of α3 nAChR subunit-immunoreactivity in this same region, but not that for α5 and β4.  Relatively high levels of α2 and α3 subunits were also identified in monkey cortex, in addn. to α4 and β2.  Expts. were next done to det. whether striatal subunit expression was changed with nigrostriatal damage.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment decreased α6 and β3 subunit immunoreactivity by ∼80% in parallel with the dopamine transporter, suggesting that they are predominantly expressed on nigrostriatal dopaminergic projections.  In contrast, α3, α4, and β2 subunit immunoreactivity was decreased ∼50%, whereas α2 was not changed.  These data, together with those from dual immunopptn. and radioligand binding studies ([3H]cytisine, 125I-α-bungarotoxin, and 125I-α-conotoxin MII) suggest the following: that α6β2β3, α6α4β2β3, and α3β2* nAChR subtypes are present on dopaminergic terminals and that the α4β2 subtype is localized on both dopaminergic and nondopaminergic neurons, whereas α2β2* and α7 receptors are localized on nondopaminergic cells in monkey striatum.  Overall, these results suggest that drugs targeting non-α7 nicotinic receptors may be useful in the treatment of disorders characterized by nigrostriatal dopaminergic damage, such as Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfYoM-4rzm1bVg90H21EOLACvtfcHk0lhqoXr3h6vLlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt12ktg%253D%253D&md5=11bbf456c9535606260ea6290818d63f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006015%26sid%3Dliteratum%253Aachs%26aulast%3DQuik%26aufirst%3DM.%26aulast%3DVailati%26aufirst%3DS.%26aulast%3DBordia%26aufirst%3DT.%26aulast%3DKulak%26aufirst%3DJ.%2BM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DGotti%26aufirst%3DC.%26atitle%3DSubunit%2520composition%2520of%2520nicotinic%2520receptors%2520in%2520monkey%2520striatum%253A%2520effect%2520of%2520treatments%2520with%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520or%2520L-DOPA%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D32%26epage%3D41%26doi%3D10.1124%2Fmol.104.006015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5263</span>– <span class="NLM_lpage">5270</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.17-14-05263.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.17-14-05263.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=9204910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADyaK2sXksVSgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=5263-5270&author=J.+M.+Kulakauthor=T.+A.+Nguyenauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Alpha-conotoxin+MII+blocks+nicotine-stimulated+dopamine+release+in+rat+striatal+synaptosomes&doi=10.1523%2FJNEUROSCI.17-14-05263.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes</span></div><div class="casAuthors">Kulak, Jennifer M.; Nguyen, Thu A.; Olivera, Baldomero M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5263-5270</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Activation of presynaptic nicotinic acetylcholine receptors (nAChRs) can induce the release of neurotransmitters such as dopamine and norepinephrine in the CNS.  Accumulating evidence suggests that distinct nAChR subtypes are involved; however, it has been difficult to det. the subunit compn. of these receptors, in part because of the lack of a sufficient variety of selective nAChR ligands.  We present exptl. data that at least two different nAChR complexes are involved in dopamine release, one of which has an α3/β2 subunit interface.  The recently discovered peptide α-conotoxin MII is a potent and selective inhibitor of rat nAChRs contg. an interface formed by α3 and β2 subunits.  We used this peptide to examine nicotine-stimulated release of dopamine from rat striatal synaptosomes and of norepinephrine from hippocampal synaptosomes.  MII (100 nM) blocks 34-49% of the nicotine-stimulated dopamine release, but not dopamine release evoked by elevated[K+].  Furthermore, two peptides structurally related to α-conotoxin MII, namely α-conotoxin MI (selective for α1β1γδ nAChRs) and α-conotoxin ImI (selective for α7-contg. nAChRs), have no effect on nicotine-stimulated dopamine release.  The results indicate that one third to half of the dopamine release in the striatal prepn. is mediated by nAChRs with an α3/β2 subunit interface.  In contrast, ≤10% of nicotine-stimulated release of norepinephrine from hippocampal synaptosomes is modulated by nAChRs with α3/β2 subunit interfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCDub8lqnGxbVg90H21EOLACvtfcHk0ljdAcrXg-z93w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksVSgsbg%253D&md5=766107bb112c64bbfb6cbc29b0ae81d5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-14-05263.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-14-05263.1997%26sid%3Dliteratum%253Aachs%26aulast%3DKulak%26aufirst%3DJ.%2BM.%26aulast%3DNguyen%26aufirst%3DT.%2BA.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DAlpha-conotoxin%2520MII%2520blocks%2520nicotine-stimulated%2520dopamine%2520release%2520in%2520rat%2520striatal%2520synaptosomes%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D5263%26epage%3D5270%26doi%3D10.1523%2FJNEUROSCI.17-14-05263.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grady, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span> <span> </span><span class="NLM_article-title">Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.2.651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fjpet.301.2.651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11961070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=651-660&author=S.+R.+Gradyauthor=K.+L.+Murphyauthor=J.+Caoauthor=M.+J.+Marksauthor=J.+M.+McIntoshauthor=A.+C.+Collins&title=Characterization+of+nicotinic+agonist-induced+%5B%283%29H%5Ddopamine+release+from+synaptosomes+prepared+from+four+mouse+brain+regions&doi=10.1124%2Fjpet.301.2.651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of nicotinic agonist-induced [3H]dopamine release from synaptosomes prepared from four mouse brain regions</span></div><div class="casAuthors">Grady, Sharon R.; Murphy, Karen L.; Cao, Jian; Marks, Michael J.; McIntosh, J. Michael; Collins, Allan C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-660</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The inhibition of uptake of [3H]dopamine into synaptosomes prepd. from four mouse brain regions was investigated.  The inhibition curves demonstrated that in three regions: the striatum, nucleus accumbens, and olfactory tubercle, [3H]dopamine was taken up exclusively by dopaminergic terminals.  In the frontal cortex, however, only a portion of the uptake was into dopaminergic terminals, with a larger amt. taken up by noradrenergic terminals, and another small portion by serotonergic terminals.  Release studies in the frontal cortex indicated that in this region only dopaminergic and noradrenergic terminals are capable of packaging [3H]dopamine in a form allowing vesicle-mediated release; addnl., only the dopaminergic terminals have functional presynaptic nicotinic receptors (nAChRs) that, when stimulated by nicotinic agonists, evoke [3H]dopamine release.  Agonist-stimulated [3H]dopamine release was also characterized from synaptosomes prepd. from four mouse brain regions.  α-Conotoxin MII was a partial inhibitor of dopamine release in all of the brain regions studied, which suggests that a min. of two nAChRs are expressed in the nerve terminals of all four brain regions.  No nicotine-induced [3H]dopamine release was detected in any brain region studied when the synaptosomes were prepd. from β2 null mutant mice, which indicates that the β2 subunit is required for all nAChRs mediating this release.  Dose-response curves were constructed for seven agonists in each of the brain regions.  The pharmacol. properties of synaptosomal [3H]dopamine release appeared to be similar in all four brain regions.  The results suggest that all four regions express the same nAChRs, although subtle regional differences may exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgS8nj0_VWa7Vg90H21EOLACvtfcHk0ljdAcrXg-z93w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKisrc%253D&md5=ae83385c1ed735bd9a0ca39a82dd7449</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.2.651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.2.651%26sid%3Dliteratum%253Aachs%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26atitle%3DCharacterization%2520of%2520nicotinic%2520agonist-induced%2520%255B%25283%2529H%255Ddopamine%2520release%2520from%2520synaptosomes%2520prepared%2520from%2520four%2520mouse%2520brain%2520regions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D651%26epage%3D660%26doi%3D10.1124%2Fjpet.301.2.651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span> <span> </span><span class="NLM_article-title">Expression of nigrostriatal alpha6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta3 subunit gene deletion</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2015</span>, <span class="refDoi"> DOI: 10.1124/mol.105.011940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.105.011940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15749993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=2007-2015&author=C.+Gottiauthor=M.+Morettiauthor=F.+Clementiauthor=L.+Rigantiauthor=J.+M.+McIntoshauthor=A.+C.+Collinsauthor=M.+J.+Marksauthor=P.+Whiteaker&title=Expression+of+nigrostriatal+alpha6-containing+nicotinic+acetylcholine+receptors+is+selectively+reduced%2C+but+not+eliminated%2C+by+beta3+subunit+gene+deletion&doi=10.1124%2Fmol.105.011940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of nigrostriatal α6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by β3 subunit gene deletion</span></div><div class="casAuthors">Gotti, Cecilia; Moretti, Milena; Clementi, Francesco; Riganti, Loredana; McIntosh, J. Michael; Collins, Allan C.; Marks, Michael J.; Whiteaker, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2007-2015</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mRNAs for the neuronal nicotinic acetylcholine receptor (nAChR) α6 and β3 subunits are abundantly expressed and colocalized in dopaminergic cells of the substantia nigra and ventral tegmental area.  Studies using subunit-null mutant mice have shown that α6- or β3-dependent nAChRs bind α-conotoxin MII (α-CtxMII) with high affinity and modulate striatal dopamine release.  This study explores the effects of β3 subunit-null mutation on striatal and midbrain nAChR expression, compn., and pharmacol.  Ligand binding and immunopptn. expts. using subunit-specific antibodies indicated that β3-null mutation selectively reduced striatal α6* nAChR expression by 76% vs. β3+/+ control.  Parallel expts. showed a smaller redn. in both midbrain α3* and α6* nAChRs (34 and 42% vs. β3+/+ control, resp.).  Sedimentation coeff. detns. indicated that residual α6* nAChRs in β3-/- striatum were pentameric, like their wild-type counterparts.  Immunopptn. expts. on immunopurified β3* nAChRs demonstrated that almost all wild-type striatal β3* nAChRs also contain α4, α6, and β2 subunits, although a small population of non-β3 α6* nAChRs is also expressed.  β3 Subunit incorporation seemed to increase α4 participation in α6β2* complexes.  125I-Epibatidine competition binding studies showed that the α-CtxMII affinity of α6* nAChRs from the striata of β3-/- mice was similar to those isolated from β3+/+ animals.  Together, the results of these expts. show that the β3 subunit is important for the correct assembly, stability and/or transport of α6* nAChRs in dopaminergic neurons and influences their subunit compn.  However, β3 subunit expression is not essential for the expression of α6*, high-affinity α-CtxMII binding nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDHKIOr-LPj7Vg90H21EOLACvtfcHk0ljdAcrXg-z93w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGisrc%253D&md5=7e8ba400791a42769484817633f82772</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.011940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.011940%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DRiganti%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DWhiteaker%26aufirst%3DP.%26atitle%3DExpression%2520of%2520nigrostriatal%2520alpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%2520is%2520selectively%2520reduced%252C%2520but%2520not%2520eliminated%252C%2520by%2520beta3%2520subunit%2520gene%2520deletion%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D2007%26epage%3D2015%26doi%3D10.1124%2Fmol.105.011940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuraszkiewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr-Urtreger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens-Gruber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholze, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huck, S.</span></span> <span> </span><span class="NLM_article-title">The role of the nAChR subunits alpha5, beta2, and beta4 on synaptic transmission in the mouse superior cervical ganglion</span>. <i>Physiol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e14023</span> <span class="refDoi"> DOI: 10.14814/phy2.14023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.14814%2Fphy2.14023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=30891952" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&author=X.+Simeoneauthor=R.+Karchauthor=A.+Ciuraszkiewiczauthor=A.+Orr-Urtregerauthor=R.+Lemmens-Gruberauthor=P.+Scholzeauthor=S.+Huck&title=The+role+of+the+nAChR+subunits+alpha5%2C+beta2%2C+and+beta4+on+synaptic+transmission+in+the+mouse+superior+cervical+ganglion&doi=10.14814%2Fphy2.14023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.14814%2Fphy2.14023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14814%252Fphy2.14023%26sid%3Dliteratum%253Aachs%26aulast%3DSimeone%26aufirst%3DX.%26aulast%3DKarch%26aufirst%3DR.%26aulast%3DCiuraszkiewicz%26aufirst%3DA.%26aulast%3DOrr-Urtreger%26aufirst%3DA.%26aulast%3DLemmens-Gruber%26aufirst%3DR.%26aulast%3DScholze%26aufirst%3DP.%26aulast%3DHuck%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520the%2520nAChR%2520subunits%2520alpha5%252C%2520beta2%252C%2520and%2520beta4%2520on%2520synaptic%2520transmission%2520in%2520the%2520mouse%2520superior%2520cervical%2520ganglion%26jtitle%3DPhysiol.%2520Rep.%26date%3D2019%26volume%3D7%26doi%3D10.14814%2Fphy2.14023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. H.</span></span> <span> </span><span class="NLM_article-title">Solution conformation of a neuronal nicotinic acetylcholine receptor antagonist alpha-conotoxin OmIA that discriminates alpha3 vs. alpha6 nAChR subtypes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.04.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.bbrc.2006.04.099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16678128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslSnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2006&pages=248-254&author=S.+W.+Chiauthor=D.+H.+Kimauthor=B.+M.+Oliveraauthor=J.+M.+McIntoshauthor=K.+H.+Han&title=Solution+conformation+of+a+neuronal+nicotinic+acetylcholine+receptor+antagonist+alpha-conotoxin+OmIA+that+discriminates+alpha3+vs.+alpha6+nAChR+subtypes&doi=10.1016%2Fj.bbrc.2006.04.099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Solution conformation of a neuronal nicotinic acetylcholine receptor antagonist α-conotoxin OmIA that discriminates α3 vs. α6 nAChR subtypes</span></div><div class="casAuthors">Chi, Seung-Wook; Kim, Do-Hyoung; Olivera, Baldomero M.; McIntosh, J. Michael; Han, Kyou-Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">α-Conotoxin OmIA from Conus omaria is the only α-conotoxin that shows a ∼20-fold higher affinity to the α3β2 over the α6β2 subtype of nicotinic acetylcholine receptor.  We have detd. a three-dimensional structure of α-conotoxin OmIA by NMR spectroscopy.  α-Conotoxin OmIA has an "ω-shaped" overall topol. with His5-Asn12 forming an α-helix.  Structural features of α-conotoxin OmIA responsible for its selectivity are suggested by comparing its surface characteristics with other functionally related α4/7 subfamily conotoxins.  Reduced size of the hydrophilic area in α-conotoxin OmIA seems to be assocd. with the reduced affinity towards the α6β2 nAChR subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtnWTjeKeN8rVg90H21EOLACvtfcHk0linVt6MJZc99A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslSnu7s%253D&md5=e64419c9f40d215bc4c13f9419e76d48</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.04.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.04.099%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DHan%26aufirst%3DK.%2BH.%26atitle%3DSolution%2520conformation%2520of%2520a%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%2520alpha-conotoxin%2520OmIA%2520that%2520discriminates%2520alpha3%2520vs.%2520alpha6%2520nAChR%2520subtypes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D345%26spage%3D248%26epage%3D254%26doi%3D10.1016%2Fj.bbrc.2006.04.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weltzin, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span> <span> </span><span class="NLM_article-title">A novel alpha4/7-conotoxin LvIA from <i>Conus lividus</i> that selectively blocks alpha3beta2 vs. alpha6/alpha3beta2beta3 nicotinic acetylcholine receptors</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.1096/fj.13-244103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1096%2Ffj.13-244103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=24398291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVGrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1842-1853&author=S.+Luoauthor=D.+Zhangsunauthor=C.+I.+Schroederauthor=X.+Zhuauthor=Y.+Huauthor=Y.+Wuauthor=M.+M.+Weltzinauthor=S.+Eberhardauthor=Q.+Kaasauthor=D.+J.+Craikauthor=J.+M.+McIntoshauthor=P.+Whiteaker&title=A+novel+alpha4%2F7-conotoxin+LvIA+from+Conus+lividus+that+selectively+blocks+alpha3beta2+vs.+alpha6%2Falpha3beta2beta3+nicotinic+acetylcholine+receptors&doi=10.1096%2Ffj.13-244103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Luo, Sulan; Zhangsun, Dongting; Schroeder, Christina I.; Zhu, Xiaopeng; Hu, Yuanyan; Wu, Yong; Weltzin, Maegan M.; Eberhard, Spencer; Kaas, Quentin; Craik, David J.; McIntosh, J. Michael; Whiteaker, Paul</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1842-1853, 10.1096/fj.13-244103</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">This study was performed to discover and characterize the first potent α3β2-subtype-selective nicotinic acetylcholine receptor (nAChR) ligand.  A novel α4/7-conotoxin, α-CTxLvIA, was cloned from Conus lividus.  Its pharmacol. profile at Xenopus laevis oocyte-expressed rat nAChR subtypes was detd. by 2-electrode voltage-clamp electrophysiol., and its 3-dimensional (3D) structure was detd. by NMR spectroscopy.  α-CTx LvIA is a 16-aa C-terminally-amidated peptide with 2-disulfide bridges.  Using rat subunits expressed in Xenopus oocytes, we found the highest affinity of α-CTxLvIA was for α3β2 nAChRs (IC50 8.7 nM), where blockade was reversible within 2 min.  IC50 values were >100 nM at α6/α3β2β3, α6/α3β4, and α3β4 nAChRs, and ≥3 μM at all other subtypes tested.  α3β2 Vs. α6β2 subtype selectivity was confirmed for human-subunit nAChRs with much greater preference (300-fold) for α3β2 over α6β2 nAChRs.  This is the first α-CTx reported to show high selectivity for human α3β2 vs. α6β2 nAChRs.  α-CTxLvIA adopts two similarly populated conformations water: one (assumed to be bioactive) is highly structured, whereas the other is mostly random coil in nature.  Selectivity differences with the similarly potent, but less selective, α3β2 nAChR antagonist α-CTx PeIA probably reside within the three residues, which differ in loop 2, given their otherwise similar 3D structures.  α4/7-CTx LvIA is a new, potent, selective α3β2 nAChR antagonist, which will enable detailed studies of α3β2 nAChR structure, function, and physiol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3AdcmYJJbTLVg90H21EOLACvtfcHk0linVt6MJZc99A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVGrsb8%253D&md5=6a6a4276e5660e894f68439d8373ce0c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1096%2Ffj.13-244103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.13-244103%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DSchroeder%26aufirst%3DC.%2BI.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWeltzin%26aufirst%3DM.%2BM.%26aulast%3DEberhard%26aufirst%3DS.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DWhiteaker%26aufirst%3DP.%26atitle%3DA%2520novel%2520alpha4%252F7-conotoxin%2520LvIA%2520from%2520Conus%2520lividus%2520that%2520selectively%2520blocks%2520alpha3beta2%2520vs.%2520alpha6%252Falpha3beta2beta3%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DFASEB%2520J.%26date%3D2014%26volume%3D28%26spage%3D1842%26epage%3D1853%26doi%3D10.1096%2Ffj.13-244103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albillos, A.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxins identify the alpha3beta4* subtype as the predominant nicotinic acetylcholine receptor expressed in human adrenal chromaffin cells</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1124/mol.115.100982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.115.100982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=26330550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVOjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=881-893&author=A.+J.+Honeauthor=J.+M.+McIntoshauthor=L.+Azamauthor=J.+Lindstromauthor=L.+Luceroauthor=P.+Whiteakerauthor=J.+Passasauthor=J.+Blazquezauthor=A.+Albillos&title=alpha-Conotoxins+identify+the+alpha3beta4*+subtype+as+the+predominant+nicotinic+acetylcholine+receptor+expressed+in+human+adrenal+chromaffin+cells&doi=10.1124%2Fmol.115.100982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxins identify the α3β4* subtype as the predominant nicotinic acetylcholine receptor expressed in human adrenal chromaffin cells</span></div><div class="casAuthors">Hone, Arik J.; McIntosh, J. Michael; Azam, Layla; Lindstrom, Jon; Lucero, Linda; Whiteaker, Paul; Passas, Juan; Blazquez, Jesus; Albillos, Almudena</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">881-893</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ligands that selectively inhibit human α3β2 and α6β2 nicotinic acetylcholine receptor (nAChRs) and not the closely related α3β4 and α6β4 subtypes are lacking.  Current α-conotoxins (α-Ctxs) that discriminate among these nAChR subtypes in rat fail to discriminate among the human receptor homologs.  In this study, we describe the development of α-Ctx LvIA(N9R,V10A) that is 3000-fold more potent on oocyte-expressed human α3β2 than α3β4 and 165-fold more potent on human α6/α3β2β3 than α6/α3β4 nAChRs.  This analog was used in conjunction with three other α-Ctx analogs and patch-clamp electrophysiol. to characterize the nAChR subtypes expressed by human adrenal chromaffin cells.  LvIA(N9R,V10A) showed little effect on the acetylcholine-evoked currents in these cells at concns. expected to inhibit nAChRs with β2 ligand-binding sites.  In contrast, the β4-selective α-Ctx BuIA(T5A,P6O) inhibited >98% of the acetylcholine-evoked current, indicating that most of the heteromeric receptors contained β4 ligand-binding sites.  Addnl. studies using the α6-selective α-Ctx PeIA(A7V,S9H,V10A,N11R,E14A) indicated that the predominant heteromeric nAChR expressed by human adrenal chromaffin cells is the α3β4* subtype (asterisk indicates the possible presence of addnl. subunits).  This conclusion was supported by polymerase chain reaction expts. of human adrenal medulla gland and of cultured human adrenal chromaffin cells that demonstrated prominent expression of RNAs for α3, α5, α7, β2, and β4 subunits and a low abundance of RNAs for α2, α4, α6, and α10 subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNG3Y49bvNbVg90H21EOLACvtfcHk0linVt6MJZc99A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVOjtLo%253D&md5=6a08e2032ec2a5b7e156168b9e53c02e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100982%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DLucero%26aufirst%3DL.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DPassas%26aufirst%3DJ.%26aulast%3DBlazquez%26aufirst%3DJ.%26aulast%3DAlbillos%26aufirst%3DA.%26atitle%3Dalpha-Conotoxins%2520identify%2520the%2520alpha3beta4%252A%2520subtype%2520as%2520the%2520predominant%2520nicotinic%2520acetylcholine%2520receptor%2520expressed%2520in%2520human%2520adrenal%2520chromaffin%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D881%26epage%3D893%26doi%3D10.1124%2Fmol.115.100982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazioso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallanoce, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Micheli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Amici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span> <span> </span><span class="NLM_article-title">Engineering of alpha-conotoxin MII-derived peptides with increased selectivity for native alpha6beta2* nicotinic acetylcholine receptors</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3775</span>– <span class="NLM_lpage">3789</span>, <span class="refDoi"> DOI: 10.1096/fj.10-179853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1096%2Ffj.10-179853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=21778325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=3775-3789&author=L.+Pucciauthor=G.+Graziosoauthor=C.+Dallanoceauthor=L.+Rizziauthor=C.+De+Micheliauthor=F.+Clementiauthor=S.+Bertrandauthor=D.+Bertrandauthor=R.+Longhiauthor=M.+De+Amiciauthor=C.+Gotti&title=Engineering+of+alpha-conotoxin+MII-derived+peptides+with+increased+selectivity+for+native+alpha6beta2*+nicotinic+acetylcholine+receptors&doi=10.1096%2Ffj.10-179853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors</span></div><div class="casAuthors">Pucci, Luca; Grazioso, Giovanni; Dallanoce, Clelia; Rizzi, Luca; De Micheli, Carlo; Clementi, Francesco; Bertrand, Sonia; Bertrand, Daniel; Longhi, Renato; De Amici, Marco; Gotti, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3775-3789, 10.1096/fj.10-179853</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">α6β2* Nicotinic acetylcholine receptors are expressed in selected central nervous system areas, where they are involved in striatal dopamine (DA) release and its behavioral consequences, and other still uncharacterized brain activities.  α6β2* receptors are selectively blocked by the α-conotoxins MII and PIA, which bear a characteristic N-terminal amino acid tail [arginine (R), aspartic acid (D), and proline (P)].  The authors synthesized a group of PIA-related peptides in which R1 was mutated or the RDP motif gradually removed.  Binding and striatal DA release assays of native rat α6β2* receptors showed that the RDP sequence, and particularly residue R1, is essential for the activity of PIA.  On the basis of mol. modeling analyses, the authors synthesized a hybrid peptide (RDP-MII) that had increased potency (7-fold) and affinity (13-fold) for α6β2* receptors but not for the very similar α3β2* subtype.  As docking studies also suggested that E11 of MII might be a key residue engendering α6β2* vs. α3β2* selectivity, the authors prepd. MII[E11R] and RDP-MII[E11R] peptides.  Their affinity and potency for native α6β2* receptors were similar to those of their parent analogs, whereas, for the oocyte expressed rat α3β2* subtype, they showed a 31- and 14-fold lower affinity and 21- and 3.5-fold lower potency.  Thus, MII[E11R] and RDP-MII[E11R] are potent antagonists showing a degree of α6β2* vs. α3β2* selectivity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSzQlF3SYurrVg90H21EOLACvtfcHk0lhdsYepzQYqgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrjE&md5=689af1cc89bdd3ea2d107d8a83fd1f57</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1096%2Ffj.10-179853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.10-179853%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DGrazioso%26aufirst%3DG.%26aulast%3DDallanoce%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DL.%26aulast%3DDe%2BMicheli%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DLonghi%26aufirst%3DR.%26aulast%3DDe%2BAmici%26aufirst%3DM.%26aulast%3DGotti%26aufirst%3DC.%26atitle%3DEngineering%2520of%2520alpha-conotoxin%2520MII-derived%2520peptides%2520with%2520increased%2520selectivity%2520for%2520native%2520alpha6beta2%252A%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D3775%26epage%3D3789%26doi%3D10.1096%2Ffj.10-179853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladonato, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercado, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of alpha9alpha10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E1825</span>– <span class="NLM_lpage">E1832</span>, <span class="refDoi"> DOI: 10.1073/pnas.1621433114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1073%2Fpnas.1621433114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=28223528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E1825-E1832&author=H.+K.+Romeroauthor=S.+Christensenauthor=L.+Di+Cesare+Mannelliauthor=J.+Gajewiakauthor=R.+Ramachandraauthor=K.+S.+Elmslieauthor=D.+E.+Vetterauthor=C.+Ghelardiniauthor=S.+P.+Ladonatoauthor=J.+L.+Mercadoauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Inhibition+of+alpha9alpha10+nicotinic+acetylcholine+receptors+prevents+chemotherapy-induced+neuropathic+pain&doi=10.1073%2Fpnas.1621433114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span></div><div class="casAuthors">Romero, Haylie K.; Christensen, Sean B.; Di Cesare Mannelli, Lorenzo; Gajewiak, Joanna; Ramachandra, Renuka; Elmslie, Keith S.; Vetter, Douglas E.; Ghelardini, Carla; Iadonato, Shawn P.; Mercado, Jose L.; Olivera, Baldomera M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">E1825-E1832</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Opioids are first-line drugs for moderate to severe acute pain and cancer pain.  However, these medications are assocd. with severe side effects, and whether they are efficacious in treatment of chronic nonmalignant pain remains controversial.  Medications that act through alternative mol. mechanisms are critically needed.  Antagonists of α9α10 nicotinic acetylcholine receptors (nAChRs) have been proposed as an important nonopioid mechanism based on studies demonstrating prevention of neuropathol. after trauma-induced nerve injury.  However, the key α9α10 ligands characterized to date are at least two orders of magnitude less potent on human vs. rodent nAChRs, limiting their translational application.  Furthermore, an alternative proposal that these ligands achieve their beneficial effects by acting as agonists of GABAB receptors has caused confusion over whether blockade of α9α10 nAChRs is the fundamental underlying mechanism.  To address these issues definitively, we developed RgIA4, a peptide that exhibits high potency for both human and rodent α9α10 nAChRs, and was at least 1,000-fold more selective for α9α10 nAChRs vs. all other mol. targets tested, including opioid and GABAB receptors.  A daily s.c. dose of RgIA4 prevented chemotherapy-induced neuropathic pain in rats.  In wild-type mice, oxaliplatin treatment produced cold allodynia that could be prevented by RgIA4.  Addnl., in α9 KO mice, chemotherapy-induced development of cold allodynia was attenuated and the milder, temporary cold allodynia was not relieved by RgIA4.  These findings establish blockade of α9-contg. nAChRs as the basis for the efficacy of RgIA4, and that α9-contg. nAChRs are a crit. target for prevention of chronic cancer chemotherapy-induced neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_cYkcGhDBrVg90H21EOLACvtfcHk0lhdsYepzQYqgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D&md5=2372b9f813b9c628cef156f7d114c7c1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1621433114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1621433114%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DH.%2BK.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DRamachandra%26aufirst%3DR.%26aulast%3DElmslie%26aufirst%3DK.%2BS.%26aulast%3DVetter%26aufirst%3DD.%2BE.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DLadonato%26aufirst%3DS.%2BP.%26aulast%3DMercado%26aufirst%3DJ.%2BL.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520alpha9alpha10%2520nicotinic%2520acetylcholine%2520receptors%2520prevents%2520chemotherapy-induced%2520neuropathic%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE1825%26epage%3DE1832%26doi%3D10.1073%2Fpnas.1621433114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span> <span> </span><span class="NLM_article-title">Single amino acid substitution in alpha-conotoxin TxID reveals a specific alpha3beta4 nicotinic acetylcholine receptor antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9256</span>– <span class="NLM_lpage">9265</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00967</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00967" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOls77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9256-9265&author=J.+Yuauthor=X.+Zhuauthor=P.+J.+Harveyauthor=Q.+Kaasauthor=D.+Zhangsunauthor=D.+J.+Craikauthor=S.+Luo&title=Single+amino+acid+substitution+in+alpha-conotoxin+TxID+reveals+a+specific+alpha3beta4+nicotinic+acetylcholine+receptor+antagonist&doi=10.1021%2Facs.jmedchem.8b00967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist</span></div><div class="casAuthors">Yu, Jinpeng; Zhu, Xiaopeng; Harvey, Peta J.; Kaas, Quentin; Zhangsun, Dongting; Craik, David J.; Luo, Sulan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9256-9265</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The α3β4 nicotinic acetylcholine receptor (nAChR) is an important target implicated in various disease states. α-Conotoxin TxID (1) is the most potent antagonist of α3β4 nAChR, but it also exhibits inhibition of α6/α3β4 nAChR.  The results of alanine scanning of 1 suggested a vital role for Ser9 in the selectivity of the peptide.  In this study, Ser9 was substituted with a series of 14 amino acids, including some non-natural amino acids, displaying different physicochem. characteristics to further improve the selectivity of 1 toward α3β4 nAChR.  The pharmacol. activities of the mutants were evaluated using an electrophysiol. approach.  The best selectivity was obtained with [S9K]TxID, 12, which inhibited α3β4 nAChR with an IC50 of 6.9 nM and had no effects on other nAChRs.  Mol. modeling suggested a possible explanation for the high selectivity of 12 toward α3β4 nAChR, providing deeper insight into the interaction between α-conotoxins and nAChRs as well as potential treatments for nAChR-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr88F8OOlR5f7Vg90H21EOLACvtfcHk0lh32QZ5r74i1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOls77K&md5=b8f7a7026c156eb47f534989d79da50e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00967%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLuo%26aufirst%3DS.%26atitle%3DSingle%2520amino%2520acid%2520substitution%2520in%2520alpha-conotoxin%2520TxID%2520reveals%2520a%2520specific%2520alpha3beta4%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9256%26epage%3D9265%26doi%3D10.1021%2Facs.jmedchem.8b00967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staheli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuryatov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span> <span> </span><span class="NLM_article-title">Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1124/mol.65.4.944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.65.4.944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15044624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFaltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=944-952&author=J.+M.+McIntoshauthor=L.+Azamauthor=S.+Staheliauthor=C.+Dowellauthor=J.+M.+Lindstromauthor=A.+Kuryatovauthor=J.+E.+Garrettauthor=M.+J.+Marksauthor=P.+Whiteaker&title=Analogs+of+alpha-conotoxin+MII+are+selective+for+alpha6-containing+nicotinic+acetylcholine+receptors&doi=10.1124%2Fmol.65.4.944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors</span></div><div class="casAuthors">McIntosh, J. Michael; Azam, Layla; Staheli, Sarah; Dowell, Cheryl; Lindstrom, Jon M.; Kuryatov, Alexander; Garrett, James E.; Marks, Michael J.; Whiteaker, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">944-952</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic acetylcholine receptors (nAChRs) both mediate direct cholinergic synaptic transmission and modulate synaptic transmission by other neurotransmitters.  Novel ligands are needed as probes to discriminate among structurally related nAChR subtypes.  α-Conotoxin MII, a selective ligand that discriminates among a variety of nAChR subtypes, fails to discriminate well between some subtypes contg. the closely related α3 and α6 subunits.  Structure-function anal. of α-conotoxin MII was performed in an attempt to generate analogs with preference for α6-contg. [α6* (asterisks indicate the possible presence of addnl. subunits)] nAChRs.  Alanine substitution resulted in several analogs with decreased activity at α3* vs. α6* nAChRs heterologously expressed in Xenopus laevis oocytes.  From the initial analogs, a series of mutations with two alanine substitutions was synthesized.  Substitution at His9 and Leu15 (MII[H9A;L15A]) resulted in a 29-fold lower IC50 at α6β4 vs. α3β4 nAChRs.  The peptide had a 590-fold lower IC50 for α6/α3β2 vs. α3β2 and a 2020-fold lower IC50 for α6/α3β2β3 vs. α3β2 nAChRs.  MII[H9A;L15A] had little or no activity at α2β2, α2β4, α3β4, α4β2, α4β4, and α7 nAChRs.  Functional block by MII[H9A;L15A] of rat α6/α3β2β3 nAChRs (IC50 = 2.4 nM) correlated well with the inhibition const. of MII[H9A;L15A] for [125I]α-conotoxin MII binding to putative α6β2* nAChRs in mouse brain homogenates (Ki = 3.3 nM).  Thus, structure-function anal. of α-conotoxin MII enabled the creation of novel selective antagonists for discriminating among nAChRs contg. α3 and α6 subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrunT11Fm6fe7Vg90H21EOLACvtfcHk0lh32QZ5r74i1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFaltLk%253D&md5=8cbc3c187e7fed0fe29f9955b10bb736</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.4.944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.4.944%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DStaheli%26aufirst%3DS.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DLindstrom%26aufirst%3DJ.%2BM.%26aulast%3DKuryatov%26aufirst%3DA.%26aulast%3DGarrett%26aufirst%3DJ.%2BE.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DWhiteaker%26aufirst%3DP.%26atitle%3DAnalogs%2520of%2520alpha-conotoxin%2520MII%2520are%2520selective%2520for%2520alpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D944%26epage%3D952%26doi%3D10.1124%2Fmol.65.4.944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6628</span>– <span class="NLM_lpage">6638</span>, <span class="refDoi"> DOI: 10.1021/bi7004202</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7004202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFCjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=6628-6638&author=P.+Whiteakerauthor=S.+Christensenauthor=D.+Yoshikamiauthor=C.+Dowellauthor=M.+Watkinsauthor=J.+Gulyasauthor=J.+Rivierauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Discovery%2C+synthesis%2C+and+structure+activity+of+a+highly+selective+alpha7+nicotinic+acetylcholine+receptor+antagonist&doi=10.1021%2Fbi7004202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Synthesis, and Structure Activity of a Highly Selective α7 Nicotinic Acetylcholine Receptor Antagonist</span></div><div class="casAuthors">Whiteaker, Paul; Christensen, Sean; Yoshikami, Doju; Dowell, Cheryl; Watkins, Maren; Gulyas, Jozsef; Rivier, Jean; Olivera, Baldomero M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6628-6638</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) that contain an α7 subunit are widely distributed in neuronal and nonneuronal tissue.  These receptors are implicated in the release of neurotransmitters such as glutamate and in functions ranging from thought processing to inflammation.  Currently available ligands for α7 nAChRs have substantial affinity for one or more other nAChR subtypes, including those with an α1, α3, α6, and/or α9 subunit.  An α-conotoxin gene was cloned from Conus arenatus.  Predicted peptides were synthesized and found to potently block α3-, α6-, and α7-contg. nAChRs.  Structure-activity information regarding conotoxins from distantly related Conus species was employed to modify the C.  Arenatus derived toxin into a novel, highly selective α7 nAChR antagonist.  This ligand, α-CtxArIB[V11A,V16D], has low nanomolar affinity for rat α7 homomers expressed in Xenopus laevis oocytes, and antagonism is slowly reversible.  Kinetic anal. provided insight into the mechanism of antagonism. α-CtxArIB interacts with five ligand binding sites per α7 receptor, and occupation of a single site is sufficient to block function.  The peptide was also shown to be highly selective in competition binding assays in rat brain membranes. α-CtxArIB[V11A,V16D] is the most selective ligand yet reported for α7 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ7lxdry-9OLVg90H21EOLACvtfcHk0lh32QZ5r74i1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFCjsrk%253D&md5=bb573590d0e71949d96a0bcb0151e9d4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi7004202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7004202%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DGulyas%26aufirst%3DJ.%26aulast%3DRivier%26aufirst%3DJ.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520structure%2520activity%2520of%2520a%2520highly%2520selective%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D6628%26epage%3D6638%26doi%3D10.1021%2Fbi7004202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maskos, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Biasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between alpha6beta4 and alpha6beta2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5113</span>– <span class="NLM_lpage">5123</span>, <span class="refDoi"> DOI: 10.1096/fj.10-166272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1096%2Ffj.10-166272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=20739611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOms7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=5113-5123&author=L.+Azamauthor=U.+Maskosauthor=J.+P.+Changeuxauthor=C.+D.+Dowellauthor=S.+Christensenauthor=M.+De+Biasiauthor=J.+M.+McIntosh&title=alpha-Conotoxin+BuIA%5BT5A%3BP6O%5D%3A+a+novel+ligand+that+discriminates+between+alpha6beta4+and+alpha6beta2+nicotinic+acetylcholine+receptors+and+blocks+nicotine-stimulated+norepinephrine+release&doi=10.1096%2Ffj.10-166272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6β4 and α6β2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release</span></div><div class="casAuthors">Azam, Layla; Maskos, Uwe; Changeux, Jean-Pierre; Dowell, Cheryl D.; Christensen, Sean; De Biasi, Mariella; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5113-5123, 10.1096/fj.10-166272</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">α6* (asterisk indicates the presence of addnl. subunits) nicotinic acetylcholine receptors (nAChRs) are broadly implicated in catecholamine-dependent disorders that involve attention, motor movement, and nicotine self-administration.  Different mol. forms of α6 nAChRs mediate catecholamine release, but receptor differentiation is greatly hampered by a paucity of subtype selective ligands.  α-Conotoxins are nAChR-targeted peptides used by Conus species to incapacitate prey.  We hypothesized that distinct conotoxin-binding kinetics could be exploited to develop a series of selective probes to enable study of native receptor subtypes.  Proline-6 of α-conotoxin BuIA was found to be crit. for nAChR selectivity; substitution of proline-6 with 4-hydroxy-proline increased the IC50 by 2800-fold at α6/α3β2β3 but only by 6-fold at α6/α3β4 nAChRs (to 1300 and 12 nM, resp.).  We used conotoxin probes together with subunit-null mice to interrogate nAChR subtypes that modulate hippocampal norepinephrine release.  Release was abolished in α6-null mutant mice.  α-Conotoxin BuIA[T5A;P6O] partially blocked norepinephrine release in wild-type controls but failed to block release in β4-/- mice.  In contrast, BuIA[T5A;P6O] failed to block dopamine release in the wild-type striatum known to contain α6β2* nAChRs.  BuIA[T5A;P6O] is a novel ligand for distinguishing between closely related α6* nAChRs; α6β4* nAChRs modulate norepinephrine release in hippocampus but not dopamine release in striatum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGVPbPP_ert7Vg90H21EOLACvtfcHk0liZ4LAvvZUODw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOms7jP&md5=99c3d9648e5f207b12b123cefc338da7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1096%2Ffj.10-166272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.10-166272%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DDowell%26aufirst%3DC.%2BD.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DDe%2BBiasi%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3Dalpha-Conotoxin%2520BuIA%255BT5A%253BP6O%255D%253A%2520a%2520novel%2520ligand%2520that%2520discriminates%2520between%2520alpha6beta4%2520and%2520alpha6beta2%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520blocks%2520nicotine-stimulated%2520norepinephrine%2520release%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D5113%26epage%3D5123%26doi%3D10.1096%2Ffj.10-166272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougal, O. M.</span></span> <span> </span><span class="NLM_article-title">Mutagenesis of alpha-conotoxins for enhancing activity and selectivity for nicotinic acetylcholine receptors</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">113</span>, <span class="refDoi"> DOI: 10.3390/toxins11020113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.3390%2Ftoxins11020113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=113&author=M.+W.+Turnerauthor=L.+A.+Marquartauthor=P.+D.+Phillipsauthor=O.+M.+McDougal&title=Mutagenesis+of+alpha-conotoxins+for+enhancing+activity+and+selectivity+for+nicotinic+acetylcholine+receptors&doi=10.3390%2Ftoxins11020113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Ftoxins11020113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins11020113%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%2BW.%26aulast%3DMarquart%26aufirst%3DL.%2BA.%26aulast%3DPhillips%26aufirst%3DP.%2BD.%26aulast%3DMcDougal%26aufirst%3DO.%2BM.%26atitle%3DMutagenesis%2520of%2520alpha-conotoxins%2520for%2520enhancing%2520activity%2520and%2520selectivity%2520for%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DToxins%26date%3D2019%26volume%3D11%26spage%3D113%26doi%3D10.3390%2Ftoxins11020113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giribaldi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>679</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2017.11.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.neulet.2017.11.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=29199094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=679&publication_year=2018&pages=24-34&author=J.+Giribaldiauthor=S.+Dutertre&title=alpha-Conotoxins+to+explore+the+molecular%2C+physiological+and+pathophysiological+functions+of+neuronal+nicotinic+acetylcholine+receptors&doi=10.1016%2Fj.neulet.2017.11.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors</span></div><div class="casAuthors">Giribaldi, Julien; Dutertre, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">679</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-34</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The vast diversity of neuronal nicotinic acetylcholine subunits expressed in the central and peripheral nervous systems, as well as in non-neuronal tissues, constitutes a formidable challenge for researchers and clinicians to decipher the role of particular subtypes, including complex subunit assocns., in physiol. and pathophysiol. functions.  Many natural products target the nAChRs, but there is no richer source of nicotinic ligands than the venom of predatory gastropods known as cone snails.  Indeed, every single species of cone snail was shown to produce at least one type of such α-conotoxins.  These tiny peptides (10-25 amino acids), constrained by disulfide bridges, proved to be unvaluable tools to investigate the structure and function of nAChRs, some of them having also therapeutic potential.  In this review, we provide a recent update on the pharmacol. and subtype specificity of several major α-conotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1wEl9NcdLXrVg90H21EOLACvtfcHk0liZ4LAvvZUODw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3J&md5=6fd8e2c02424c0355431dc846bd0f073</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2017.11.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2017.11.063%26sid%3Dliteratum%253Aachs%26aulast%3DGiribaldi%26aufirst%3DJ.%26aulast%3DDutertre%26aufirst%3DS.%26atitle%3Dalpha-Conotoxins%2520to%2520explore%2520the%2520molecular%252C%2520physiological%2520and%2520pathophysiological%2520functions%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DNeurosci.%2520Lett.%26date%3D2018%26volume%3D679%26spage%3D24%26epage%3D34%26doi%3D10.1016%2Fj.neulet.2017.11.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V. I.</span></span> <span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.neuropharm.2017.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=28623170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=196-223&author=S.+Dutertreauthor=A.+Nickeauthor=V.+I.+Tsetlin&title=Nicotinic+acetylcholine+receptor+inhibitors+derived+from+snake+and+snail+venoms&doi=10.1016%2Fj.neuropharm.2017.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms</span></div><div class="casAuthors">Dutertre, Sebastien; Nicke, Annette; Tsetlin, Victor I.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">196-223</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nicotinic acetylcholine receptor (nAChR) represents the prototype of ligand-gated ion channels.  It is vital for neuromuscular transmission and an important regulator of neurotransmission.  A variety of toxic compds. derived from diverse species target this receptor and have been of elemental importance in basic and applied research.  They enabled milestone discoveries in pharmacol. and biochem. ranging from the original formulation of the receptor concept, the first isolation and structural anal. of a receptor protein (the nAChR) to the identification, localization, and differentiation of its diverse subtypes and their validation as a target for therapeutic intervention.  Among the venom-derived compds., α-neurotoxins and α-conotoxins provide the largest families and still represent indispensable pharmacol. tools.  Application of modified α-neurotoxins provided substantial structural and functional details of the nAChR long before high resoln. structures were available. α-bungarotoxin represents not only a std. pharmacol. tool and label in nAChR research but also for unrelated proteins tagged with a minimal α-bungarotoxin binding motif.  A major advantage of α-conotoxins is their smaller size, as well as superior selectivity for diverse nAChR subtypes that allows their development into ligands with optimized pharmacol. and chem. properties and potentially novel drugs.  In the following, these two groups of nAChR antagonists will be described focusing on their resp. roles in the structural and functional characterization of nAChRs and their development into research tools.  In addn., we provide a comparative overview of the diverse α-conotoxin selectivities that can serve as a practical guide for both structure activity studies and subtype classification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBiFz12d6Zw7Vg90H21EOLACvtfcHk0liZ4LAvvZUODw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3N&md5=95bfb80a1d00feb940c58b4df16fc1a7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DNicke%26aufirst%3DA.%26aulast%3DTsetlin%26aufirst%3DV.%2BI.%26atitle%3DNicotinic%2520acetylcholine%2520receptor%2520inhibitors%2520derived%2520from%2520snake%2520and%2520snail%2520venoms%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D127%26spage%3D196%26epage%3D223%26doi%3D10.1016%2Fj.neuropharm.2017.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxin [S9A]TxID potently discriminates between alpha3beta4 and alpha6/alpha3beta4 nicotinic acetylcholine receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5826</span>– <span class="NLM_lpage">5833</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00546</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00546" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5826-5833&author=Y.+Wuauthor=D.+Zhangsunauthor=X.+Zhuauthor=Q.+Kaasauthor=M.+Zhangsunauthor=P.+J.+Harveyauthor=D.+J.+Craikauthor=J.+M.+McIntoshauthor=S.+Luo&title=alpha-Conotoxin+%5BS9A%5DTxID+potently+discriminates+between+alpha3beta4+and+alpha6%2Falpha3beta4+nicotinic+acetylcholine+receptors&doi=10.1021%2Facs.jmedchem.7b00546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Wu, Yong; Zhangsun, Dongting; Zhu, Xiaopeng; Kaas, Quentin; Zhangsun, Manqi; Harvey, Peta J.; Craik, David J.; McIntosh, J. Michael; Luo, Sulan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5826-5833</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α3β4 NAChRs have been implicated in various pathophysiol. conditions.  However, the expression profile of α3β4 nAChRs and α6/α3β4 nAChRs overlap in a variety of tissues.  To distinguish between these two subtypes, the authors redesigned peptide (α-conotoxin TxID), which inhibits α3β4 and α6/α3β4 nAChR subtypes.  The authors systematically mutated TxID to evaluate analog selectivity for α3β4 vs. α6/α3β4 nAChRs expressed in Xenopus laevis oocytes.  One analog, peptide [S9A]TxID, had 46-fold greater potency for α3β4 vs. α6/α3β4 nAChRs.  Peptide [S9A]TxID had IC50s > 10 μM for other nAChR subtypes.  Mol. dynamics simulations suggested that Ser-9 of TxID was involved in a weak hydrogen bond with β4 Lys-81 in the α6β4 binding site but not in the α3β4 binding site.  When Ser-9 was substituted by an Ala, this hydrogen bond interaction was disrupted.  These results provide further mol. insights into the selectivity of [S9A]TxID and provide a guide for designing ligands that block α3β4 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5R3bImuXjbVg90H21EOLACvtfcHk0ljiyaw0L797bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSks7g%253D&md5=9110eec83730945d572ebc5e5bbac3bd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00546%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DZhangsun%26aufirst%3DM.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DS.%26atitle%3Dalpha-Conotoxin%2520%255BS9A%255DTxID%2520potently%2520discriminates%2520between%2520alpha3beta4%2520and%2520alpha6%252Falpha3beta4%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5826%26epage%3D5833%26doi%3D10.1021%2Facs.jmedchem.7b00546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocent, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingstone, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonnacott, S.</span></span> <span> </span><span class="NLM_article-title">Alpha-conotoxin <i>Arenatus</i> IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.142943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fjpet.108.142943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=18664588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=529-537&author=N.+Innocentauthor=P.+D.+Livingstoneauthor=A.+Honeauthor=A.+Kimuraauthor=T.+Youngauthor=P.+Whiteakerauthor=J.+M.+McIntoshauthor=S.+Wonnacott&title=Alpha-conotoxin+Arenatus+IB%5BV11L%2CV16D%5D+%5Bcorrected%5D+is+a+potent+and+selective+antagonist+at+rat+and+human+native+alpha7+nicotinic+acetylcholine+receptors&doi=10.1124%2Fjpet.108.142943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">α-conotoxin Arenatus IB[V11L,V16D] is a potent and selective antagonist at rat and human native α7 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Innocent, Neal; Livingstone, Phil D.; Hone, Arik; Kimura, Atsuko; Young, Tracey; Whiteaker, Paul; McIntosh, J. Michael; Wonnacott, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A recently developed α-conotoxin, α-conotoxin Arenatus IB[V11L,V16D] (α-CtxArIB[V11L,V16D]), is a potent and selective competitive antagonist at rat recombinant α7 nicotinic acetylcholine receptors (nAChRs), making it an attractive probe for this receptor subtype.  α7 NAChRs are potential therapeutic targets that are widely expressed in both neuronal and non-neuronal tissues, where they are implicated in a variety of functions.  In this study, we evaluate this toxin at rat and human native nAChRs.  Functional α7 nAChR responses were evoked by choline plus the allosteric potentiator PNU-120596 [1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea] in rat PC12 cells and human SH-SY5Y cells loaded with calcium indicators.  α-CtxArIB[V11L,V16D] specifically inhibited α7 nAChR-mediated increases in Ca2+ in PC12 cells.  Responses to other stimuli, 5-I-A-85380 [5-iodo-3-(2(S)-azetidinylmethoxy)pyridine dihydrochloride], nicotine, or KCl, that did not activate α7 nAChRs were unaffected.  Human α7 nAChRs were also sensitive to α-CtxArIB[V11L,V16D]; acetylcholine-evoked currents in Xenopus laevis oocytes expressing human α7 nAChRs were inhibited by α-CtxArIB[V11L,V16D] (IC50, 3.4 nM) in a slowly reversible manner, with full recovery taking 15 min.  This is consistent with the time course of recovery from blockade of rat α7 nAChRs in PC12 cells.  α-CtxArIB[V11L,V16D] inhibited human native α7 nAChRs in SHSY5Y cells, activated by either choline or AR-R17779 [(2)-spiro[1-azabicyclo[2.2.2]octane-3,59-oxazolidin]-29-one] plus PNU-120596.  Rat brain α7 nAChRs contribute to dopamine release from striatal minces; α-CtxArIB[V11L,V16D] (300 nM) selectively inhibited choline-evoked dopamine release without affecting responses evoked by nicotine that activates heteromeric nAChRs.  This study establishes that α-CtxArIB[V11L,V16D] selectively inhibits human and rat native α7 nAChRs with comparable potency, making this a potentially useful antagonist for investigating α7 nAChR functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx07uZv7pR_rVg90H21EOLACvtfcHk0ljiyaw0L797bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vM&md5=93fbd4e9eadf0a64a05770e05e07ecbe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.142943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.142943%26sid%3Dliteratum%253Aachs%26aulast%3DInnocent%26aufirst%3DN.%26aulast%3DLivingstone%26aufirst%3DP.%2BD.%26aulast%3DHone%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DWonnacott%26aufirst%3DS.%26atitle%3DAlpha-conotoxin%2520Arenatus%2520IB%255BV11L%252CV16D%255D%2520%255Bcorrected%255D%2520is%2520a%2520potent%2520and%2520selective%2520antagonist%2520at%2520rat%2520and%2520human%2520native%2520alpha7%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D529%26epage%3D537%26doi%3D10.1124%2Fjpet.108.142943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utkin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasheverov, I.</span></span> <span> </span><span class="NLM_article-title">Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.05.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.bcp.2009.05.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=19501053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=720-731&author=V.+Tsetlinauthor=Y.+Utkinauthor=I.+Kasheverov&title=Polypeptide+and+peptide+toxins%2C+magnifying+lenses+for+binding+sites+in+nicotinic+acetylcholine+receptors&doi=10.1016%2Fj.bcp.2009.05.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors</span></div><div class="casAuthors">Tsetlin, Victor; Utkin, Yuri; Kasheverov, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">720-731</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  At present the cryo-electron microscopy structure at 4 Å resoln. is known for the Torpedo marmorata nicotinic acetylcholine receptor (nAChR), and high-resoln. X-ray structures have been recently detd. for bacterial ligand-gated ion channels which have the same type of spatial organization.  Together all these structures provide the basis for better understanding functioning of muscle-type and neuronal nAChRs, as well as of other Cys-loop receptors: 5HT3-, glycine-, GABA-A and some other.  Detailed information about the ligand-binding sites in nAChRs, necessary both for understanding the receptor functioning and for rational drug design, became available when the X-ray structures were solved for the acetylcholine-binding proteins (AChBP), excellent models for the ligand-binding domains of all Cys-loop receptors.  Of special value in this respect are the X-ray structures of AChBP complexes with agonists and antagonists.  Among the latter are the complexes with polypeptide and peptide antagonists, that is with protein neurotoxins from snake venoms and peptide neurotoxins (α-conotoxins) from poisonous marine snails of Conus genus.  The role of a bridge between the AChBP and nAChRs is played by the X-ray structure of the ligand-binding domain of α1 subunit of nAChR in the complex with α-bungarotoxin.  The purpose of this review is to show the role of well-known and new polypeptide and peptide neurotoxins, from the earlier days of nAChRs research until present time, in identification of different nAChR subtypes and mapping their binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUDx8nxOpOCrVg90H21EOLACvtfcHk0ljiyaw0L797bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjF&md5=ee273583f19c9e66799dbf4634929ea4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.05.032%26sid%3Dliteratum%253Aachs%26aulast%3DTsetlin%26aufirst%3DV.%26aulast%3DUtkin%26aufirst%3DY.%26aulast%3DKasheverov%26aufirst%3DI.%26atitle%3DPolypeptide%2520and%2520peptide%2520toxins%252C%2520magnifying%2520lenses%2520for%2520binding%2520sites%2520in%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D720%26epage%3D731%26doi%3D10.1016%2Fj.bcp.2009.05.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgi, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boss, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viveros-Paredes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, J. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent positive allosteric modulators of the alpha3beta2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1021/cn4002297</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4002297" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=346-359&author=J.+J.+Burgiauthor=M.+Awaleauthor=S.+D.+Bossauthor=T.+Schaerauthor=F.+Margerauthor=J.+M.+Viveros-Paredesauthor=S.+Bertrandauthor=J.+Gertschauthor=D.+Bertrandauthor=J.+L.+Reymond&title=Discovery+of+potent+positive+allosteric+modulators+of+the+alpha3beta2+nicotinic+acetylcholine+receptor+by+a+chemical+space+walk+in+ChEMBL&doi=10.1021%2Fcn4002297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-benzylamino quinuclidones as potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL</span></div><div class="casAuthors">Burgi, Justus J.; Awale, Mahendra; Boss, Silvan D.; Schaer, Tifany; Marger, Fabrice; Viveros-Paredes, Juan M.; Bertrand, Sonia; Gertsch, Jurg; Bertrand, Daniel; Reymond, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-359</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">While a plethora of ligands are known for the well studied α7 and α4β2 nicotinic acetylcholine receptor (nAChR), only very few ligands address the related α3β2 nAChR expressed in the central nervous system and at the neuromuscular junction.  Starting with the public database ChEMBL organized in the chem. space of Mol. Quantum Nos. (MQN, a series of 42 integer value descriptors of mol. structure), a visual survey of nearest neighbors of the α7 nAChR partial agonist N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) pointed to N-(2-halobenzyl)-3-aminoquinuclidines as possible nAChR modulators.  This simple "chem. space walk" was performed using a web-browser available at www.gdb.unibe.ch.  Electrophysiol. recordings revealed that these ligands represent a new and to date most potent class of pos. allosteric modulators (PAMs) of the α3β2 nAChR, which also exert significant effects in vivo.  The present discovery highlights the value of surveying chem. space neighbors of known drugs within public databases to uncover new pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohp7MkRxzVCLVg90H21EOLACvtfcHk0ljMtmMFyPzixg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrs%253D&md5=d5e47fc46e98fc395a975d421386be86</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcn4002297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4002297%26sid%3Dliteratum%253Aachs%26aulast%3DBurgi%26aufirst%3DJ.%2BJ.%26aulast%3DAwale%26aufirst%3DM.%26aulast%3DBoss%26aufirst%3DS.%2BD.%26aulast%3DSchaer%26aufirst%3DT.%26aulast%3DMarger%26aufirst%3DF.%26aulast%3DViveros-Paredes%26aufirst%3DJ.%2BM.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DGertsch%26aufirst%3DJ.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DReymond%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520potent%2520positive%2520allosteric%2520modulators%2520of%2520the%2520alpha3beta2%2520nicotinic%2520acetylcholine%2520receptor%2520by%2520a%2520chemical%2520space%2520walk%2520in%2520ChEMBL%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D346%26epage%3D359%26doi%3D10.1021%2Fcn4002297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuryatov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span> <span> </span><span class="NLM_article-title">Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2570</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(00)00144-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2FS0028-3908%2800%2900144-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11044728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=2570-2590&author=A.+Kuryatovauthor=F.+Olaleauthor=J.+Cooperauthor=C.+Choiauthor=J.+Lindstrom&title=Human+alpha6+AChR+subtypes%3A+subunit+composition%2C+assembly%2C+and+pharmacological+responses&doi=10.1016%2FS0028-3908%2800%2900144-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses</span></div><div class="casAuthors">Kuryatov, A.; Olale, F.; Cooper, J.; Choi, C.; Lindstrom, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2570-2590</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Many nicotinic acetylcholine receptor (AChR) subunits are known to be co-expressed with the α6 subunit in neurons.  Because α6β4 AChRs assemble inefficiently and α6β2 AChRs not at all, more complex mixts. of human subunit cDNAs were tested for their abilities to form functional AChRs when expressed in Xenopus oocytes.  α6β4β3 AChRs produced the largest and most consistent responses.  α6α3β2 AChRs exhibited reduced potency for ACh and increased potency and efficacy for nicotine compared to α3β2 AChRs, but similar resistance to functional inactivation after prolonged exposure to nicotine.  α6α4β2 AChRs differed little in potency or efficacy for ACh or nicotine compared to α4β2 AChRs, and had similarly high sensitivity to inactivation by prolonged exposure to nicotine.  Co-expression of α6 and β2 cRNAs resulted in large nos. of 3H-epibatidine binding sites in the form of large aggregates but not in functional pentameric AChRs.  Co-expression of α6, β2, and α5 resulted in assembly of some functional pentameric AChRs.  Chimeras with the large extracellular domain of α6 and the rest from either α3 or α4 efficiently formed functional AChRs.  Thus, the extracellular domain of α6 efficiently assembles with β2 to form ACh binding sites, but more C-terminal domains cause difficulties in forming pentameric AChRs.  Chimeric α6/α3 and α6/α4 AChRs contg. either β2 or β4 subunits were blocked by α-conotoxin MII which had previously been reported to be specific for α3β2 AChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWNBNRp2ofWLVg90H21EOLACvtfcHk0ljMtmMFyPzixg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlGqsL4%253D&md5=21e6fe5f12e8f82579cd03dc019c7659</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2800%2900144-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252800%252900144-1%26sid%3Dliteratum%253Aachs%26aulast%3DKuryatov%26aufirst%3DA.%26aulast%3DOlale%26aufirst%3DF.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DLindstrom%26aufirst%3DJ.%26atitle%3DHuman%2520alpha6%2520AChR%2520subtypes%253A%2520subunit%2520composition%252C%2520assembly%252C%2520and%2520pharmacological%2520responses%26jtitle%3DNeuropharmacology%26date%3D2000%26volume%3D39%26spage%3D2570%26epage%3D2590%26doi%3D10.1016%2FS0028-3908%2800%2900144-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talley, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobango, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huidobro
Melo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hararah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of alpha-conotoxin potency for inhibition of human and rat alpha6beta4 nicotinic acetylcholine receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">17838</span>– <span class="NLM_lpage">17852</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.005649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.RA118.005649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=30249616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aqsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=17838-17852&author=A.+J.+Honeauthor=T.+T.+Talleyauthor=J.+Bobangoauthor=C.+Huidobro%0AMeloauthor=F.+Hararahauthor=J.+Gajewiakauthor=S.+Christensenauthor=P.+J.+Harveyauthor=D.+J.+Craikauthor=J.+M.+McIntosh&title=Molecular+determinants+of+alpha-conotoxin+potency+for+inhibition+of+human+and+rat+alpha6beta4+nicotinic+acetylcholine+receptors&doi=10.1074%2Fjbc.RA118.005649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Hone, Arik J.; Talley, Todd T.; Bobango, Janet; Melo, Cesar Huidobro; Hararah, Fuaad; Gajewiak, Joanna; Christensen, Sean; Harvey, Peta J.; Craik, David J.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">17838-17852</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) contg. α6 and β4 subunits are expressed by dorsal root ganglion neurons and have been implicated in neuropathic pain.  Rodent models are often used to evaluate the efficacy of analgesic compds., but species differences may affect the activity of some nAChR ligands.  A previous candidate α-conotoxin-based therapeutic yielded promising results in rodent models, but failed in human clin. trials, emphasizing the importance of understanding species differences in ligand activity.  Human and rat α6/α3β4 nAChRs expressed in Xenopus laevis oocytes exhibit differential sensitivity to α-conotoxins.  Sequence homol. comparisons of human and rat α6β4 nAChR subunits indicated that α6 residues forming the ligand-binding pocket are highly conserved between the two species, but several residues of β4 differed, including a Leu-Gln difference at position 119.  X-ray crystallog. of α-conotoxin PeIA complexed with the Aplysia californica acetylcholine-binding protein (AChBP) revealed that binding of PeIA orients Pro 13 in close proximity to residue 119 of the AChBP complementary subunit.  Site-directed mutagenesis studies revealed that Leu 119 of human β4 contributes to higher sensitivity of human α6/α3β4 nAChRs to α-conotoxins, and structure-activity studies indicated that PeIA Pro 13 is crit. for high potency.  Human and rat α6/α3β4 nAChRs displayed differential sensitivities to perturbations of the interaction between PeIA Pro 13 and residue 119 of the β4 subunit.  These results highlight the potential significance of species differences in α6β4 nAChR pharmacol. that should be taken into consideration when evaluating the activity of candidate human therapeutics in rodent models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpghB2KpjOnOrVg90H21EOLACvtfcHk0ljMtmMFyPzixg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aqsLfI&md5=10531f0e5744c1b066d62924ee070923</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.005649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.005649%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DTalley%26aufirst%3DT.%2BT.%26aulast%3DBobango%26aufirst%3DJ.%26aulast%3DHuidobro%2BMelo%26aufirst%3DC.%26aulast%3DHararah%26aufirst%3DF.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DMolecular%2520determinants%2520of%2520alpha-conotoxin%2520potency%2520for%2520inhibition%2520of%2520human%2520and%2520rat%2520alpha6beta4%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D17838%26epage%3D17852%26doi%3D10.1074%2Fjbc.RA118.005649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Arik J. Hone, Quentin Kaas, Ireland Kearns, Fuaad Hararah, Joanna Gajewiak, Sean Christensen, David J. Craik, <span class="NLM_string-name hlFld-ContribAuthor">J. Michael McIntosh</span>. </span><span class="cited-content_cbyCitation_article-title">Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1685-1700. <a href="https://doi.org/10.1021/acs.jmedchem.0c01973" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01973%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComputational%252Band%252BFunctional%252BMapping%252Bof%252BHuman%252Band%252BRat%252B%2525CE%2525B16%2525CE%2525B24%252BNicotinic%252BAcetylcholine%252BReceptors%252BReveals%252BSpecies-Specific%252BLigand-Binding%252BMotifs%26aulast%3DHone%26aufirst%3DArik%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13112020%26date%3D01022021%26volume%3D64%26issue%3D3%26spage%3D1685%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huying  Ning</span>, <span class="hlFld-ContribAuthor ">Biling  Huang</span>, <span class="hlFld-ContribAuthor ">Han‐Shen  Tae</span>, <span class="hlFld-ContribAuthor ">Zhuguo  Liu</span>, <span class="hlFld-ContribAuthor ">Shuo  Yu</span>, <span class="hlFld-ContribAuthor ">Liang  Li</span>, <span class="hlFld-ContribAuthor ">Longxiao  Zhang</span>, <span class="hlFld-ContribAuthor ">David J.  Adams</span>, <span class="hlFld-ContribAuthor ">Chenyun  Guo</span>, <span class="hlFld-ContribAuthor ">Qiuyun  Dai</span>. </span><span class="cited-content_cbyCitation_article-title">α‐Conotoxin Bt1.8 from
              Conus betulinus
              selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2021,</strong> <em>16 </em><a href="https://doi.org/10.1111/jnc.15434" title="DOI URL">https://doi.org/10.1111/jnc.15434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.15434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.15434%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3D%2525CE%2525B1%2525E2%252580%252590Conotoxin%252BBt1.8%252Bfrom%252BConus%252Bbetulinus%252Bselectively%252Binhibits%252B%2525CE%2525B16%25252F%2525CE%2525B13%2525CE%2525B22%2525CE%2525B23%252Band%252B%2525CE%2525B13%2525CE%2525B22%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bsubtypes%26aulast%3DNing%26aufirst%3DHuying%26date%3D2021%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayaulym  Bekbossynova</span>, <span class="hlFld-ContribAuthor ">Albina  Zharylgap</span>, <span class="hlFld-ContribAuthor ">Olena  Filchakova</span>. </span><span class="cited-content_cbyCitation_article-title">Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3373. <a href="https://doi.org/10.3390/molecules26113373" title="DOI URL">https://doi.org/10.3390/molecules26113373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113373%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DVenom-Derived%252BNeurotoxins%252BTargeting%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DBekbossynova%26aufirst%3DAyaulym%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arik J.  Hone</span>, <span class="hlFld-ContribAuthor ">Lola  Rueda‐Ruzafa</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Gordon</span>, <span class="hlFld-ContribAuthor ">Joanna  Gajewiak</span>, <span class="hlFld-ContribAuthor ">Sean  Christensen</span>, <span class="hlFld-ContribAuthor ">Tino  Dyhring</span>, <span class="hlFld-ContribAuthor ">Almudena  Albillos</span>, <span class="hlFld-ContribAuthor ">J. Michael  McIntosh</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2020,</strong> <em>154 </em>
                                    (2)
                                     , 158-176. <a href="https://doi.org/10.1111/jnc.14966" title="DOI URL">https://doi.org/10.1111/jnc.14966</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.14966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.14966%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DExpression%252Bof%252B%2525CE%2525B13%2525CE%2525B22%2525CE%2525B24%252Bnicotinic%252Bacetylcholine%252Breceptors%252Bby%252Brat%252Badrenal%252Bchromaffin%252Bcells%252Bdetermined%252Busing%252Bnovel%252Bconopeptide%252Bantagonists%26aulast%3DHone%26aufirst%3DArik%2BJ.%26date%3D2020%26date%3D2020%26volume%3D154%26issue%3D2%26spage%3D158%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marloes  van Hout</span>, <span class="hlFld-ContribAuthor ">Amanda  Valdes</span>, <span class="hlFld-ContribAuthor ">Sean B.  Christensen</span>, <span class="hlFld-ContribAuthor ">Phuong T.  Tran</span>, <span class="hlFld-ContribAuthor ">Maren  Watkins</span>, <span class="hlFld-ContribAuthor ">Joanna  Gajewiak</span>, <span class="hlFld-ContribAuthor ">Anders A.  Jensen</span>, <span class="hlFld-ContribAuthor ">Baldomero M.  Olivera</span>, <span class="hlFld-ContribAuthor ">J. Michael  McIntosh</span>. </span><span class="cited-content_cbyCitation_article-title">α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>157 </em>, 107691. <a href="https://doi.org/10.1016/j.neuropharm.2019.107691" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.107691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.107691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.107691%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3D%2525CE%2525B1-Conotoxin%252BVnIB%252Bfrom%252BConus%252Bventricosus%252Bis%252Ba%252Bpotent%252Band%252Bselective%252Bantagonist%252Bof%252B%2525CE%2525B16%2525CE%2525B24%252A%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3Dvan%2BHout%26aufirst%3DMarloes%26date%3D2019%26volume%3D157%26spage%3D107691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Amino acid sequence and structure of PeIA and RP-HPLC of analogs containing non-natural amino acid residues. (A) The linear sequence of PeIA shown with the disulfide connectivity and Asn<sup>11</sup> as the line structure. (B) Cartoon rendition of the crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JME">5JME</a>, chain H)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(41)</a> of PeIA highlighting the position of Asn<sup>11</sup> (blue). (C) Side-chain structures of the non-natural amino acids Aad, Api, and Asu used in analog synthesis and corresponding RP-HPLC traces of the fully folded peptides. [Aad<sup>11</sup>]PeIA, [Api<sup>11</sup>]PeIA, and [Asu<sup>11</sup>]PeIA eluted at 37.5, 39.0, and 42.4% solvent B, respectively, using an ACN gradient of 10–50% in 40 min and a C18 analytical column.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PeIA analogs with negatively charged amino acid residues in position 11 show increased selectivity for α3β2 nAChRs. Analogs with substitutions of Asn<sup>11</sup> were synthesized and a concentration–response analysis was performed for each to determine the IC<sub>50</sub> values. The value obtained for each analog was compared to that of the native peptide (red dashed curves) to assess the effects of the substitution. (A) Analogs with Asp, Glu, or Api substitutions showed <3-fold change in potency for α3β2 nAChRs. Aad, with a one-carbon longer side chain than Glu and one-carbon shorter than Api, reduced PeIA potency by 6-fold. (B) By contrast, all analogs showed substantially reduced potency (6- to 274-fold) for α6/α3β2β3 nAChRs. The most α3β2-selective of these analogs was determined to be [Api<sup>11</sup>]PeIA (blue curve), which showed a 300-fold preference for the α3β2 subtype. A minimum of four oocytes was used for each IC<sub>50</sub> determination, and the error bars indicate the SD. The analogs are listed in rank order of potency from top (most potent) to bottom (least potent); values are presented in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure–function analysis of PeIA identifies amino acid substitutions that increase potency for α3β2 nAChRs. PeIA analogs with substitutions of Ser<sup>9</sup>, Val<sup>10</sup>, Glu<sup>14</sup>, or Leu<sup>15</sup> were synthesized and a concentration–response analysis was performed for each to determine the IC<sub>50</sub> values. The value for each analog was compared to that of the native peptide to evaluate the interaction between the substituted positions and α3β2 nAChRs. (A) Analogs with Asn, Tyr, or Thr substitutions of Ser<sup>9</sup> showed a <3-fold change in potency for α3β2 nAChRs. Substitution of Ser<sup>9</sup> with His increased the potency of PeIA by 15-fold. (B) Substitution of Val<sup>10</sup> with Ala increased (6-fold) PeIA potency, whereas other hydrophobic amino acids showed a <3-fold change but trended toward increased potency. Substitution with Thr also showed a <3-fold change. (C) Substitutions of Glu<sup>14</sup> revealed the importance of a Glu in this position for PeIA potency on α3β2 nAChRs. Substitution with any other negatively charged amino acid reduced potency by 3- to 10-fold. A <3-fold change in potency was observed by changing Glu to Gla. Substitution of Glu<sup>14</sup> with Gln or Arg reduced PeIA potency by 4- and 6-fold, respectively. (D) Varying effects on PeIA potency were observed when Leu<sup>15</sup> was substituted with other hydrophobic amino acids, whereas Ile increased PeIA potency by 3-fold, Ala reduced potency by 38-fold; Nle and Val produced a <3-fold change. Arg reduced PeIA potency by 8-fold. A minimum of four oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD. The analogs are listed in rank order of potency from top (most potent) to bottom (least potent); values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Data for PeIA (red dashed curves) were previously presented in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and shown for the ease of comparison to the curves of the analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure–function analysis of PeIA identifies amino acid substitutions that decrease potency for α6/α3β2β3 nAChRs. A concentration–response analysis was performed for the newly synthesized PeIA analogs, and the IC<sub>50</sub> values compared to that of the native peptide and the IC<sub>50</sub> values for α3β2 nAChRs. (A) Analogs with substitutions of Ser<sup>9</sup> displayed changes in potencies similar to those for α3β2 nAChRs. [Thr<sup>9</sup>]PeIA displayed increased (4-fold) potency for α6/α3β2β3 nAChRs, whereas all others showed <3-fold change. Note that none of the Ser<sup>9</sup> substitutions changed α3β2-α6/α3β2β3 selectivity. (B) Very little change in potency was observed for the newly synthesized analogs with substitutions of Val<sup>10</sup>. (C) In contrast to the results obtained for α3β2 nAChRs, α6/α3β2β3 nAChRs were less sensitive to perturbations of the interaction between PeIA position 14 and the receptor. Of the analogs with other negatively charged amino acids, only [Asu<sup>14</sup>]PeIA showed a change in potency (7-fold loss). Substitution of Glu<sup>14</sup> with Gln showed a very little effect (<3-fold) on PeIA potency for α6/α3β2β3 nAChRs, whereas Arg reduced the IC<sub>50</sub> value by 3-fold. (D) Like α3β2, varying effects on PeIA potency were also observed for α6/α3β2β3 nAChRs when Leu<sup>15</sup> was substituted with other hydrophobic amino acids. Whereas the L15I substitutions increased the IC<sub>50</sub> value for α3β2, a <3-fold change was observed for α6/α3β2β3 nAChRs. The L15Nle substitution resulted in a <3-fold change in the IC<sub>50</sub>, whereas L15V decreased the IC<sub>50</sub> for α6/α3β2β3 nAChRs by 4-fold. A minimum of four oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD. The analogs are listed in rank order of potency from top (most potent) to bottom (least potent); values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Data for PeIA (red dashed curves) were previously presented in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and shown for the ease of comparison to the curves of the analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Novel peptides containing the non-natural amino acids Aad, Api, or Asu show enhanced selectivity for α3β2 over α6/α3β2β3 nAChRs. Based on the structure–activity results with PeIA, a series of peptides were synthesized and a concentration–response analysis was performed for each to determine the IC<sub>50</sub> values for the inhibition of α3β2 and α6/α3β2β3 nAChRs as well as the selectivity ratio. (A) The first peptide synthesized, PeIA-4769, shares many of the residues found in PeIA (see <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) but has His and Leu residues in positions 9 and 10, respectively. PeIA-4769 was 68-fold more potent (blue curve) than PeIA on α3β2 nAChRs. Five additional peptides, based on PeIA-4769, were synthesized containing non-natural amino acid residues in position 11 and of them PeIA-5355, with Api in position 11, was the most potent (pM IC<sub>50</sub> value) on α3β2 nAChRs. (B) The IC<sub>50</sub> values for the peptides in (A) were determined for the inhibition of α6/α3β2β3 nAChRs and the α3β2-α6/α3β2β3 selectivity ratios calculated. PeIA-4769 was also potent (nM IC<sub>50</sub> value, blue curve) α6/α3β2β3 nAChRs. PeIA-5355 displayed the highest selectivity ratio (59-fold) for α3β2 and α6/α3β2β3 nAChRs. Selectivity ratios of 52- and 39-fold were also observed with PeIA-5415 and PeIA-5587, respectively. A minimum of four oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD; values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PeIA-5466 is potent and highly selective for α3β2 over α6/α3β2β3 nAChRs. Peptides based on PeIA-4769 and PeIA-5355 were synthesized with different residues in the 10th and 15th positions and a concentration–response analysis was performed for each. The IC<sub>50</sub> values for inhibition of α3β2 and α6/α3β2β3 nAChRs for each peptide were compared to those of PeIA and the α3β2-α6/α3β2β3 selectivity ratio calculated. (A, B) PeIA-5106 and PeIA-5416 were synthesized to evaluate the effects of Nle<sup>10</sup> and Ile<sup>15</sup>, respectively, on α3β2-α6/α3β2β3 nAChR selectivity. PeIA-5106 was 69-fold more potent than PeIA on α3β2 nAChRs, but only a minor increase (3-fold) in α3β2-α6/α3β2β3 selectivity, over PeIA-4769, was found. PeIA-5416 with Ile<sup>15</sup>, was 220-fold selective for α3β2 nAChRs. An additional 70-fold enhancement of selectivity was obtained with PeIA-5466 (red curves). A minimum of 4 oocytes was used for each IC<sub>50</sub> determination and the error bars indicate the SD; values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Kinetic analysis of PeIA-5466 for α3β2 and α6/α3β2β3 nAChRs. <i>Xenopus</i> oocytes expressing α3β2 or α6/α3β2β3 nAChRs were subjected to TEVC electrophysiology as described in <a class="ref internalNav" href="#sec4_1" aria-label="Methods">Methods</a>. (A) Representative current traces from an oocytes expressing α3β2 nAChRs before, during, and after exposure to 10 nM PeIA-5466. (B) Representative current traces from an oocyte expressing α6/α3β2β3 nAChRs before, during, and after exposure to 10 nM PeIA-5466. (C) The exponential fit of the data for the inhibition of α3β2 nAChRs yielded a <i>k</i><sub>obs</sub> of 0.617 ± 0.023 min<sup>–1</sup> and a <i>t</i><sub>1/2</sub> of 1.1 (1.0–1.2) min. (C, D) The current amplitudes in the presence of 10 nM PeIA-5466 were inhibited to 8 ± 1% (<i>n</i> = 5, SD) of control values for α3β2 nAChRs and to 90 ± 4% (<i>n</i> = 6, SD) of control values for α6/α3β2β3 nAChRs. (E) Representative current traces from an oocyte expressing α3β2 nAChRs showing the inhibition and recovery kinetics during and after exposure to 100 nM PeIA-5466. The current amplitudes in the presence of 100 nM peptide were inhibited to 2 ± 1% (<i>n</i> = 4, SD) of control values. (F) The exponential fit of the data for recovery from inhibition yielded an observed off-rate constant (<i>k</i><sub>off</sub>) of 0.065 ± 0.001 min<sup>–1</sup> and a <i>t</i><sub>1/2</sub> for recovery of 10.6 (10.2–11.0) min. The <i>K</i><sub>d</sub> was determined to be 1.18 ± 0.47 nM. The 30 s traces in A, B, and E are shown concatenated omitting the 30 s intersweep interval for brevity. The error bars in (C, D, and F) indicate the SD. The <i>K</i><sub>d</sub> was calculated from <i>K</i><sub>d</sub> = <i>k</i><sub>off</sub>/<i>k</i><sub>on</sub> where <i>k</i><sub>on</sub> = (<i>k</i><sub>obs</sub> – <i>k</i><sub>off</sub>)/[ligand].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/medium/jm-2019-00566q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Selectivity profiles of peptides containing non-natural amino acid residues. (A–D) The IC<sub>50</sub> values of PeIA-5106, PeIA-5413, PeIA-5416, and PeIA-5466 were determined for a panel of nAChR subtypes including α3β4, α4β2, α6/α3β4, and α7. PeIA-5355 displayed the largest selectivity ratio for α3β2 and α3β4 subtypes (1329-fold). PeIA-5466 displayed the largest selectivity ratio between α3β2 nAChRs and both α4β2 and α6/α3β4 subtypes. A minimum of four oocytes was used for each IC<sub>50</sub> curve with the exception of those for α3β4 where three oocytes were used. The exceptionally slow on-rate kinetics of all peptides for α3β4 nAChRs required 45–60 min to reach equilibrium using a concentration of 1 μM (data not shown). Two successive applications of 10 μM were then applied immediately after the equilibrium was achieved with 1 μM. The long perfusion time required for concentrations <300 nM exceeded practical recording times and only a few data points were obtained (<3). The error bars indicate the SD; values are provided in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. Data for α3β2 nAChRs (dashed red curves) were previously presented in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and shown for the ease of comparison to the curves for other subtypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00566/20190705/images/large/jm-2019-00566q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00566&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span> <span> </span><span class="NLM_article-title">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.tips.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16876883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=482-491&author=C.+Gottiauthor=M.+Zoliauthor=F.+Clementi&title=Brain+nicotinic+acetylcholine+receptors%3A+native+subtypes+and+their+relevance&doi=10.1016%2Fj.tips.2006.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span></div><div class="casAuthors">Gotti, Cecilia; Zoli, Michele; Clementi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors comprise a heterogeneous class of cationic channels that is present throughout the nervous system.  These channels are involved both in physiol. functions (including cognition, reward, motor activity and analgesia) and in pathol. conditions such as Alzheimer's disease, Parkinson's disease, some forms of epilepsy, depression, autism and schizophrenia.  They are also the targets of tobacco-smoking effects and addiction.  Neuronal nicotinic acetylcholine receptors are pentamers of homomeric or heteromeric combinations of α (α2-α10) and β (β2-β4) subunits, which have different pharmacol. and biophys. properties and locations in the brain.  The lack of subtype-specific ligands and the fact that many neuronal cells express multiple subtypes initially hampered the identification of the different native nicotinic acetylcholine receptor subtypes, but the increasing knowledge of subtype compn. and roles will be of considerable interest for the development of new and clin. useful nicotinic acetylcholine receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEGpOWmD0nkrVg90H21EOLACvtfcHk0lixxgil50V7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D&md5=3c913a4e614585b2f3f52fdfb523d28f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DBrain%2520nicotinic%2520acetylcholine%2520receptors%253A%2520native%2520subtypes%2520and%2520their%2520relevance%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D482%26epage%3D491%26doi%3D10.1016%2Fj.tips.2006.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors in neuropathic and inflammatory pain</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>592</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.12884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1002%2F1873-3468.12884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=29030971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslansr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=592&publication_year=2018&pages=1045-1062&author=A.+J.+Honeauthor=J.+M.+McIntosh&title=Nicotinic+acetylcholine+receptors+in+neuropathic+and+inflammatory+pain&doi=10.1002%2F1873-3468.12884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors in neuropathic and inflammatory pain</span></div><div class="casAuthors">Hone, Arik J.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">592</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1045-1062</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) are actively being investigated as therapeutic targets for the treatment of pain and inflammation, but despite more than 30 years of research, there are currently no FDA-approved analgesics that are specific for these receptors.  Much of the initial research effort focused on the α4β2 nAChR subtype, but more recently, addnl. subtypes have been identified as promising new leads and include α6β4, α7, and α9-contg. nAChRs.  This Review will focus on the distribution of these nAChRs in the cell types involved in neuropathic pain and inflammation and the activity of currently available nicotinic ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2oGGynDFQerVg90H21EOLACvtfcHk0lixxgil50V7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslansr%252FI&md5=f69f8999c25ad12272d2108c9b9cd6ae</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.12884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.12884%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%2520in%2520neuropathic%2520and%2520inflammatory%2520pain%26jtitle%3DFEBS%2520Lett.%26date%3D2018%26volume%3D592%26spage%3D1045%26epage%3D1062%26doi%3D10.1002%2F1873-3468.12884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunzell, D. H.</span></span> <span> </span><span class="NLM_article-title">Preclinical evidence that activation of mesolimbic alpha6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype</span>. <i>Nicotine Tob. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1258</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1093/ntr/nts089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1093%2Fntr%2Fnts089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=22492084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Srur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=1258-1269&author=D.+H.+Brunzell&title=Preclinical+evidence+that+activation+of+mesolimbic+alpha6+subunit+containing+nicotinic+acetylcholine+receptors+supports+nicotine+addiction+phenotype&doi=10.1093%2Fntr%2Fnts089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype</span></div><div class="casAuthors">Brunzell, Darlene H.</div><div class="citationInfo"><span class="NLM_cas:title">Nicotine & Tobacco Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1258-1269</span>CODEN:
                <span class="NLM_cas:coden">NTREF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-2203</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Introduction: Nicotine is a major psychoactive ingredient in tobacco yet very few individuals quit smoking with the aid of nicotine replacement therapy.  Targeted therapies with more selective action at nicotinic acetylcholine receptors (nAChRs) that contain a β2 subunit (β2*nAChRs; *denotes assembly with other subunits) have enjoyed significantly greater success, but exhibit potential for unwanted cardiac, gastrointestinal, and emotive side effects.  Discussion: This literature review focuses on the preclin. evidence that suggests that subclasses of β2*nAChRs that assemble with the α6 subunit may provide an effective target for tobacco cessation. α6β2*nAChRs have a highly selective pattern of neuroanatomical expression in catecholaminergic nuclei including the ventral tegmental area and its projection regions. α6β2*nAChRs promote dopamine (DA) neuron activity and DA release in the mesolimbic dopamine system, a brain circuitry that is well-studied for its contributions to addiction behavior.  A combination of genetic and pharmacol. studies indicates that activation of α6β2*nAChRs is necessary and sufficient for nicotine psychostimulant effects and nicotine self-administration. α6β2*nAChRs support maintenance of nicotine use, support the conditioned reinforcing effects of drug-assocd. cues, and regulate nicotine withdrawal.  Conclusions: These data suggest that α6β2*nAChRs represent a crit. pool of high affinity β2*nAChRs that regulates nicotine dependence phenotype and suggest that inhibition of these receptors may provide an effective strategy for tobacco cessation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomGwdGfeDdyLVg90H21EOLACvtfcHk0ljoGnF1OSN61w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Srur3P&md5=56014398337b177ef892e209462a2f68</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fntr%2Fnts089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fntr%252Fnts089%26sid%3Dliteratum%253Aachs%26aulast%3DBrunzell%26aufirst%3DD.%2BH.%26atitle%3DPreclinical%2520evidence%2520that%2520activation%2520of%2520mesolimbic%2520alpha6%2520subunit%2520containing%2520nicotinic%2520acetylcholine%2520receptors%2520supports%2520nicotine%2520addiction%2520phenotype%26jtitle%3DNicotine%2520Tob.%2520Res.%26date%3D2012%26volume%3D14%26spage%3D1258%26epage%3D1269%26doi%3D10.1093%2Fntr%2Fnts089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrion, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccenda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. A.</span></span> <span> </span><span class="NLM_article-title">CGTP Collaborators. The concise guide to PHARMACOLOGY 2015/16: ligand-gated ion channels</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">5870</span>– <span class="NLM_lpage">5903</span>, <span class="refDoi"> DOI: 10.1111/bph.13350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1111%2Fbph.13350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=26650440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKqtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=5870-5903&author=S.%0AP.+Alexanderauthor=J.+A.+Petersauthor=E.+Kellyauthor=N.+Marrionauthor=H.+E.+Bensonauthor=E.+Faccendaauthor=A.+J.+Pawsonauthor=J.+L.+Sharmanauthor=C.+Southanauthor=J.+A.+Davies&title=CGTP+Collaborators.+The+concise+guide+to+PHARMACOLOGY+2015%2F16%3A+ligand-gated+ion+channels&doi=10.1111%2Fbph.13350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels</span></div><div class="casAuthors">Alexander, Stephen P. H.; Peters, John A.; Kelly, Eamonn; Marrion, Neil; Benson, Helen E.; Faccenda, Elena; Pawson, Adam J.; Sharman, Joanna L.; Southan, Christopher; Davies, Jamie A.; CGTP Collaborators</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5870-5903</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The Concise Guide to PHARMACOl. 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacol., plus links to an open access knowledge base of drug targets and their ligands (www.guidetopharmacol.org), which provides more detailed views of target and ligand properties.  The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13349/full.  Ligand-gated ion channels are one of the eight major pharmacol. targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters.  These are presented with nomenclature guidance and summary information on the best available pharmacol. tools, alongside key refs. and suggestions for further reading.  The Concise Guide is published in landscape format in order to facilitate comparison of related targets.  It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacol.org, superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOl. 2013/14.  It is produced in conjunction with NC-IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate.  It consolidates information previously curated and displayed sep. in IUPHAR-DB and GRAC and provides a permanent, citable, point-in-time record that will survive database updates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT4dRlIqrJpLVg90H21EOLACvtfcHk0ljoGnF1OSN61w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKqtrnO&md5=91b1d9a402109b312e0be1eab89b5ca6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fbph.13350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13350%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DS.%2BP.%26aulast%3DPeters%26aufirst%3DJ.%2BA.%26aulast%3DKelly%26aufirst%3DE.%26aulast%3DMarrion%26aufirst%3DN.%26aulast%3DBenson%26aufirst%3DH.%2BE.%26aulast%3DFaccenda%26aufirst%3DE.%26aulast%3DPawson%26aufirst%3DA.%2BJ.%26aulast%3DSharman%26aufirst%3DJ.%2BL.%26aulast%3DSouthan%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DJ.%2BA.%26atitle%3DCGTP%2520Collaborators.%2520The%2520concise%2520guide%2520to%2520PHARMACOLOGY%25202015%252F16%253A%2520ligand-gated%2520ion%2520channels%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D5870%26epage%3D5903%26doi%3D10.1111%2Fbph.13350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baddick, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span> <span> </span><span class="NLM_article-title">An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.bcp.2011.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=21575611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKksLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=828-841&author=C.+G.+Baddickauthor=M.+J.+Marks&title=An+autoradiographic+survey+of+mouse+brain+nicotinic+acetylcholine+receptors+defined+by+null+mutants&doi=10.1016%2Fj.bcp.2011.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants</span></div><div class="casAuthors">Baddick, Christopher G.; Marks, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nine nicotinic receptor subunits are expressed in the central nervous system indicating that a variety of nicotinic acetylcholine receptors (nAChR) may be assembled.  A useful method with which to identify putative nAChR is radioligand binding.  In the current study the binding of [125I]α-bungarotoxin, [125I]α-conotoxinMII, 5[125I]-3-((2S)-azetidinylmethoxy)pyridine (A-85380), and [125I]epibatidine has been measured autoradiog. to provide data on many nAChR binding sites.  Each binding site was evaluated semi-quant. for samples prepd. from wild-type and α2, α4, α6, α7, β2, β4, α5 and β3 null mutant mice.  Deletion of the α7 subunit completely and selectively eliminated [125I]α-bungarotoxin binding.  The binding of [125I]α-conotoxinMII was eliminated in most brain regions by deletion of either the α6 or β2 subunit and is reduced by deletion of either the α4 or β3 subunit.  The binding of 5[125I]A-85380 was completely eliminated by deletion of the β2 subunit and significantly reduced by deletion of the α4 subunit.  Most, but not all, α4-independent sites require expression of the α6 subunit.  The effect of gene deletion on total [125I]epibatidine binding was very similar to that on [125I]A-85380 binding. [125I]Epibatidine also labels β4* nAChR, which was readily apparent for incubations conducted in the presence of 100 nM cytisine.  The effects of α3 gene deletion could not be evaluated, but persistence of residual sites implies the expression of α3* nAChR.  Taken together these results confirm and extend previously published evaluations of the effect of nAChR gene deletion and help to define the nAChR subtypes measurable by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfbL6hRbAVfbVg90H21EOLACvtfcHk0ljoGnF1OSN61w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKksLjL&md5=8ed112053333147a42745dfa31b9959d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DBaddick%26aufirst%3DC.%2BG.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26atitle%3DAn%2520autoradiographic%2520survey%2520of%2520mouse%2520brain%2520nicotinic%2520acetylcholine%2520receptors%2520defined%2520by%2520null%2520mutants%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D828%26epage%3D841%26doi%3D10.1016%2Fj.bcp.2011.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span> <span> </span><span class="NLM_article-title">Involvement of the alpha3 subunit in central nicotinic binding populations</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2522</span>– <span class="NLM_lpage">2529</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-07-02522.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.22-07-02522.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11923417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XisF2gurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2522-2529&author=P.+Whiteakerauthor=C.+G.+Petersonauthor=W.+Xuauthor=J.+M.+McIntoshauthor=R.+Paylorauthor=A.+L.+Beaudetauthor=A.+C.+Collinsauthor=M.+J.+Marks&title=Involvement+of+the+alpha3+subunit+in+central+nicotinic+binding+populations&doi=10.1523%2FJNEUROSCI.22-07-02522.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the α3 subunit in central nicotinic binding populations</span></div><div class="casAuthors">Whiteaker, Paul; Peterson, Cyrus G.; Xu, Wei; McIntosh, J. Michael; Paylor, Richard; Beaudet, Arthur L.; Collins, Allan C.; Marks, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2522-2529</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The α3 subunit gene was one of the first neuronal nicotinic acetylcholine receptor (nAChR) subunits to be cloned (Boulter et al., 1986), but direct evidence of α3 subunit contributions to mammalian central nAChR populations has not been presented.  The studies reported here used mice engineered to contain a null mutation in the α3 nAChR subunit gene (Xu et al., 1999) to examine the involvement of the α3 subunit in central nAChR populations.  Heterologously expressed αββ2 and αββ4 nAChRs are pharmacol. similar to native [125I]α-conotoxin MII (α-CtxMII)-binding and A 85380-resistant [125I]epibatidine-binding nAChR subtypes nAChRs was tested using quant. autoradiog. in α3-null mutant mice.  Somewhat surprisingly, deletion of the α3 nAChR subunit gene did not affect expression of the great majority of [125I]α-CtxMII-binding sites, indicating that they do not correspond to heterologously expressed α3β2 nAChRs.  The only exception to this was obsd. in the habenulointerpeduncular tract, where α3-dependent [125l]α-CtxMII binding was obsd.  This finding may suggest the presence of an addnl., minor nicotinic population in this pathway.  In contrast, most A 85380-resistant [125I]epibatidine-binding nAChRs were dependent on α3 gene expression, suggesting that they do indeed correspond to an α3 nAChR subtype.  However, widespread but lower levels of α3-independent A 85380-resistant [125I]epibatidine binding were also seen.  Again, this may indicate the existence of an addnl., minor population of non-α3 A 85380-resistant sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbSs2pQ4bQVrVg90H21EOLACvtfcHk0ljoGnF1OSN61w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisF2gurg%253D&md5=fdfac6437aaa0b0f849a50d02ff3aad5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-07-02522.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-07-02522.2002%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DPaylor%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DA.%2BL.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26atitle%3DInvolvement%2520of%2520the%2520alpha3%2520subunit%2520in%2520central%2520nicotinic%2520binding%2520populations%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D2522%26epage%3D2529%26doi%3D10.1523%2FJNEUROSCI.22-07-02522.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">David, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuraszkiewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr-Urtreger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papke, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholze, P.</span></span> <span> </span><span class="NLM_article-title">Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">978</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.2010.07133.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1111%2Fj.1460-9568.2010.07133.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=20377613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A280%3ADC%252BC3c3kvVKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=978-993&author=R.+Davidauthor=A.+Ciuraszkiewiczauthor=X.+Simeoneauthor=A.+Orr-Urtregerauthor=R.+L.+Papkeauthor=J.+M.+McIntoshauthor=S.+Huckauthor=P.+Scholze&title=Biochemical+and+functional+properties+of+distinct+nicotinic+acetylcholine+receptors+in+the+superior+cervical+ganglion+of+mice+with+targeted+deletions+of+nAChR+subunit+genes&doi=10.1111%2Fj.1460-9568.2010.07133.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes</span></div><div class="casAuthors">David Reinhard; Ciuraszkiewicz Anna; Simeone Xenia; Orr-Urtreger Avi; Papke Roger L; McIntosh J M; Huck Sigismund; Scholze Petra</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">978-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) mediate fast synaptic transmission in ganglia of the autonomic nervous system.  Here, we determined the subunit composition of hetero-pentameric nAChRs in the mouse superior cervical ganglion (SCG), the function of distinct receptors (obtained by deletions of nAChR subunit genes) and mechanisms at the level of nAChRs that might compensate for the loss of subunits.  As shown by immunoprecipitation and Western blots, wild-type (WT) mice expressed: alpha 3 beta 4 (55%), alpha 3 beta 4 alpha 5 (24%) and alpha 3 beta 4 beta 2 (21%) nAChRs. nAChRs in beta 4 knockout (KO) mice were reduced to < 15% of controls and no longer contained the alpha 5 subunit.  Compound action potentials, recorded from the postganglionic (internal carotid) nerve and induced by preganglionic nerve stimulation, did not differ between alpha 5 beta 4 KO and WT mice, suggesting that the reduced number of receptors in the KO mice did not impair transganglionic transmission.  Deletions of alpha 5 or beta2 did not affect the overall number of receptors and we found no evidence that the two subunits substitute for each other.  In addition, dual KOs allowed us to study the functional properties of distinct alpha 3 beta4 and alpha 3 beta 2 receptors that have previously only been investigated in heterologous expression systems.  The two receptors strikingly differed in the decay of macroscopic currents, the efficacy of cytisine, and their responses to the alpha-conotoxins AuIB and MII.  Our data, based on biochemical and functional experiments and several mouse KO models, clarify and significantly extend previous observations on the function of nAChRs in heterologous systems and the SCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUSUN5ZuqB2cKL0FlyGHDofW6udTcc2eZZnPk5eI4FS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3kvVKhuw%253D%253D&md5=e3e60e56e35d6489042efd44ef8b19af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2010.07133.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2010.07133.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DR.%26aulast%3DCiuraszkiewicz%26aufirst%3DA.%26aulast%3DSimeone%26aufirst%3DX.%26aulast%3DOrr-Urtreger%26aufirst%3DA.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DHuck%26aufirst%3DS.%26aulast%3DScholze%26aufirst%3DP.%26atitle%3DBiochemical%2520and%2520functional%2520properties%2520of%2520distinct%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520the%2520superior%2520cervical%2520ganglion%2520of%2520mice%2520with%2520targeted%2520deletions%2520of%2520nAChR%2520subunit%2520genes%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2010%26volume%3D31%26spage%3D978%26epage%3D993%26doi%3D10.1111%2Fj.1460-9568.2010.07133.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellar, K. J.</span></span> <span> </span><span class="NLM_article-title">Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose ganglia</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1699</span>, <span class="refDoi"> DOI: 10.1124/mol.106.027458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.106.027458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16882879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFygsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1693-1699&author=D.+Maoauthor=R.+P.+Yasudaauthor=H.+Fanauthor=B.+B.+Wolfeauthor=K.+J.+Kellar&title=Heterogeneity+of+nicotinic+cholinergic+receptors+in+rat+superior+cervical+and+nodose+ganglia&doi=10.1124%2Fmol.106.027458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose ganglia</span></div><div class="casAuthors">Mao, Danyan; Yasuda, Robert P.; Fan, Hong; Wolfe, Barry B.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1693-1699</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic cholinergic receptors (nAChRs) are present in ganglia in the peripheral nervous system.  In autonomic ganglia, they are responsible for fast synaptic transmission, whereas in the sensory ganglia and sensory neurons, they may be involved in modulation of neurotransmission.  The present study measured nAChRs in several rat autonomic ganglia: the superior cervical ganglia (SCG), sensory nodose ganglia, stellate ganglia, and pelvic ganglia.  The densities of the heteromeric nAChRs detd. by receptor binding assay in those four ganglia are 481, 45, 9, and 11 fmol/mg protein, resp.  Immunopptn. studies with subunit-specific antibodies showed that a majority of the nAChRs in the SCG and nodose ganglia contain the α3 and β4 subunits, but a significant percentage of the nAChRs in these ganglia also contain α5 and β2 subunits.  A small percentage of the nAChRs in nodose ganglia also contain α2 and α4 subunits.  Sequential immunopptn. assays indicated that in the SCG, all α5 subunits are assocd. with α3 and β4 subunits, forming the mixed heteromeric α3β4α5 subtype.  A receptor composed of α3, β2, and β4 subunits in the SCG was also detected.  In rat SCG, we found the following distribution of nAChRs subtypes: 55 to 60% simple α3β4 subtype, 25 to 30% α3β4α5 subtype, and 10 to 15% α3β4β2 subtype.  These findings indicate that the nAChRs in SCG and nodose ganglia are heterogeneous, which suggests that different receptor subtypes may play different roles in these ganglia or may be activated under different conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnjpJGg1ir7Vg90H21EOLACvtfcHk0ljopek42kkXrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFygsbbL&md5=4822eabbd069389ba81972fe75b0a0a9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.027458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.027458%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DD.%26aulast%3DYasuda%26aufirst%3DR.%2BP.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DHeterogeneity%2520of%2520nicotinic%2520cholinergic%2520receptors%2520in%2520rat%2520superior%2520cervical%2520and%2520nodose%2520ganglia%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1693%26epage%3D1699%26doi%3D10.1124%2Fmol.106.027458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marritt, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellar, K. J.</span></span> <span> </span><span class="NLM_article-title">Nicotinic cholinergic receptors in the rat retina: simple and mixed heteromeric subtypes</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1656</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1124/mol.105.012369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.105.012369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16129735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yksbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1656-1668&author=A.+M.+Marrittauthor=B.+C.+Coxauthor=R.+P.+Yasudaauthor=J.+M.+McIntoshauthor=Y.+Xiaoauthor=B.+B.+Wolfeauthor=K.+J.+Kellar&title=Nicotinic+cholinergic+receptors+in+the+rat+retina%3A+simple+and+mixed+heteromeric+subtypes&doi=10.1124%2Fmol.105.012369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic cholinergic receptors in the rat retina: Simple and mixed heteromeric subtypes</span></div><div class="casAuthors">Marritt, Andrea M.; Cox, Brandon C.; Yasuda, Robert P.; McIntosh, J. Michael; Xiao, Yingxian; Wolfe, Barry B.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1656-1668</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic acetylcholine receptors (nAChRs) were measured in the rat retina to det. the heteromeric subtypes.  The authors detected seven nicotinic receptor subunit mRNA transcripts, α2-α4, α6, and β2-β4, with RNase protection assays.  The d. of heteromeric nAChR binding sites is ∼3 times higher in the retina than in the cerebral cortex.  Moreover, the d. of the sites in the retina measured with [3H]epibatidine ([3H]EB) is ∼30% higher than with 125I-3-(2(S)-azetidinylmethoxy)pyridine (A-85380) and more than twice that measured with [3H]cytisine or [3H](-)nicotine.  These data suggest that the retina expresses multiple subtypes of nAChRs, including a large fraction of receptors contg. the β2 subunit and a smaller fraction contg. the β4 subunit.  Consistent with this, in binding competition studies, nicotinic ligands fit a model for two affinity classes of binding sites, with the higher affinity sites representing 70 to 80% of the nAChRs in the retina.  To det. the specific subtypes of nAChRs in the rat retina, the authors used subunit-specific antibodies in immunopptn. assays.  Immunopptn. of [3H]EB-labeled nAChRs with antibodies specific to the β2 and β4 subunits indicated that ∼80% of the receptors contained β2 subunits and ∼25% contained β4 receptors, consistent with the binding pharmacol. results.  Sequential immunopptn. assays indicated that the rat retina contains multiple subtypes of nAChRs.  The majority of the receptors measured seemed to be simple heteromeric subtypes, composed of a single type of α and a single type of β subunit; but a significant fraction are mixed heteromeric subtypes, composed of two or more α and/or β subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf3diaS65kBLVg90H21EOLACvtfcHk0ljopek42kkXrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yksbbJ&md5=5e81aa65a247d9cbab6e57991f7f86fd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.012369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.012369%26sid%3Dliteratum%253Aachs%26aulast%3DMarritt%26aufirst%3DA.%2BM.%26aulast%3DCox%26aufirst%3DB.%2BC.%26aulast%3DYasuda%26aufirst%3DR.%2BP.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DNicotinic%2520cholinergic%2520receptors%2520in%2520the%2520rat%2520retina%253A%2520simple%2520and%2520mixed%2520heteromeric%2520subtypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1656%26epage%3D1668%26doi%3D10.1124%2Fmol.105.012369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prashanth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of predatory and defensive venom peptides in cone snails</span>. <i>Mol. Biosyst.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2453</span>– <span class="NLM_lpage">2465</span>, <span class="refDoi"> DOI: 10.1039/C7MB00511C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1039%2FC7MB00511C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=29090697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGgsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=2453-2465&author=J.+R.+Prashanthauthor=S.+Dutertreauthor=R.+J.+Lewis&title=Pharmacology+of+predatory+and+defensive+venom+peptides+in+cone+snails&doi=10.1039%2FC7MB00511C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of predatory and defensive venom peptides in cone snails</span></div><div class="casAuthors">Prashanth, Jutty Rajan; Dutertre, Sebastien; Lewis, Richard James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2453-2465</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cone snails are predatory gastropods whose neurotoxic venom peptides (conotoxins) have been extensively studied for pharmacol. probes, venom evolution mechanisms and potential therapeutics.  Conotoxins have a wide range of structural and functional classes that continue to undergo accelerated evolution that underlies the rapid expansion of the genus over their short evolutionary history.  A no. of pharmacol. classes, driven by sep. evolved defensive and predatory venoms, have been hypothesised to facilitate shifts in prey that exemplify the adaptability of cone snails.  Here we provide an overview of these pharmacol. families and discuss their ecol. roles and evolutionary impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxcPA_aaO_t7Vg90H21EOLACvtfcHk0lh9XOLm0eRitA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGgsL3O&md5=289c17b0ba0357aa94a6069952187387</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC7MB00511C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MB00511C%26sid%3Dliteratum%253Aachs%26aulast%3DPrashanth%26aufirst%3DJ.%2BR.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26atitle%3DPharmacology%2520of%2520predatory%2520and%2520defensive%2520venom%2520peptides%2520in%2520cone%2520snails%26jtitle%3DMol.%2520Biosyst.%26date%3D2017%26volume%3D13%26spage%3D2453%26epage%3D2465%26doi%3D10.1039%2FC7MB00511C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plazas, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Casati, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgoyhen, A. B.</span></span> <span> </span><span class="NLM_article-title">A novel alpha-conotoxin, PeIA, cloned from <i>Conus pergrandis</i>, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">30107</span>– <span class="NLM_lpage">30112</span>, <span class="refDoi"> DOI: 10.1074/jbc.M504102200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M504102200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15983035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1CrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30107-30112&author=J.+M.+McIntoshauthor=P.+V.+Plazasauthor=M.+Watkinsauthor=M.+E.+Gomez-Casatiauthor=B.+M.+Oliveraauthor=A.+B.+Elgoyhen&title=A+novel+alpha-conotoxin%2C+PeIA%2C+cloned+from+Conus+pergrandis%2C+discriminates+between+rat+alpha9alpha10+and+alpha7+nicotinic+cholinergic+receptors&doi=10.1074%2Fjbc.M504102200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel α-Conotoxin, PeIA, Cloned from Conus pergrandis, Discriminates between Rat α9α10 and α7 Nicotinic Cholinergic Receptors</span></div><div class="casAuthors">McIntosh, J. Michael; Plazas, Paola V.; Watkins, Maren; Gomez-Casati, Maria E.; Olivera, Baldomero M.; Elgoyhen, A. Belen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">30107-30112</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The α9 and α10 nicotinic cholinergic subunits assemble to form the receptor believed to mediate synaptic transmission between efferent olivocochlear fibers and hair cells of the cochlea, one of the few examples of postsynaptic function for a non-muscle nicotinic acetylcholine receptor (nAChR).  However, it has been suggested that the expression profile of α9 and α10 overlaps with that of α7 in the cochlea and in sites such as dorsal root ganglion neurons, peripheral blood lymphocytes, developing thymocytes, and skin.  We now report the cloning, total synthesis, and characterization of a novel toxin α-conotoxin PeIA that discriminates between α9α10 and α7 nAChRs.  This is the first toxin to be identified from Conus pergrandis, a species found in deep waters of the Western Pacific.  α-Conotoxin PeIA displayed a 260-fold higher selectivity for α-bungarotoxin-sensitive α9α10 nAChRs compared with α-bungarotoxin-sensitive α7 receptors.  The IC50 of the toxin was 6.9±0.5 nM and 4.4±0.5 nM for recombinant α9α10 and wild-type hair cell nAChRs, resp.  α-Conotoxin PeIA bears high resemblance to α-conotoxins MII and GIC isolated from Conus magus and Conus geographus, resp.  However, neither α-conotoxin MII nor α-conotoxin GIC at concns. of 10 μM blocked acetylcholine responses elicited in Xenopus oocytes injected with the α9 and α10 subunits.  Among neuronal non-α-bungarotoxin-sensitive receptors, α-conotoxin PeIA was also active at α3β2 receptors and chimeric α6/α3β2β3 receptors.  α-Conotoxin PeIA represents a novel probe to differentiate responses mediated either through α9α10 or α7 nAChRs in those tissues where both receptors are expressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryUnClGrq7DrVg90H21EOLACvtfcHk0lh9XOLm0eRitA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1CrsLw%253D&md5=95d518d0f5c06356d47d021092c3a6af</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504102200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504102200%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DPlazas%26aufirst%3DP.%2BV.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DGomez-Casati%26aufirst%3DM.%2BE.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DElgoyhen%26aufirst%3DA.%2BB.%26atitle%3DA%2520novel%2520alpha-conotoxin%252C%2520PeIA%252C%2520cloned%2520from%2520Conus%2520pergrandis%252C%2520discriminates%2520between%2520rat%2520alpha9alpha10%2520and%2520alpha7%2520nicotinic%2520cholinergic%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30107%26epage%3D30112%26doi%3D10.1074%2Fjbc.M504102200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scadden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks alpha6beta2beta3 versus alpha6beta4 nicotinic acetylcholine receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">982</span>, <span class="refDoi"> DOI: 10.1124/mol.112.080853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.112.080853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=22914547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=972-982&author=A.+J.+Honeauthor=M.+Scaddenauthor=J.+Gajewiakauthor=S.+Christensenauthor=J.+Lindstromauthor=J.+M.+McIntosh&title=alpha-Conotoxin+PeIA%5BS9H%2CV10A%2CE14N%5D+potently+and+selectively+blocks+alpha6beta2beta3+versus+alpha6beta4+nicotinic+acetylcholine+receptors&doi=10.1124%2Fmol.112.080853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin PeIA[S9H, V10A, E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Hone, Arik J.; Scadden, Mick'l; Gajewiak, Joanna; Christensen, Sean; Lindstrom, Jon; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">972-982</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) contg. α6 and β2 subunits modulate dopamine release in the basal ganglia and are therapeutically relevant targets for treatment of neurol. and psychiatric disorders including Parkinson's disease and nicotine dependence.  However, the expression profile of β2 and β4 subunits overlap in a variety of tissues including locus ceruleus, retina, hippocampus, dorsal root ganglia, and adrenal chromaffin cells.  Ligands that bind α6β2 nAChRs also potently bind the closely related α6β4 subtype.  To distinguish between these two subtypes, we synthesized novel analogs of a recently described α-conotoxin, PeIA.  PeIA is a peptide antagonist that blocks several nAChR subtypes, including α6/α3β2β3 and α6/α3β4 nAChRs, with low nanomolar potency.  We systematically mutated PeIA and evaluated the resulting analogs for enhanced potency and/or selectivity for α6/α3β2β3 nAChRs expressed in Xenopus oocytes (α6/α3 is a subunit chimera that contains the N-terminal ligand-binding domain of the α6 subunit).  On the basis of these results, second-generation analogs were then synthesized.  The final analog, PeIA[S9H,V10A,E14N], potently blocked acetylcholine-gated currents mediated by α6/α3β2β3 and α6/α3β4 nAChRs with IC50 values of 223 pM and 65 nM, resp., yielding a >290-fold sepn. between the two subtypes.  Kinetic studies of ligand binding to α6/α3β2β3 nAChRs yielded a koff of 0.096±0.001 min-1 and a kon of 0.23±0.019 min-1 M-9.  The synthesis of PeIA[S9H,V10A,E14N] demonstrates that ligands can be developed to discriminate between α6β2 and α6β4 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK4nivcsuLRbVg90H21EOLACvtfcHk0lh9XOLm0eRitA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktLjF&md5=31cd7b436adad233ea33f7ff3c480579</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.080853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.080853%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DScadden%26aufirst%3DM.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3Dalpha-Conotoxin%2520PeIA%255BS9H%252CV10A%252CE14N%255D%2520potently%2520and%2520selectively%2520blocks%2520alpha6beta2beta3%2520versus%2520alpha6beta4%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D972%26epage%3D982%26doi%3D10.1124%2Fmol.112.080853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scadden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Positional scanning mutagenesis of alpha-conotoxin PeIA identifies critical residues that confer potency and selectivity for alpha6/alpha3beta2beta3 and alpha3beta2 nicotinic acetylcholine receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">25428</span>– <span class="NLM_lpage">25439</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.482059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M113.482059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=23846688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyisbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=25428-25439&author=A.+J.+Honeauthor=M.+Ruizauthor=M.+Scaddenauthor=S.+Christensenauthor=J.+Gajewiakauthor=L.+Azamauthor=J.+M.+McIntosh&title=Positional+scanning+mutagenesis+of+alpha-conotoxin+PeIA+identifies+critical+residues+that+confer+potency+and+selectivity+for+alpha6%2Falpha3beta2beta3+and+alpha3beta2+nicotinic+acetylcholine+receptors&doi=10.1074%2Fjbc.M113.482059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Positional Scanning Mutagenesis of α-Conotoxin PeIA Identifies Critical Residues That Confer Potency and Selectivity for α6/α3β2β3 and α3β2 Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Hone, Arik J.; Ruiz, Miguel; Scadden, Mick'l; Christensen, Sean; Gajewiak, Joanna; Azam, Layla; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">25428-25439</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The nicotinic acetylcholine receptor (nAChR) subtype α6β2* (the asterisk denotes the possible presence of addnl. subunits) has been identified as an important mol. target for the pharmacotherapy of Parkinson disease and nicotine dependence.  The α6 subunit is closely related to the α3 subunit, and this presents a problem in designing ligands that discriminate between α6β2* and α3β2* nAChRs.  The authors used positional scanning mutagenesis of α-conotoxin PeIA, which targets both α6β2* and α3β2*, in combination with mutagenesis of the α6 and α3 subunits, to gain mol. insights into the interaction of PeIA with heterologously expressed α6/α3β2β3 and α3β2 receptors.  Mutagenesis of PeIA revealed that Asn11 was located in an important position that interacts with the α6 and α3 subunits.  Substitution of Asn11 with a pos. charged amino acid essentially abolished the activity of PeIA for α3β2 but not for α6/α3β2β3 receptors.  These results were used to synthesize a PeIA analog that was >15,000-fold more potent on α6/α3β2β3 than α3β2 receptors.  Analogs with an N11R substitution were then used to show a crit. interaction between the 11th position of PeIA and Glu152 of the α6 subunit and Lys152 of the α3 subunit.  The results of these studies provide mol. insights into designing ligands that selectively target α6β2* nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa4UrcdUyLH7Vg90H21EOLACvtfcHk0liZcekL7CuM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyisbvN&md5=f07548e4b525c3f67d19c283dc4bf720</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.482059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.482059%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DRuiz%26aufirst%3DM.%26aulast%3DScadden%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DPositional%2520scanning%2520mutagenesis%2520of%2520alpha-conotoxin%2520PeIA%2520identifies%2520critical%2520residues%2520that%2520confer%2520potency%2520and%2520selectivity%2520for%2520alpha6%252Falpha3beta2beta3%2520and%2520alpha3beta2%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D25428%26epage%3D25439%26doi%3D10.1074%2Fjbc.M113.482059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Amino acid residues that confer high selectivity of the alpha6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A,E11A,L15A]</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">11625</span>– <span class="NLM_lpage">11632</span>, <span class="refDoi"> DOI: 10.1074/jbc.M710288200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M710288200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=18299323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=11625-11632&author=L.+Azamauthor=D.+Yoshikamiauthor=J.+M.+McIntosh&title=Amino+acid+residues+that+confer+high+selectivity+of+the+alpha6+nicotinic+acetylcholine+receptor+subunit+to+alpha-conotoxin+MII%5BS4A%2CE11A%2CL15A%5D&doi=10.1074%2Fjbc.M710288200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Residues That Confer High Selectivity of the α6 Nicotinic Acetylcholine Receptor Subunit to α-Conotoxin MII[S4A,E11A,L15A]</span></div><div class="casAuthors">Azam, Layla; Yoshikami, Doju; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11625-11632</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) contg. α3 and β2 subunits are found in autonomic ganglia and mediate ganglionic transmission.  The closely related α6 nAChR subtype is found in the central nervous system where changes in its level of expression are obsd. in Parkinson's disease.  To obtain a ligand that discriminates between these two receptors, the authors designed and synthesized a novel analog of α-conotoxin MII, MII[S4A,E11A,L15A], and tested it on nAChRs expressed in Xenopus oocytes.  The peptide blocked chimeric α6/α3β2β3 nAChRs with an IC50 of 1.2 nM; in contrast, its IC50 on the closely related α3β2 as well as non-α6 nAChRs was three orders of magnitude higher.  The authors identified the residues in the receptors that are responsible for their differential sensitivity to the peptide.  The authors constructed chimeras with increasingly longer fragments of the N-terminal ligand binding domain of the α3 subunit inserted into the homologous positions of the α6 subunit, and these were used to det. that the region downstream of the first 140 amino acids was involved.  Further mutagenesis of this region revealed that the α6 subunit residues Glu 152, Asp 184, and Thr 195 were crit., and replacement of these three residues with their homologs from the α3 subunit increased the IC50 of the peptide by >1000-fold.  Conversely, when these key residues in α3 were replaced with those from α6, the IC50 decreased by almost 150-fold.  Similar effects were seen with other α6-selective conotoxins, suggesting the general importance of these α6 residues in conferring selective binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKOAKc153j1rVg90H21EOLACvtfcHk0liZcekL7CuM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSgtb0%253D&md5=a1abf4d7afff19417b0eb22507aaa978</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M710288200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M710288200%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DAmino%2520acid%2520residues%2520that%2520confer%2520high%2520selectivity%2520of%2520the%2520alpha6%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520to%2520alpha-conotoxin%2520MII%255BS4A%252CE11A%252CL15A%255D%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D11625%26epage%3D11632%26doi%3D10.1074%2Fjbc.M710288200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talley, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsigelny, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">24678</span>– <span class="NLM_lpage">24686</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602969200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.M602969200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16803900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1eqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=24678-24686&author=T.+T.+Talleyauthor=B.+M.+Oliveraauthor=K.+H.+Hanauthor=S.+B.+Christensenauthor=C.+Dowellauthor=I.+Tsigelnyauthor=K.+Y.+Hoauthor=P.+Taylorauthor=J.+M.+McIntosh&title=Alpha-conotoxin+OmIA+is+a+potent+ligand+for+the+acetylcholine-binding+protein+as+well+as+alpha3beta2+and+alpha7+nicotinic+acetylcholine+receptors&doi=10.1074%2Fjbc.M602969200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin OmIA Is a Potent Ligand for the Acetylcholine-binding Protein as Well as α3β2 and α7 Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Talley, Todd T.; Olivera, Baldomero M.; Han, Kyou-Hoon; Christensen, Sean B.; Dowell, Cheryl; Tsigelny, Igor; Ho, Kwok-Yiu; Taylor, Palmer; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">24678-24686</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The molluskan acetylcholine-binding protein (AChBP) is a homolog of the extracellular binding domain of the pentameric ligand-gated ion channel family.  AChBP most closely resembles the α-subunit of nicotinic acetylcholine receptors and in particular the homomeric α7 nicotinic receptor.  We report the isolation and characterization of an α-conotoxin that has the highest known affinity for the Lymnaea AChBP and also potently blocks the α7 nAChR subtype when expressed in Xenopus oocytes.  Remarkably, the peptide also has high affinity for the α3β2 nAChR indicating that α-conotoxin OmIA in combination with the AChBP may serve as a model system for understanding the binding determinants of α3β2 nAChRs.  α-Conotoxin OmIA was purified from the venom of Conus omaria.  It is a 17-amino-acid, two-disulfide bridge peptide.  The ligand is the first α-conotoxin with higher affinity for the closely related receptor subtypes, α3β2 vs. α6β2, and selectively blocks these two subtypes when compared with α2β2, α4β2, and α1β1δε nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGk7LsNVTHLVg90H21EOLACvtfcHk0liZcekL7CuM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1eqtL4%253D&md5=fb284ad12ed0d254efeea3b6e0605804</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602969200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602969200%26sid%3Dliteratum%253Aachs%26aulast%3DTalley%26aufirst%3DT.%2BT.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DHan%26aufirst%3DK.%2BH.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DTsigelny%26aufirst%3DI.%26aulast%3DHo%26aufirst%3DK.%2BY.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DAlpha-conotoxin%2520OmIA%2520is%2520a%2520potent%2520ligand%2520for%2520the%2520acetylcholine-binding%2520protein%2520as%2520well%2520as%2520alpha3beta2%2520and%2520alpha7%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D24678%26epage%3D24686%26doi%3D10.1074%2Fjbc.M602969200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span> <span> </span><span class="NLM_article-title">Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">8785</span>– <span class="NLM_lpage">8789</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-20-08785.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.22-20-08785.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=12388584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XosV2jurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=8785-8789&author=M.+Zoliauthor=M.+Morettiauthor=A.+Zanardiauthor=J.+M.+McIntoshauthor=F.+Clementiauthor=C.+Gotti&title=Identification+of+the+nicotinic+receptor+subtypes+expressed+on+dopaminergic+terminals+in+the+rat+striatum&doi=10.1523%2FJNEUROSCI.22-20-08785.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum</span></div><div class="casAuthors">Zoli, Michele; Moretti, Milena; Zanardi, Alessio; McIntosh, J. Michael; Clementi, Francesco; Gotti, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8785-8789</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal nicotinic acetylcholine receptors (nAChRs) expressed on mesostriatal dopaminergic neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement.  Using immunopptn. and ligand-binding techniques, the authors have shown that both α6β2* and α4(nonα6)β2* nAChRs are expressed in the caudate-putamen and that only α6* nAChRs can bind α-conotoxin MII and methyllycaconitine with affinities of 1.3 and 40 nM, resp.  Further studies performed on 6-hydroxydopamine-lesioned striatum led to the identification of nAChR subtypes selectively expressed on dopaminergic terminals [α4α5β2, α4α6β2(β3), and α6β2(β3)], nondopaminergic neuronal structures (α2α4β2), or both structures (α4β2).  The identification of the nAChRs expressed on striatal dopaminergic terminals opens up the possibility of developing selective nAChR ligands active on dopaminergic systems and assocd. diseases, such as Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohdPx-pMamHrVg90H21EOLACvtfcHk0liZcekL7CuM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosV2jurw%253D&md5=3e65f80387d6cec795ce85a3f9284caa</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-20-08785.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-20-08785.2002%26sid%3Dliteratum%253Aachs%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DGotti%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520the%2520nicotinic%2520receptor%2520subtypes%2520expressed%2520on%2520dopaminergic%2520terminals%2520in%2520the%2520rat%2520striatum%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D8785%26epage%3D8789%26doi%3D10.1523%2FJNEUROSCI.22-20-08785.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champtiaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marubio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span> <span> </span><span class="NLM_article-title">Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1208</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-04-01208.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.22-04-01208.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11850448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFeksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=1208-1217&author=N.+Champtiauxauthor=Z.+Y.+Hanauthor=A.+Bessisauthor=F.+M.+Rossiauthor=M.+Zoliauthor=L.+Marubioauthor=J.+M.+McIntoshauthor=J.+P.+Changeux&title=Distribution+and+pharmacology+of+alpha+6-containing+nicotinic+acetylcholine+receptors+analyzed+with+mutant+mice&doi=10.1523%2FJNEUROSCI.22-04-01208.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice</span></div><div class="casAuthors">Champtiaux, Nicolas; Han, Zhi-Yan; Bessis, Alain; Rossi, Francesco Mattia; Zoli, Michele; Marubio, Lisa; McIntosh, J. Michael; Changeux, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1208-1217</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The α6 subunit of the nicotinic acetylcholine receptor (nAChR) is expressed at very high levels in dopaminergic (DA) neurons.  However, because of the lack of pharmacol. tools selective for α6-contg. nAChRs, the role of this subunit in the etiol. of nicotine addiction remains unknown.  To provide new tools to investigate this issue, the authors generated an α6 nAChR knock-out mouse.  Homozygous null mutants (α6-/-) did not exhibit any gross neurol. or behavioral deficits.  A careful anat. and mol. examn. of α6-/- mouse brains demonstrated the absence of developmental alterations in these animals, esp. in the visual and dopaminergic pathways, where the α6 subunit is normally expressed at the highest levels.  On the other hand, receptor autoradiog. revealed a decrease in [3H]nicotine, [3H]epibatidine, and [3H]cytisine high-affinity binding in the terminal fields of retinal ganglion cells of α6-/- animals, whereas high-affinity [125I]α-conotoxinMII (αCtxMII) binding completely disappeared in the brain.  Moreover, inhibition of [3H]epibatidine binding on striatal membranes, using unlabeled αCtxMII or cytisine, revealed the absence of αCtxMII-sensitive and cytisine-resistant [3H]epibatidine binding sites in α6-/- mice, although the total amt. of binding was unchanged.  Because αCtxMII, a toxin formerly thought to be specific for α3β2-contg. nAChRs, is known to partially inhibit nicotine-induced dopamine release, these results support the conclusion that α6 rather than α3 is the partner of β2 in the nicotinic modulation of DA neurons.  They further show that α6-/- mice might be useful tools to understand the mechanisms of nicotine addiction, although some developmental compensation might occur in these mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIjWbQ1jwkLVg90H21EOLACvtfcHk0ljOmfT_iFMuyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFeksr4%253D&md5=1c980791f21ea6863b8d31628ee16447</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-04-01208.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-04-01208.2002%26sid%3Dliteratum%253Aachs%26aulast%3DChamptiaux%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DZ.%2BY.%26aulast%3DBessis%26aufirst%3DA.%26aulast%3DRossi%26aufirst%3DF.%2BM.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DMarubio%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DDistribution%2520and%2520pharmacology%2520of%2520alpha%25206-containing%2520nicotinic%2520acetylcholine%2520receptors%2520analyzed%2520with%2520mutant%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D1208%26epage%3D1217%26doi%3D10.1523%2FJNEUROSCI.22-04-01208.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span> <span> </span><span class="NLM_article-title">The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.neuropharm.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15814104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1KhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=696-705&author=O.+Salminenauthor=P.+Whiteakerauthor=S.+R.+Gradyauthor=A.+C.+Collinsauthor=J.+M.+McIntoshauthor=M.+J.+Marks&title=The+subunit+composition+and+pharmacology+of+alpha-Conotoxin+MII-binding+nicotinic+acetylcholine+receptors+studied+by+a+novel+membrane-binding+assay&doi=10.1016%2Fj.neuropharm.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The subunit composition and pharmacology of α-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay</span></div><div class="casAuthors">Salminen, Outi; Whiteaker, Paul; Grady, Sharon R.; Collins, Allan C.; McIntosh, J. Michael; Marks, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">696-705</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The subunit compn. and pharmacol. of α-Conotoxin MII-binding (α-CtxMII) nicotinic acetylcholine receptors (nAChR) was studied by an improved [125I]-α-CtxMII membrane binding method.  This binding method facilitates pharmacol. studies that have been difficult to accomplish with [125I]-α-CtxMII autoradiog. or α-CtxMII inhibition of [125I]-epibatidine binding.  Binding densities and Kd-values obtained by this [125I]-α-CtxMII membrane binding were similar to the values obtained by autoradiog. or α-CtxMII inhibition of [125I]-epibatidine binding, verifying that each of these approaches measures the same nAChR population.  Binding results with nAChR subunit-null mutant mice confirm and extend observations from earlier studies: [125I]-α-CtxMII binding measures two sets of α6β2* nAChR (α4α6β2β3 or α6β2β3).  Most nicotinic agonists and antagonists show monophasic inhibition of [125I]-α-CtxMII binding, indicating that α4α6β2β3 and α6β2β3 have similar binding properties.  Comparison of the binding and activation profiles of α6β2* nAChR to those of other nAChR subtypes (α4β2* and β4*) indicates that these receptors have distinctly different pharmacol. indicating that it may be possible to target α6β2* nAChR selectively to develop compds. that might be therapeutically useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-j_xt2Pmj7LVg90H21EOLACvtfcHk0ljOmfT_iFMuyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1KhtLk%253D&md5=0d0cb2418f06d4e5c37aa03eb13a7a64</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DO.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520subunit%2520composition%2520and%2520pharmacology%2520of%2520alpha-Conotoxin%2520MII-binding%2520nicotinic%2520acetylcholine%2520receptors%2520studied%2520by%2520a%2520novel%2520membrane-binding%2520assay%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D48%26spage%3D696%26epage%3D705%26doi%3D10.1016%2Fj.neuropharm.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vailati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span> <span> </span><span class="NLM_article-title">Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1124/mol.104.006015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.104.006015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15470079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt12ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=32-41&author=M.+Quikauthor=S.+Vailatiauthor=T.+Bordiaauthor=J.+M.+Kulakauthor=H.+Fanauthor=J.+M.+McIntoshauthor=F.+Clementiauthor=C.+Gotti&title=Subunit+composition+of+nicotinic+receptors+in+monkey+striatum%3A+effect+of+treatments+with+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+or+L-DOPA&doi=10.1124%2Fmol.104.006015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit composition of nicotinic receptors in monkey striatum: Effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA</span></div><div class="casAuthors">Quik, Maryka; Vailati, Silvia; Bordia, Tanuja; Kulak, Jennifer M.; Fan, Hong; McIntosh, J. Michael; Clementi, Francesco; Gotti, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) represent an important modulator of striatal function both under normal conditions and in pathol. states such as Parkinson's disease.  Because different nAChR subtypes may have unique functions, immunopptn. and ligand binding studies were done to identify their subunit compn.  As in the rodent, α2, α4, α6, β2, and β3 nAChR subunit immunoreactivity was identified in monkey striatum.  However, distinct from the rodent, the present results also revealed the novel presence of α3 nAChR subunit-immunoreactivity in this same region, but not that for α5 and β4.  Relatively high levels of α2 and α3 subunits were also identified in monkey cortex, in addn. to α4 and β2.  Expts. were next done to det. whether striatal subunit expression was changed with nigrostriatal damage.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment decreased α6 and β3 subunit immunoreactivity by ∼80% in parallel with the dopamine transporter, suggesting that they are predominantly expressed on nigrostriatal dopaminergic projections.  In contrast, α3, α4, and β2 subunit immunoreactivity was decreased ∼50%, whereas α2 was not changed.  These data, together with those from dual immunopptn. and radioligand binding studies ([3H]cytisine, 125I-α-bungarotoxin, and 125I-α-conotoxin MII) suggest the following: that α6β2β3, α6α4β2β3, and α3β2* nAChR subtypes are present on dopaminergic terminals and that the α4β2 subtype is localized on both dopaminergic and nondopaminergic neurons, whereas α2β2* and α7 receptors are localized on nondopaminergic cells in monkey striatum.  Overall, these results suggest that drugs targeting non-α7 nicotinic receptors may be useful in the treatment of disorders characterized by nigrostriatal dopaminergic damage, such as Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfYoM-4rzm1bVg90H21EOLACvtfcHk0ljpK5vvtZs05A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt12ktg%253D%253D&md5=11bbf456c9535606260ea6290818d63f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006015%26sid%3Dliteratum%253Aachs%26aulast%3DQuik%26aufirst%3DM.%26aulast%3DVailati%26aufirst%3DS.%26aulast%3DBordia%26aufirst%3DT.%26aulast%3DKulak%26aufirst%3DJ.%2BM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DGotti%26aufirst%3DC.%26atitle%3DSubunit%2520composition%2520of%2520nicotinic%2520receptors%2520in%2520monkey%2520striatum%253A%2520effect%2520of%2520treatments%2520with%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520or%2520L-DOPA%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D32%26epage%3D41%26doi%3D10.1124%2Fmol.104.006015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5263</span>– <span class="NLM_lpage">5270</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.17-14-05263.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1523%2FJNEUROSCI.17-14-05263.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=9204910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADyaK2sXksVSgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=5263-5270&author=J.+M.+Kulakauthor=T.+A.+Nguyenauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Alpha-conotoxin+MII+blocks+nicotine-stimulated+dopamine+release+in+rat+striatal+synaptosomes&doi=10.1523%2FJNEUROSCI.17-14-05263.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes</span></div><div class="casAuthors">Kulak, Jennifer M.; Nguyen, Thu A.; Olivera, Baldomero M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5263-5270</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Activation of presynaptic nicotinic acetylcholine receptors (nAChRs) can induce the release of neurotransmitters such as dopamine and norepinephrine in the CNS.  Accumulating evidence suggests that distinct nAChR subtypes are involved; however, it has been difficult to det. the subunit compn. of these receptors, in part because of the lack of a sufficient variety of selective nAChR ligands.  We present exptl. data that at least two different nAChR complexes are involved in dopamine release, one of which has an α3/β2 subunit interface.  The recently discovered peptide α-conotoxin MII is a potent and selective inhibitor of rat nAChRs contg. an interface formed by α3 and β2 subunits.  We used this peptide to examine nicotine-stimulated release of dopamine from rat striatal synaptosomes and of norepinephrine from hippocampal synaptosomes.  MII (100 nM) blocks 34-49% of the nicotine-stimulated dopamine release, but not dopamine release evoked by elevated[K+].  Furthermore, two peptides structurally related to α-conotoxin MII, namely α-conotoxin MI (selective for α1β1γδ nAChRs) and α-conotoxin ImI (selective for α7-contg. nAChRs), have no effect on nicotine-stimulated dopamine release.  The results indicate that one third to half of the dopamine release in the striatal prepn. is mediated by nAChRs with an α3/β2 subunit interface.  In contrast, ≤10% of nicotine-stimulated release of norepinephrine from hippocampal synaptosomes is modulated by nAChRs with α3/β2 subunit interfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCDub8lqnGxbVg90H21EOLACvtfcHk0ljpK5vvtZs05A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksVSgsbg%253D&md5=766107bb112c64bbfb6cbc29b0ae81d5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-14-05263.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-14-05263.1997%26sid%3Dliteratum%253Aachs%26aulast%3DKulak%26aufirst%3DJ.%2BM.%26aulast%3DNguyen%26aufirst%3DT.%2BA.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DAlpha-conotoxin%2520MII%2520blocks%2520nicotine-stimulated%2520dopamine%2520release%2520in%2520rat%2520striatal%2520synaptosomes%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D5263%26epage%3D5270%26doi%3D10.1523%2FJNEUROSCI.17-14-05263.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grady, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span> <span> </span><span class="NLM_article-title">Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.2.651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fjpet.301.2.651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11961070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=651-660&author=S.+R.+Gradyauthor=K.+L.+Murphyauthor=J.+Caoauthor=M.+J.+Marksauthor=J.+M.+McIntoshauthor=A.+C.+Collins&title=Characterization+of+nicotinic+agonist-induced+%5B%283%29H%5Ddopamine+release+from+synaptosomes+prepared+from+four+mouse+brain+regions&doi=10.1124%2Fjpet.301.2.651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of nicotinic agonist-induced [3H]dopamine release from synaptosomes prepared from four mouse brain regions</span></div><div class="casAuthors">Grady, Sharon R.; Murphy, Karen L.; Cao, Jian; Marks, Michael J.; McIntosh, J. Michael; Collins, Allan C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-660</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The inhibition of uptake of [3H]dopamine into synaptosomes prepd. from four mouse brain regions was investigated.  The inhibition curves demonstrated that in three regions: the striatum, nucleus accumbens, and olfactory tubercle, [3H]dopamine was taken up exclusively by dopaminergic terminals.  In the frontal cortex, however, only a portion of the uptake was into dopaminergic terminals, with a larger amt. taken up by noradrenergic terminals, and another small portion by serotonergic terminals.  Release studies in the frontal cortex indicated that in this region only dopaminergic and noradrenergic terminals are capable of packaging [3H]dopamine in a form allowing vesicle-mediated release; addnl., only the dopaminergic terminals have functional presynaptic nicotinic receptors (nAChRs) that, when stimulated by nicotinic agonists, evoke [3H]dopamine release.  Agonist-stimulated [3H]dopamine release was also characterized from synaptosomes prepd. from four mouse brain regions.  α-Conotoxin MII was a partial inhibitor of dopamine release in all of the brain regions studied, which suggests that a min. of two nAChRs are expressed in the nerve terminals of all four brain regions.  No nicotine-induced [3H]dopamine release was detected in any brain region studied when the synaptosomes were prepd. from β2 null mutant mice, which indicates that the β2 subunit is required for all nAChRs mediating this release.  Dose-response curves were constructed for seven agonists in each of the brain regions.  The pharmacol. properties of synaptosomal [3H]dopamine release appeared to be similar in all four brain regions.  The results suggest that all four regions express the same nAChRs, although subtle regional differences may exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgS8nj0_VWa7Vg90H21EOLACvtfcHk0lghxnMvZ6TArA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKisrc%253D&md5=ae83385c1ed735bd9a0ca39a82dd7449</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.2.651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.2.651%26sid%3Dliteratum%253Aachs%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26atitle%3DCharacterization%2520of%2520nicotinic%2520agonist-induced%2520%255B%25283%2529H%255Ddopamine%2520release%2520from%2520synaptosomes%2520prepared%2520from%2520four%2520mouse%2520brain%2520regions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D651%26epage%3D660%26doi%3D10.1124%2Fjpet.301.2.651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span> <span> </span><span class="NLM_article-title">Expression of nigrostriatal alpha6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta3 subunit gene deletion</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2015</span>, <span class="refDoi"> DOI: 10.1124/mol.105.011940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.105.011940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15749993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=2007-2015&author=C.+Gottiauthor=M.+Morettiauthor=F.+Clementiauthor=L.+Rigantiauthor=J.+M.+McIntoshauthor=A.+C.+Collinsauthor=M.+J.+Marksauthor=P.+Whiteaker&title=Expression+of+nigrostriatal+alpha6-containing+nicotinic+acetylcholine+receptors+is+selectively+reduced%2C+but+not+eliminated%2C+by+beta3+subunit+gene+deletion&doi=10.1124%2Fmol.105.011940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of nigrostriatal α6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by β3 subunit gene deletion</span></div><div class="casAuthors">Gotti, Cecilia; Moretti, Milena; Clementi, Francesco; Riganti, Loredana; McIntosh, J. Michael; Collins, Allan C.; Marks, Michael J.; Whiteaker, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2007-2015</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mRNAs for the neuronal nicotinic acetylcholine receptor (nAChR) α6 and β3 subunits are abundantly expressed and colocalized in dopaminergic cells of the substantia nigra and ventral tegmental area.  Studies using subunit-null mutant mice have shown that α6- or β3-dependent nAChRs bind α-conotoxin MII (α-CtxMII) with high affinity and modulate striatal dopamine release.  This study explores the effects of β3 subunit-null mutation on striatal and midbrain nAChR expression, compn., and pharmacol.  Ligand binding and immunopptn. expts. using subunit-specific antibodies indicated that β3-null mutation selectively reduced striatal α6* nAChR expression by 76% vs. β3+/+ control.  Parallel expts. showed a smaller redn. in both midbrain α3* and α6* nAChRs (34 and 42% vs. β3+/+ control, resp.).  Sedimentation coeff. detns. indicated that residual α6* nAChRs in β3-/- striatum were pentameric, like their wild-type counterparts.  Immunopptn. expts. on immunopurified β3* nAChRs demonstrated that almost all wild-type striatal β3* nAChRs also contain α4, α6, and β2 subunits, although a small population of non-β3 α6* nAChRs is also expressed.  β3 Subunit incorporation seemed to increase α4 participation in α6β2* complexes.  125I-Epibatidine competition binding studies showed that the α-CtxMII affinity of α6* nAChRs from the striata of β3-/- mice was similar to those isolated from β3+/+ animals.  Together, the results of these expts. show that the β3 subunit is important for the correct assembly, stability and/or transport of α6* nAChRs in dopaminergic neurons and influences their subunit compn.  However, β3 subunit expression is not essential for the expression of α6*, high-affinity α-CtxMII binding nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDHKIOr-LPj7Vg90H21EOLACvtfcHk0lghxnMvZ6TArA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGisrc%253D&md5=7e8ba400791a42769484817633f82772</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.011940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.011940%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DRiganti%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DWhiteaker%26aufirst%3DP.%26atitle%3DExpression%2520of%2520nigrostriatal%2520alpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%2520is%2520selectively%2520reduced%252C%2520but%2520not%2520eliminated%252C%2520by%2520beta3%2520subunit%2520gene%2520deletion%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D2007%26epage%3D2015%26doi%3D10.1124%2Fmol.105.011940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuraszkiewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr-Urtreger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens-Gruber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholze, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huck, S.</span></span> <span> </span><span class="NLM_article-title">The role of the nAChR subunits alpha5, beta2, and beta4 on synaptic transmission in the mouse superior cervical ganglion</span>. <i>Physiol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e14023</span> <span class="refDoi"> DOI: 10.14814/phy2.14023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.14814%2Fphy2.14023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=30891952" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&author=X.+Simeoneauthor=R.+Karchauthor=A.+Ciuraszkiewiczauthor=A.+Orr-Urtregerauthor=R.+Lemmens-Gruberauthor=P.+Scholzeauthor=S.+Huck&title=The+role+of+the+nAChR+subunits+alpha5%2C+beta2%2C+and+beta4+on+synaptic+transmission+in+the+mouse+superior+cervical+ganglion&doi=10.14814%2Fphy2.14023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.14814%2Fphy2.14023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14814%252Fphy2.14023%26sid%3Dliteratum%253Aachs%26aulast%3DSimeone%26aufirst%3DX.%26aulast%3DKarch%26aufirst%3DR.%26aulast%3DCiuraszkiewicz%26aufirst%3DA.%26aulast%3DOrr-Urtreger%26aufirst%3DA.%26aulast%3DLemmens-Gruber%26aufirst%3DR.%26aulast%3DScholze%26aufirst%3DP.%26aulast%3DHuck%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520the%2520nAChR%2520subunits%2520alpha5%252C%2520beta2%252C%2520and%2520beta4%2520on%2520synaptic%2520transmission%2520in%2520the%2520mouse%2520superior%2520cervical%2520ganglion%26jtitle%3DPhysiol.%2520Rep.%26date%3D2019%26volume%3D7%26doi%3D10.14814%2Fphy2.14023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. H.</span></span> <span> </span><span class="NLM_article-title">Solution conformation of a neuronal nicotinic acetylcholine receptor antagonist alpha-conotoxin OmIA that discriminates alpha3 vs. alpha6 nAChR subtypes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.04.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.bbrc.2006.04.099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=16678128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslSnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2006&pages=248-254&author=S.+W.+Chiauthor=D.+H.+Kimauthor=B.+M.+Oliveraauthor=J.+M.+McIntoshauthor=K.+H.+Han&title=Solution+conformation+of+a+neuronal+nicotinic+acetylcholine+receptor+antagonist+alpha-conotoxin+OmIA+that+discriminates+alpha3+vs.+alpha6+nAChR+subtypes&doi=10.1016%2Fj.bbrc.2006.04.099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Solution conformation of a neuronal nicotinic acetylcholine receptor antagonist α-conotoxin OmIA that discriminates α3 vs. α6 nAChR subtypes</span></div><div class="casAuthors">Chi, Seung-Wook; Kim, Do-Hyoung; Olivera, Baldomero M.; McIntosh, J. Michael; Han, Kyou-Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">α-Conotoxin OmIA from Conus omaria is the only α-conotoxin that shows a ∼20-fold higher affinity to the α3β2 over the α6β2 subtype of nicotinic acetylcholine receptor.  We have detd. a three-dimensional structure of α-conotoxin OmIA by NMR spectroscopy.  α-Conotoxin OmIA has an "ω-shaped" overall topol. with His5-Asn12 forming an α-helix.  Structural features of α-conotoxin OmIA responsible for its selectivity are suggested by comparing its surface characteristics with other functionally related α4/7 subfamily conotoxins.  Reduced size of the hydrophilic area in α-conotoxin OmIA seems to be assocd. with the reduced affinity towards the α6β2 nAChR subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtnWTjeKeN8rVg90H21EOLACvtfcHk0lghxnMvZ6TArA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslSnu7s%253D&md5=e64419c9f40d215bc4c13f9419e76d48</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.04.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.04.099%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DHan%26aufirst%3DK.%2BH.%26atitle%3DSolution%2520conformation%2520of%2520a%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%2520alpha-conotoxin%2520OmIA%2520that%2520discriminates%2520alpha3%2520vs.%2520alpha6%2520nAChR%2520subtypes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D345%26spage%3D248%26epage%3D254%26doi%3D10.1016%2Fj.bbrc.2006.04.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weltzin, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span> <span> </span><span class="NLM_article-title">A novel alpha4/7-conotoxin LvIA from <i>Conus lividus</i> that selectively blocks alpha3beta2 vs. alpha6/alpha3beta2beta3 nicotinic acetylcholine receptors</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.1096/fj.13-244103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1096%2Ffj.13-244103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=24398291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVGrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1842-1853&author=S.+Luoauthor=D.+Zhangsunauthor=C.+I.+Schroederauthor=X.+Zhuauthor=Y.+Huauthor=Y.+Wuauthor=M.+M.+Weltzinauthor=S.+Eberhardauthor=Q.+Kaasauthor=D.+J.+Craikauthor=J.+M.+McIntoshauthor=P.+Whiteaker&title=A+novel+alpha4%2F7-conotoxin+LvIA+from+Conus+lividus+that+selectively+blocks+alpha3beta2+vs.+alpha6%2Falpha3beta2beta3+nicotinic+acetylcholine+receptors&doi=10.1096%2Ffj.13-244103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Luo, Sulan; Zhangsun, Dongting; Schroeder, Christina I.; Zhu, Xiaopeng; Hu, Yuanyan; Wu, Yong; Weltzin, Maegan M.; Eberhard, Spencer; Kaas, Quentin; Craik, David J.; McIntosh, J. Michael; Whiteaker, Paul</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1842-1853, 10.1096/fj.13-244103</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">This study was performed to discover and characterize the first potent α3β2-subtype-selective nicotinic acetylcholine receptor (nAChR) ligand.  A novel α4/7-conotoxin, α-CTxLvIA, was cloned from Conus lividus.  Its pharmacol. profile at Xenopus laevis oocyte-expressed rat nAChR subtypes was detd. by 2-electrode voltage-clamp electrophysiol., and its 3-dimensional (3D) structure was detd. by NMR spectroscopy.  α-CTx LvIA is a 16-aa C-terminally-amidated peptide with 2-disulfide bridges.  Using rat subunits expressed in Xenopus oocytes, we found the highest affinity of α-CTxLvIA was for α3β2 nAChRs (IC50 8.7 nM), where blockade was reversible within 2 min.  IC50 values were >100 nM at α6/α3β2β3, α6/α3β4, and α3β4 nAChRs, and ≥3 μM at all other subtypes tested.  α3β2 Vs. α6β2 subtype selectivity was confirmed for human-subunit nAChRs with much greater preference (300-fold) for α3β2 over α6β2 nAChRs.  This is the first α-CTx reported to show high selectivity for human α3β2 vs. α6β2 nAChRs.  α-CTxLvIA adopts two similarly populated conformations water: one (assumed to be bioactive) is highly structured, whereas the other is mostly random coil in nature.  Selectivity differences with the similarly potent, but less selective, α3β2 nAChR antagonist α-CTx PeIA probably reside within the three residues, which differ in loop 2, given their otherwise similar 3D structures.  α4/7-CTx LvIA is a new, potent, selective α3β2 nAChR antagonist, which will enable detailed studies of α3β2 nAChR structure, function, and physiol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3AdcmYJJbTLVg90H21EOLACvtfcHk0lhh9Vll0P39tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVGrsb8%253D&md5=6a6a4276e5660e894f68439d8373ce0c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1096%2Ffj.13-244103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.13-244103%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DSchroeder%26aufirst%3DC.%2BI.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWeltzin%26aufirst%3DM.%2BM.%26aulast%3DEberhard%26aufirst%3DS.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DWhiteaker%26aufirst%3DP.%26atitle%3DA%2520novel%2520alpha4%252F7-conotoxin%2520LvIA%2520from%2520Conus%2520lividus%2520that%2520selectively%2520blocks%2520alpha3beta2%2520vs.%2520alpha6%252Falpha3beta2beta3%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DFASEB%2520J.%26date%3D2014%26volume%3D28%26spage%3D1842%26epage%3D1853%26doi%3D10.1096%2Ffj.13-244103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albillos, A.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxins identify the alpha3beta4* subtype as the predominant nicotinic acetylcholine receptor expressed in human adrenal chromaffin cells</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1124/mol.115.100982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.115.100982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=26330550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVOjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=881-893&author=A.+J.+Honeauthor=J.+M.+McIntoshauthor=L.+Azamauthor=J.+Lindstromauthor=L.+Luceroauthor=P.+Whiteakerauthor=J.+Passasauthor=J.+Blazquezauthor=A.+Albillos&title=alpha-Conotoxins+identify+the+alpha3beta4*+subtype+as+the+predominant+nicotinic+acetylcholine+receptor+expressed+in+human+adrenal+chromaffin+cells&doi=10.1124%2Fmol.115.100982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxins identify the α3β4* subtype as the predominant nicotinic acetylcholine receptor expressed in human adrenal chromaffin cells</span></div><div class="casAuthors">Hone, Arik J.; McIntosh, J. Michael; Azam, Layla; Lindstrom, Jon; Lucero, Linda; Whiteaker, Paul; Passas, Juan; Blazquez, Jesus; Albillos, Almudena</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">881-893</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ligands that selectively inhibit human α3β2 and α6β2 nicotinic acetylcholine receptor (nAChRs) and not the closely related α3β4 and α6β4 subtypes are lacking.  Current α-conotoxins (α-Ctxs) that discriminate among these nAChR subtypes in rat fail to discriminate among the human receptor homologs.  In this study, we describe the development of α-Ctx LvIA(N9R,V10A) that is 3000-fold more potent on oocyte-expressed human α3β2 than α3β4 and 165-fold more potent on human α6/α3β2β3 than α6/α3β4 nAChRs.  This analog was used in conjunction with three other α-Ctx analogs and patch-clamp electrophysiol. to characterize the nAChR subtypes expressed by human adrenal chromaffin cells.  LvIA(N9R,V10A) showed little effect on the acetylcholine-evoked currents in these cells at concns. expected to inhibit nAChRs with β2 ligand-binding sites.  In contrast, the β4-selective α-Ctx BuIA(T5A,P6O) inhibited >98% of the acetylcholine-evoked current, indicating that most of the heteromeric receptors contained β4 ligand-binding sites.  Addnl. studies using the α6-selective α-Ctx PeIA(A7V,S9H,V10A,N11R,E14A) indicated that the predominant heteromeric nAChR expressed by human adrenal chromaffin cells is the α3β4* subtype (asterisk indicates the possible presence of addnl. subunits).  This conclusion was supported by polymerase chain reaction expts. of human adrenal medulla gland and of cultured human adrenal chromaffin cells that demonstrated prominent expression of RNAs for α3, α5, α7, β2, and β4 subunits and a low abundance of RNAs for α2, α4, α6, and α10 subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNG3Y49bvNbVg90H21EOLACvtfcHk0lhh9Vll0P39tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVOjtLo%253D&md5=6a08e2032ec2a5b7e156168b9e53c02e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100982%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DLucero%26aufirst%3DL.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DPassas%26aufirst%3DJ.%26aulast%3DBlazquez%26aufirst%3DJ.%26aulast%3DAlbillos%26aufirst%3DA.%26atitle%3Dalpha-Conotoxins%2520identify%2520the%2520alpha3beta4%252A%2520subtype%2520as%2520the%2520predominant%2520nicotinic%2520acetylcholine%2520receptor%2520expressed%2520in%2520human%2520adrenal%2520chromaffin%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D881%26epage%3D893%26doi%3D10.1124%2Fmol.115.100982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazioso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallanoce, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Micheli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Amici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotti, C.</span></span> <span> </span><span class="NLM_article-title">Engineering of alpha-conotoxin MII-derived peptides with increased selectivity for native alpha6beta2* nicotinic acetylcholine receptors</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3775</span>– <span class="NLM_lpage">3789</span>, <span class="refDoi"> DOI: 10.1096/fj.10-179853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1096%2Ffj.10-179853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=21778325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=3775-3789&author=L.+Pucciauthor=G.+Graziosoauthor=C.+Dallanoceauthor=L.+Rizziauthor=C.+De+Micheliauthor=F.+Clementiauthor=S.+Bertrandauthor=D.+Bertrandauthor=R.+Longhiauthor=M.+De+Amiciauthor=C.+Gotti&title=Engineering+of+alpha-conotoxin+MII-derived+peptides+with+increased+selectivity+for+native+alpha6beta2*+nicotinic+acetylcholine+receptors&doi=10.1096%2Ffj.10-179853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors</span></div><div class="casAuthors">Pucci, Luca; Grazioso, Giovanni; Dallanoce, Clelia; Rizzi, Luca; De Micheli, Carlo; Clementi, Francesco; Bertrand, Sonia; Bertrand, Daniel; Longhi, Renato; De Amici, Marco; Gotti, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3775-3789, 10.1096/fj.10-179853</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">α6β2* Nicotinic acetylcholine receptors are expressed in selected central nervous system areas, where they are involved in striatal dopamine (DA) release and its behavioral consequences, and other still uncharacterized brain activities.  α6β2* receptors are selectively blocked by the α-conotoxins MII and PIA, which bear a characteristic N-terminal amino acid tail [arginine (R), aspartic acid (D), and proline (P)].  The authors synthesized a group of PIA-related peptides in which R1 was mutated or the RDP motif gradually removed.  Binding and striatal DA release assays of native rat α6β2* receptors showed that the RDP sequence, and particularly residue R1, is essential for the activity of PIA.  On the basis of mol. modeling analyses, the authors synthesized a hybrid peptide (RDP-MII) that had increased potency (7-fold) and affinity (13-fold) for α6β2* receptors but not for the very similar α3β2* subtype.  As docking studies also suggested that E11 of MII might be a key residue engendering α6β2* vs. α3β2* selectivity, the authors prepd. MII[E11R] and RDP-MII[E11R] peptides.  Their affinity and potency for native α6β2* receptors were similar to those of their parent analogs, whereas, for the oocyte expressed rat α3β2* subtype, they showed a 31- and 14-fold lower affinity and 21- and 3.5-fold lower potency.  Thus, MII[E11R] and RDP-MII[E11R] are potent antagonists showing a degree of α6β2* vs. α3β2* selectivity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSzQlF3SYurrVg90H21EOLACvtfcHk0lhh9Vll0P39tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrjE&md5=689af1cc89bdd3ea2d107d8a83fd1f57</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1096%2Ffj.10-179853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.10-179853%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DGrazioso%26aufirst%3DG.%26aulast%3DDallanoce%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DL.%26aulast%3DDe%2BMicheli%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DLonghi%26aufirst%3DR.%26aulast%3DDe%2BAmici%26aufirst%3DM.%26aulast%3DGotti%26aufirst%3DC.%26atitle%3DEngineering%2520of%2520alpha-conotoxin%2520MII-derived%2520peptides%2520with%2520increased%2520selectivity%2520for%2520native%2520alpha6beta2%252A%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D3775%26epage%3D3789%26doi%3D10.1096%2Ffj.10-179853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladonato, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercado, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of alpha9alpha10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E1825</span>– <span class="NLM_lpage">E1832</span>, <span class="refDoi"> DOI: 10.1073/pnas.1621433114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1073%2Fpnas.1621433114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=28223528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E1825-E1832&author=H.+K.+Romeroauthor=S.+Christensenauthor=L.+Di+Cesare+Mannelliauthor=J.+Gajewiakauthor=R.+Ramachandraauthor=K.+S.+Elmslieauthor=D.+E.+Vetterauthor=C.+Ghelardiniauthor=S.+P.+Ladonatoauthor=J.+L.+Mercadoauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Inhibition+of+alpha9alpha10+nicotinic+acetylcholine+receptors+prevents+chemotherapy-induced+neuropathic+pain&doi=10.1073%2Fpnas.1621433114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span></div><div class="casAuthors">Romero, Haylie K.; Christensen, Sean B.; Di Cesare Mannelli, Lorenzo; Gajewiak, Joanna; Ramachandra, Renuka; Elmslie, Keith S.; Vetter, Douglas E.; Ghelardini, Carla; Iadonato, Shawn P.; Mercado, Jose L.; Olivera, Baldomera M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">E1825-E1832</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Opioids are first-line drugs for moderate to severe acute pain and cancer pain.  However, these medications are assocd. with severe side effects, and whether they are efficacious in treatment of chronic nonmalignant pain remains controversial.  Medications that act through alternative mol. mechanisms are critically needed.  Antagonists of α9α10 nicotinic acetylcholine receptors (nAChRs) have been proposed as an important nonopioid mechanism based on studies demonstrating prevention of neuropathol. after trauma-induced nerve injury.  However, the key α9α10 ligands characterized to date are at least two orders of magnitude less potent on human vs. rodent nAChRs, limiting their translational application.  Furthermore, an alternative proposal that these ligands achieve their beneficial effects by acting as agonists of GABAB receptors has caused confusion over whether blockade of α9α10 nAChRs is the fundamental underlying mechanism.  To address these issues definitively, we developed RgIA4, a peptide that exhibits high potency for both human and rodent α9α10 nAChRs, and was at least 1,000-fold more selective for α9α10 nAChRs vs. all other mol. targets tested, including opioid and GABAB receptors.  A daily s.c. dose of RgIA4 prevented chemotherapy-induced neuropathic pain in rats.  In wild-type mice, oxaliplatin treatment produced cold allodynia that could be prevented by RgIA4.  Addnl., in α9 KO mice, chemotherapy-induced development of cold allodynia was attenuated and the milder, temporary cold allodynia was not relieved by RgIA4.  These findings establish blockade of α9-contg. nAChRs as the basis for the efficacy of RgIA4, and that α9-contg. nAChRs are a crit. target for prevention of chronic cancer chemotherapy-induced neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_cYkcGhDBrVg90H21EOLACvtfcHk0ljTYgGCpM5Ypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D&md5=2372b9f813b9c628cef156f7d114c7c1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1621433114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1621433114%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DH.%2BK.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DRamachandra%26aufirst%3DR.%26aulast%3DElmslie%26aufirst%3DK.%2BS.%26aulast%3DVetter%26aufirst%3DD.%2BE.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DLadonato%26aufirst%3DS.%2BP.%26aulast%3DMercado%26aufirst%3DJ.%2BL.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520alpha9alpha10%2520nicotinic%2520acetylcholine%2520receptors%2520prevents%2520chemotherapy-induced%2520neuropathic%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE1825%26epage%3DE1832%26doi%3D10.1073%2Fpnas.1621433114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span> <span> </span><span class="NLM_article-title">Single amino acid substitution in alpha-conotoxin TxID reveals a specific alpha3beta4 nicotinic acetylcholine receptor antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9256</span>– <span class="NLM_lpage">9265</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00967</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00967" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOls77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9256-9265&author=J.+Yuauthor=X.+Zhuauthor=P.+J.+Harveyauthor=Q.+Kaasauthor=D.+Zhangsunauthor=D.+J.+Craikauthor=S.+Luo&title=Single+amino+acid+substitution+in+alpha-conotoxin+TxID+reveals+a+specific+alpha3beta4+nicotinic+acetylcholine+receptor+antagonist&doi=10.1021%2Facs.jmedchem.8b00967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist</span></div><div class="casAuthors">Yu, Jinpeng; Zhu, Xiaopeng; Harvey, Peta J.; Kaas, Quentin; Zhangsun, Dongting; Craik, David J.; Luo, Sulan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9256-9265</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The α3β4 nicotinic acetylcholine receptor (nAChR) is an important target implicated in various disease states. α-Conotoxin TxID (1) is the most potent antagonist of α3β4 nAChR, but it also exhibits inhibition of α6/α3β4 nAChR.  The results of alanine scanning of 1 suggested a vital role for Ser9 in the selectivity of the peptide.  In this study, Ser9 was substituted with a series of 14 amino acids, including some non-natural amino acids, displaying different physicochem. characteristics to further improve the selectivity of 1 toward α3β4 nAChR.  The pharmacol. activities of the mutants were evaluated using an electrophysiol. approach.  The best selectivity was obtained with [S9K]TxID, 12, which inhibited α3β4 nAChR with an IC50 of 6.9 nM and had no effects on other nAChRs.  Mol. modeling suggested a possible explanation for the high selectivity of 12 toward α3β4 nAChR, providing deeper insight into the interaction between α-conotoxins and nAChRs as well as potential treatments for nAChR-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr88F8OOlR5f7Vg90H21EOLACvtfcHk0ljTYgGCpM5Ypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOls77K&md5=b8f7a7026c156eb47f534989d79da50e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00967%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLuo%26aufirst%3DS.%26atitle%3DSingle%2520amino%2520acid%2520substitution%2520in%2520alpha-conotoxin%2520TxID%2520reveals%2520a%2520specific%2520alpha3beta4%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9256%26epage%3D9265%26doi%3D10.1021%2Facs.jmedchem.8b00967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staheli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuryatov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span> <span> </span><span class="NLM_article-title">Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1124/mol.65.4.944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fmol.65.4.944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=15044624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFaltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=944-952&author=J.+M.+McIntoshauthor=L.+Azamauthor=S.+Staheliauthor=C.+Dowellauthor=J.+M.+Lindstromauthor=A.+Kuryatovauthor=J.+E.+Garrettauthor=M.+J.+Marksauthor=P.+Whiteaker&title=Analogs+of+alpha-conotoxin+MII+are+selective+for+alpha6-containing+nicotinic+acetylcholine+receptors&doi=10.1124%2Fmol.65.4.944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors</span></div><div class="casAuthors">McIntosh, J. Michael; Azam, Layla; Staheli, Sarah; Dowell, Cheryl; Lindstrom, Jon M.; Kuryatov, Alexander; Garrett, James E.; Marks, Michael J.; Whiteaker, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">944-952</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic acetylcholine receptors (nAChRs) both mediate direct cholinergic synaptic transmission and modulate synaptic transmission by other neurotransmitters.  Novel ligands are needed as probes to discriminate among structurally related nAChR subtypes.  α-Conotoxin MII, a selective ligand that discriminates among a variety of nAChR subtypes, fails to discriminate well between some subtypes contg. the closely related α3 and α6 subunits.  Structure-function anal. of α-conotoxin MII was performed in an attempt to generate analogs with preference for α6-contg. [α6* (asterisks indicate the possible presence of addnl. subunits)] nAChRs.  Alanine substitution resulted in several analogs with decreased activity at α3* vs. α6* nAChRs heterologously expressed in Xenopus laevis oocytes.  From the initial analogs, a series of mutations with two alanine substitutions was synthesized.  Substitution at His9 and Leu15 (MII[H9A;L15A]) resulted in a 29-fold lower IC50 at α6β4 vs. α3β4 nAChRs.  The peptide had a 590-fold lower IC50 for α6/α3β2 vs. α3β2 and a 2020-fold lower IC50 for α6/α3β2β3 vs. α3β2 nAChRs.  MII[H9A;L15A] had little or no activity at α2β2, α2β4, α3β4, α4β2, α4β4, and α7 nAChRs.  Functional block by MII[H9A;L15A] of rat α6/α3β2β3 nAChRs (IC50 = 2.4 nM) correlated well with the inhibition const. of MII[H9A;L15A] for [125I]α-conotoxin MII binding to putative α6β2* nAChRs in mouse brain homogenates (Ki = 3.3 nM).  Thus, structure-function anal. of α-conotoxin MII enabled the creation of novel selective antagonists for discriminating among nAChRs contg. α3 and α6 subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrunT11Fm6fe7Vg90H21EOLACvtfcHk0ljTYgGCpM5Ypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFaltLk%253D&md5=8cbc3c187e7fed0fe29f9955b10bb736</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.4.944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.4.944%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DStaheli%26aufirst%3DS.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DLindstrom%26aufirst%3DJ.%2BM.%26aulast%3DKuryatov%26aufirst%3DA.%26aulast%3DGarrett%26aufirst%3DJ.%2BE.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DWhiteaker%26aufirst%3DP.%26atitle%3DAnalogs%2520of%2520alpha-conotoxin%2520MII%2520are%2520selective%2520for%2520alpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D944%26epage%3D952%26doi%3D10.1124%2Fmol.65.4.944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6628</span>– <span class="NLM_lpage">6638</span>, <span class="refDoi"> DOI: 10.1021/bi7004202</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7004202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFCjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=6628-6638&author=P.+Whiteakerauthor=S.+Christensenauthor=D.+Yoshikamiauthor=C.+Dowellauthor=M.+Watkinsauthor=J.+Gulyasauthor=J.+Rivierauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Discovery%2C+synthesis%2C+and+structure+activity+of+a+highly+selective+alpha7+nicotinic+acetylcholine+receptor+antagonist&doi=10.1021%2Fbi7004202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Synthesis, and Structure Activity of a Highly Selective α7 Nicotinic Acetylcholine Receptor Antagonist</span></div><div class="casAuthors">Whiteaker, Paul; Christensen, Sean; Yoshikami, Doju; Dowell, Cheryl; Watkins, Maren; Gulyas, Jozsef; Rivier, Jean; Olivera, Baldomero M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6628-6638</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) that contain an α7 subunit are widely distributed in neuronal and nonneuronal tissue.  These receptors are implicated in the release of neurotransmitters such as glutamate and in functions ranging from thought processing to inflammation.  Currently available ligands for α7 nAChRs have substantial affinity for one or more other nAChR subtypes, including those with an α1, α3, α6, and/or α9 subunit.  An α-conotoxin gene was cloned from Conus arenatus.  Predicted peptides were synthesized and found to potently block α3-, α6-, and α7-contg. nAChRs.  Structure-activity information regarding conotoxins from distantly related Conus species was employed to modify the C.  Arenatus derived toxin into a novel, highly selective α7 nAChR antagonist.  This ligand, α-CtxArIB[V11A,V16D], has low nanomolar affinity for rat α7 homomers expressed in Xenopus laevis oocytes, and antagonism is slowly reversible.  Kinetic anal. provided insight into the mechanism of antagonism. α-CtxArIB interacts with five ligand binding sites per α7 receptor, and occupation of a single site is sufficient to block function.  The peptide was also shown to be highly selective in competition binding assays in rat brain membranes. α-CtxArIB[V11A,V16D] is the most selective ligand yet reported for α7 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ7lxdry-9OLVg90H21EOLACvtfcHk0lggVhl6xWQfOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFCjsrk%253D&md5=bb573590d0e71949d96a0bcb0151e9d4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi7004202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7004202%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DGulyas%26aufirst%3DJ.%26aulast%3DRivier%26aufirst%3DJ.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520structure%2520activity%2520of%2520a%2520highly%2520selective%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D6628%26epage%3D6638%26doi%3D10.1021%2Fbi7004202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maskos, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Biasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between alpha6beta4 and alpha6beta2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5113</span>– <span class="NLM_lpage">5123</span>, <span class="refDoi"> DOI: 10.1096/fj.10-166272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1096%2Ffj.10-166272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=20739611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOms7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=5113-5123&author=L.+Azamauthor=U.+Maskosauthor=J.+P.+Changeuxauthor=C.+D.+Dowellauthor=S.+Christensenauthor=M.+De+Biasiauthor=J.+M.+McIntosh&title=alpha-Conotoxin+BuIA%5BT5A%3BP6O%5D%3A+a+novel+ligand+that+discriminates+between+alpha6beta4+and+alpha6beta2+nicotinic+acetylcholine+receptors+and+blocks+nicotine-stimulated+norepinephrine+release&doi=10.1096%2Ffj.10-166272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6β4 and α6β2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release</span></div><div class="casAuthors">Azam, Layla; Maskos, Uwe; Changeux, Jean-Pierre; Dowell, Cheryl D.; Christensen, Sean; De Biasi, Mariella; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5113-5123, 10.1096/fj.10-166272</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">α6* (asterisk indicates the presence of addnl. subunits) nicotinic acetylcholine receptors (nAChRs) are broadly implicated in catecholamine-dependent disorders that involve attention, motor movement, and nicotine self-administration.  Different mol. forms of α6 nAChRs mediate catecholamine release, but receptor differentiation is greatly hampered by a paucity of subtype selective ligands.  α-Conotoxins are nAChR-targeted peptides used by Conus species to incapacitate prey.  We hypothesized that distinct conotoxin-binding kinetics could be exploited to develop a series of selective probes to enable study of native receptor subtypes.  Proline-6 of α-conotoxin BuIA was found to be crit. for nAChR selectivity; substitution of proline-6 with 4-hydroxy-proline increased the IC50 by 2800-fold at α6/α3β2β3 but only by 6-fold at α6/α3β4 nAChRs (to 1300 and 12 nM, resp.).  We used conotoxin probes together with subunit-null mice to interrogate nAChR subtypes that modulate hippocampal norepinephrine release.  Release was abolished in α6-null mutant mice.  α-Conotoxin BuIA[T5A;P6O] partially blocked norepinephrine release in wild-type controls but failed to block release in β4-/- mice.  In contrast, BuIA[T5A;P6O] failed to block dopamine release in the wild-type striatum known to contain α6β2* nAChRs.  BuIA[T5A;P6O] is a novel ligand for distinguishing between closely related α6* nAChRs; α6β4* nAChRs modulate norepinephrine release in hippocampus but not dopamine release in striatum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGVPbPP_ert7Vg90H21EOLACvtfcHk0lggVhl6xWQfOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOms7jP&md5=99c3d9648e5f207b12b123cefc338da7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1096%2Ffj.10-166272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.10-166272%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DL.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DDowell%26aufirst%3DC.%2BD.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DDe%2BBiasi%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3Dalpha-Conotoxin%2520BuIA%255BT5A%253BP6O%255D%253A%2520a%2520novel%2520ligand%2520that%2520discriminates%2520between%2520alpha6beta4%2520and%2520alpha6beta2%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520blocks%2520nicotine-stimulated%2520norepinephrine%2520release%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D5113%26epage%3D5123%26doi%3D10.1096%2Ffj.10-166272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougal, O. M.</span></span> <span> </span><span class="NLM_article-title">Mutagenesis of alpha-conotoxins for enhancing activity and selectivity for nicotinic acetylcholine receptors</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">113</span>, <span class="refDoi"> DOI: 10.3390/toxins11020113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.3390%2Ftoxins11020113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=113&author=M.+W.+Turnerauthor=L.+A.+Marquartauthor=P.+D.+Phillipsauthor=O.+M.+McDougal&title=Mutagenesis+of+alpha-conotoxins+for+enhancing+activity+and+selectivity+for+nicotinic+acetylcholine+receptors&doi=10.3390%2Ftoxins11020113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Ftoxins11020113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins11020113%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%2BW.%26aulast%3DMarquart%26aufirst%3DL.%2BA.%26aulast%3DPhillips%26aufirst%3DP.%2BD.%26aulast%3DMcDougal%26aufirst%3DO.%2BM.%26atitle%3DMutagenesis%2520of%2520alpha-conotoxins%2520for%2520enhancing%2520activity%2520and%2520selectivity%2520for%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DToxins%26date%3D2019%26volume%3D11%26spage%3D113%26doi%3D10.3390%2Ftoxins11020113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giribaldi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>679</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2017.11.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.neulet.2017.11.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=29199094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=679&publication_year=2018&pages=24-34&author=J.+Giribaldiauthor=S.+Dutertre&title=alpha-Conotoxins+to+explore+the+molecular%2C+physiological+and+pathophysiological+functions+of+neuronal+nicotinic+acetylcholine+receptors&doi=10.1016%2Fj.neulet.2017.11.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors</span></div><div class="casAuthors">Giribaldi, Julien; Dutertre, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">679</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-34</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The vast diversity of neuronal nicotinic acetylcholine subunits expressed in the central and peripheral nervous systems, as well as in non-neuronal tissues, constitutes a formidable challenge for researchers and clinicians to decipher the role of particular subtypes, including complex subunit assocns., in physiol. and pathophysiol. functions.  Many natural products target the nAChRs, but there is no richer source of nicotinic ligands than the venom of predatory gastropods known as cone snails.  Indeed, every single species of cone snail was shown to produce at least one type of such α-conotoxins.  These tiny peptides (10-25 amino acids), constrained by disulfide bridges, proved to be unvaluable tools to investigate the structure and function of nAChRs, some of them having also therapeutic potential.  In this review, we provide a recent update on the pharmacol. and subtype specificity of several major α-conotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1wEl9NcdLXrVg90H21EOLACvtfcHk0lggVhl6xWQfOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3J&md5=6fd8e2c02424c0355431dc846bd0f073</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2017.11.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2017.11.063%26sid%3Dliteratum%253Aachs%26aulast%3DGiribaldi%26aufirst%3DJ.%26aulast%3DDutertre%26aufirst%3DS.%26atitle%3Dalpha-Conotoxins%2520to%2520explore%2520the%2520molecular%252C%2520physiological%2520and%2520pathophysiological%2520functions%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DNeurosci.%2520Lett.%26date%3D2018%26volume%3D679%26spage%3D24%26epage%3D34%26doi%3D10.1016%2Fj.neulet.2017.11.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V. I.</span></span> <span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.neuropharm.2017.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=28623170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=196-223&author=S.+Dutertreauthor=A.+Nickeauthor=V.+I.+Tsetlin&title=Nicotinic+acetylcholine+receptor+inhibitors+derived+from+snake+and+snail+venoms&doi=10.1016%2Fj.neuropharm.2017.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms</span></div><div class="casAuthors">Dutertre, Sebastien; Nicke, Annette; Tsetlin, Victor I.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">196-223</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nicotinic acetylcholine receptor (nAChR) represents the prototype of ligand-gated ion channels.  It is vital for neuromuscular transmission and an important regulator of neurotransmission.  A variety of toxic compds. derived from diverse species target this receptor and have been of elemental importance in basic and applied research.  They enabled milestone discoveries in pharmacol. and biochem. ranging from the original formulation of the receptor concept, the first isolation and structural anal. of a receptor protein (the nAChR) to the identification, localization, and differentiation of its diverse subtypes and their validation as a target for therapeutic intervention.  Among the venom-derived compds., α-neurotoxins and α-conotoxins provide the largest families and still represent indispensable pharmacol. tools.  Application of modified α-neurotoxins provided substantial structural and functional details of the nAChR long before high resoln. structures were available. α-bungarotoxin represents not only a std. pharmacol. tool and label in nAChR research but also for unrelated proteins tagged with a minimal α-bungarotoxin binding motif.  A major advantage of α-conotoxins is their smaller size, as well as superior selectivity for diverse nAChR subtypes that allows their development into ligands with optimized pharmacol. and chem. properties and potentially novel drugs.  In the following, these two groups of nAChR antagonists will be described focusing on their resp. roles in the structural and functional characterization of nAChRs and their development into research tools.  In addn., we provide a comparative overview of the diverse α-conotoxin selectivities that can serve as a practical guide for both structure activity studies and subtype classification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBiFz12d6Zw7Vg90H21EOLACvtfcHk0lhjLX3spx09Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtL3N&md5=95bfb80a1d00feb940c58b4df16fc1a7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DNicke%26aufirst%3DA.%26aulast%3DTsetlin%26aufirst%3DV.%2BI.%26atitle%3DNicotinic%2520acetylcholine%2520receptor%2520inhibitors%2520derived%2520from%2520snake%2520and%2520snail%2520venoms%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D127%26spage%3D196%26epage%3D223%26doi%3D10.1016%2Fj.neuropharm.2017.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span> <span> </span><span class="NLM_article-title">alpha-Conotoxin [S9A]TxID potently discriminates between alpha3beta4 and alpha6/alpha3beta4 nicotinic acetylcholine receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5826</span>– <span class="NLM_lpage">5833</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00546</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00546" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5826-5833&author=Y.+Wuauthor=D.+Zhangsunauthor=X.+Zhuauthor=Q.+Kaasauthor=M.+Zhangsunauthor=P.+J.+Harveyauthor=D.+J.+Craikauthor=J.+M.+McIntoshauthor=S.+Luo&title=alpha-Conotoxin+%5BS9A%5DTxID+potently+discriminates+between+alpha3beta4+and+alpha6%2Falpha3beta4+nicotinic+acetylcholine+receptors&doi=10.1021%2Facs.jmedchem.7b00546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Wu, Yong; Zhangsun, Dongting; Zhu, Xiaopeng; Kaas, Quentin; Zhangsun, Manqi; Harvey, Peta J.; Craik, David J.; McIntosh, J. Michael; Luo, Sulan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5826-5833</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α3β4 NAChRs have been implicated in various pathophysiol. conditions.  However, the expression profile of α3β4 nAChRs and α6/α3β4 nAChRs overlap in a variety of tissues.  To distinguish between these two subtypes, the authors redesigned peptide (α-conotoxin TxID), which inhibits α3β4 and α6/α3β4 nAChR subtypes.  The authors systematically mutated TxID to evaluate analog selectivity for α3β4 vs. α6/α3β4 nAChRs expressed in Xenopus laevis oocytes.  One analog, peptide [S9A]TxID, had 46-fold greater potency for α3β4 vs. α6/α3β4 nAChRs.  Peptide [S9A]TxID had IC50s > 10 μM for other nAChR subtypes.  Mol. dynamics simulations suggested that Ser-9 of TxID was involved in a weak hydrogen bond with β4 Lys-81 in the α6β4 binding site but not in the α3β4 binding site.  When Ser-9 was substituted by an Ala, this hydrogen bond interaction was disrupted.  These results provide further mol. insights into the selectivity of [S9A]TxID and provide a guide for designing ligands that block α3β4 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5R3bImuXjbVg90H21EOLACvtfcHk0lhjLX3spx09Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSks7g%253D&md5=9110eec83730945d572ebc5e5bbac3bd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00546%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DZhangsun%26aufirst%3DM.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DS.%26atitle%3Dalpha-Conotoxin%2520%255BS9A%255DTxID%2520potently%2520discriminates%2520between%2520alpha3beta4%2520and%2520alpha6%252Falpha3beta4%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5826%26epage%3D5833%26doi%3D10.1021%2Facs.jmedchem.7b00546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocent, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingstone, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonnacott, S.</span></span> <span> </span><span class="NLM_article-title">Alpha-conotoxin <i>Arenatus</i> IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.142943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1124%2Fjpet.108.142943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=18664588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=529-537&author=N.+Innocentauthor=P.+D.+Livingstoneauthor=A.+Honeauthor=A.+Kimuraauthor=T.+Youngauthor=P.+Whiteakerauthor=J.+M.+McIntoshauthor=S.+Wonnacott&title=Alpha-conotoxin+Arenatus+IB%5BV11L%2CV16D%5D+%5Bcorrected%5D+is+a+potent+and+selective+antagonist+at+rat+and+human+native+alpha7+nicotinic+acetylcholine+receptors&doi=10.1124%2Fjpet.108.142943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">α-conotoxin Arenatus IB[V11L,V16D] is a potent and selective antagonist at rat and human native α7 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Innocent, Neal; Livingstone, Phil D.; Hone, Arik; Kimura, Atsuko; Young, Tracey; Whiteaker, Paul; McIntosh, J. Michael; Wonnacott, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A recently developed α-conotoxin, α-conotoxin Arenatus IB[V11L,V16D] (α-CtxArIB[V11L,V16D]), is a potent and selective competitive antagonist at rat recombinant α7 nicotinic acetylcholine receptors (nAChRs), making it an attractive probe for this receptor subtype.  α7 NAChRs are potential therapeutic targets that are widely expressed in both neuronal and non-neuronal tissues, where they are implicated in a variety of functions.  In this study, we evaluate this toxin at rat and human native nAChRs.  Functional α7 nAChR responses were evoked by choline plus the allosteric potentiator PNU-120596 [1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea] in rat PC12 cells and human SH-SY5Y cells loaded with calcium indicators.  α-CtxArIB[V11L,V16D] specifically inhibited α7 nAChR-mediated increases in Ca2+ in PC12 cells.  Responses to other stimuli, 5-I-A-85380 [5-iodo-3-(2(S)-azetidinylmethoxy)pyridine dihydrochloride], nicotine, or KCl, that did not activate α7 nAChRs were unaffected.  Human α7 nAChRs were also sensitive to α-CtxArIB[V11L,V16D]; acetylcholine-evoked currents in Xenopus laevis oocytes expressing human α7 nAChRs were inhibited by α-CtxArIB[V11L,V16D] (IC50, 3.4 nM) in a slowly reversible manner, with full recovery taking 15 min.  This is consistent with the time course of recovery from blockade of rat α7 nAChRs in PC12 cells.  α-CtxArIB[V11L,V16D] inhibited human native α7 nAChRs in SHSY5Y cells, activated by either choline or AR-R17779 [(2)-spiro[1-azabicyclo[2.2.2]octane-3,59-oxazolidin]-29-one] plus PNU-120596.  Rat brain α7 nAChRs contribute to dopamine release from striatal minces; α-CtxArIB[V11L,V16D] (300 nM) selectively inhibited choline-evoked dopamine release without affecting responses evoked by nicotine that activates heteromeric nAChRs.  This study establishes that α-CtxArIB[V11L,V16D] selectively inhibits human and rat native α7 nAChRs with comparable potency, making this a potentially useful antagonist for investigating α7 nAChR functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx07uZv7pR_rVg90H21EOLACvtfcHk0lhjLX3spx09Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vM&md5=93fbd4e9eadf0a64a05770e05e07ecbe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.142943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.142943%26sid%3Dliteratum%253Aachs%26aulast%3DInnocent%26aufirst%3DN.%26aulast%3DLivingstone%26aufirst%3DP.%2BD.%26aulast%3DHone%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DWonnacott%26aufirst%3DS.%26atitle%3DAlpha-conotoxin%2520Arenatus%2520IB%255BV11L%252CV16D%255D%2520%255Bcorrected%255D%2520is%2520a%2520potent%2520and%2520selective%2520antagonist%2520at%2520rat%2520and%2520human%2520native%2520alpha7%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D529%26epage%3D537%26doi%3D10.1124%2Fjpet.108.142943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utkin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasheverov, I.</span></span> <span> </span><span class="NLM_article-title">Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.05.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2Fj.bcp.2009.05.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=19501053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=720-731&author=V.+Tsetlinauthor=Y.+Utkinauthor=I.+Kasheverov&title=Polypeptide+and+peptide+toxins%2C+magnifying+lenses+for+binding+sites+in+nicotinic+acetylcholine+receptors&doi=10.1016%2Fj.bcp.2009.05.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors</span></div><div class="casAuthors">Tsetlin, Victor; Utkin, Yuri; Kasheverov, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">720-731</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  At present the cryo-electron microscopy structure at 4 Å resoln. is known for the Torpedo marmorata nicotinic acetylcholine receptor (nAChR), and high-resoln. X-ray structures have been recently detd. for bacterial ligand-gated ion channels which have the same type of spatial organization.  Together all these structures provide the basis for better understanding functioning of muscle-type and neuronal nAChRs, as well as of other Cys-loop receptors: 5HT3-, glycine-, GABA-A and some other.  Detailed information about the ligand-binding sites in nAChRs, necessary both for understanding the receptor functioning and for rational drug design, became available when the X-ray structures were solved for the acetylcholine-binding proteins (AChBP), excellent models for the ligand-binding domains of all Cys-loop receptors.  Of special value in this respect are the X-ray structures of AChBP complexes with agonists and antagonists.  Among the latter are the complexes with polypeptide and peptide antagonists, that is with protein neurotoxins from snake venoms and peptide neurotoxins (α-conotoxins) from poisonous marine snails of Conus genus.  The role of a bridge between the AChBP and nAChRs is played by the X-ray structure of the ligand-binding domain of α1 subunit of nAChR in the complex with α-bungarotoxin.  The purpose of this review is to show the role of well-known and new polypeptide and peptide neurotoxins, from the earlier days of nAChRs research until present time, in identification of different nAChR subtypes and mapping their binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUDx8nxOpOCrVg90H21EOLACvtfcHk0lhIPR2srtESDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjF&md5=ee273583f19c9e66799dbf4634929ea4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.05.032%26sid%3Dliteratum%253Aachs%26aulast%3DTsetlin%26aufirst%3DV.%26aulast%3DUtkin%26aufirst%3DY.%26aulast%3DKasheverov%26aufirst%3DI.%26atitle%3DPolypeptide%2520and%2520peptide%2520toxins%252C%2520magnifying%2520lenses%2520for%2520binding%2520sites%2520in%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D720%26epage%3D731%26doi%3D10.1016%2Fj.bcp.2009.05.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgi, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boss, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viveros-Paredes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, J. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent positive allosteric modulators of the alpha3beta2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1021/cn4002297</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4002297" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=346-359&author=J.+J.+Burgiauthor=M.+Awaleauthor=S.+D.+Bossauthor=T.+Schaerauthor=F.+Margerauthor=J.+M.+Viveros-Paredesauthor=S.+Bertrandauthor=J.+Gertschauthor=D.+Bertrandauthor=J.+L.+Reymond&title=Discovery+of+potent+positive+allosteric+modulators+of+the+alpha3beta2+nicotinic+acetylcholine+receptor+by+a+chemical+space+walk+in+ChEMBL&doi=10.1021%2Fcn4002297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-benzylamino quinuclidones as potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL</span></div><div class="casAuthors">Burgi, Justus J.; Awale, Mahendra; Boss, Silvan D.; Schaer, Tifany; Marger, Fabrice; Viveros-Paredes, Juan M.; Bertrand, Sonia; Gertsch, Jurg; Bertrand, Daniel; Reymond, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-359</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">While a plethora of ligands are known for the well studied α7 and α4β2 nicotinic acetylcholine receptor (nAChR), only very few ligands address the related α3β2 nAChR expressed in the central nervous system and at the neuromuscular junction.  Starting with the public database ChEMBL organized in the chem. space of Mol. Quantum Nos. (MQN, a series of 42 integer value descriptors of mol. structure), a visual survey of nearest neighbors of the α7 nAChR partial agonist N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) pointed to N-(2-halobenzyl)-3-aminoquinuclidines as possible nAChR modulators.  This simple "chem. space walk" was performed using a web-browser available at www.gdb.unibe.ch.  Electrophysiol. recordings revealed that these ligands represent a new and to date most potent class of pos. allosteric modulators (PAMs) of the α3β2 nAChR, which also exert significant effects in vivo.  The present discovery highlights the value of surveying chem. space neighbors of known drugs within public databases to uncover new pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohp7MkRxzVCLVg90H21EOLACvtfcHk0lhIPR2srtESDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrs%253D&md5=d5e47fc46e98fc395a975d421386be86</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcn4002297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4002297%26sid%3Dliteratum%253Aachs%26aulast%3DBurgi%26aufirst%3DJ.%2BJ.%26aulast%3DAwale%26aufirst%3DM.%26aulast%3DBoss%26aufirst%3DS.%2BD.%26aulast%3DSchaer%26aufirst%3DT.%26aulast%3DMarger%26aufirst%3DF.%26aulast%3DViveros-Paredes%26aufirst%3DJ.%2BM.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DGertsch%26aufirst%3DJ.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DReymond%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520potent%2520positive%2520allosteric%2520modulators%2520of%2520the%2520alpha3beta2%2520nicotinic%2520acetylcholine%2520receptor%2520by%2520a%2520chemical%2520space%2520walk%2520in%2520ChEMBL%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D346%26epage%3D359%26doi%3D10.1021%2Fcn4002297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuryatov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span> <span> </span><span class="NLM_article-title">Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2570</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(00)00144-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1016%2FS0028-3908%2800%2900144-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=11044728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=2570-2590&author=A.+Kuryatovauthor=F.+Olaleauthor=J.+Cooperauthor=C.+Choiauthor=J.+Lindstrom&title=Human+alpha6+AChR+subtypes%3A+subunit+composition%2C+assembly%2C+and+pharmacological+responses&doi=10.1016%2FS0028-3908%2800%2900144-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses</span></div><div class="casAuthors">Kuryatov, A.; Olale, F.; Cooper, J.; Choi, C.; Lindstrom, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2570-2590</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Many nicotinic acetylcholine receptor (AChR) subunits are known to be co-expressed with the α6 subunit in neurons.  Because α6β4 AChRs assemble inefficiently and α6β2 AChRs not at all, more complex mixts. of human subunit cDNAs were tested for their abilities to form functional AChRs when expressed in Xenopus oocytes.  α6β4β3 AChRs produced the largest and most consistent responses.  α6α3β2 AChRs exhibited reduced potency for ACh and increased potency and efficacy for nicotine compared to α3β2 AChRs, but similar resistance to functional inactivation after prolonged exposure to nicotine.  α6α4β2 AChRs differed little in potency or efficacy for ACh or nicotine compared to α4β2 AChRs, and had similarly high sensitivity to inactivation by prolonged exposure to nicotine.  Co-expression of α6 and β2 cRNAs resulted in large nos. of 3H-epibatidine binding sites in the form of large aggregates but not in functional pentameric AChRs.  Co-expression of α6, β2, and α5 resulted in assembly of some functional pentameric AChRs.  Chimeras with the large extracellular domain of α6 and the rest from either α3 or α4 efficiently formed functional AChRs.  Thus, the extracellular domain of α6 efficiently assembles with β2 to form ACh binding sites, but more C-terminal domains cause difficulties in forming pentameric AChRs.  Chimeric α6/α3 and α6/α4 AChRs contg. either β2 or β4 subunits were blocked by α-conotoxin MII which had previously been reported to be specific for α3β2 AChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWNBNRp2ofWLVg90H21EOLACvtfcHk0lhIPR2srtESDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlGqsL4%253D&md5=21e6fe5f12e8f82579cd03dc019c7659</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2800%2900144-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252800%252900144-1%26sid%3Dliteratum%253Aachs%26aulast%3DKuryatov%26aufirst%3DA.%26aulast%3DOlale%26aufirst%3DF.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DLindstrom%26aufirst%3DJ.%26atitle%3DHuman%2520alpha6%2520AChR%2520subtypes%253A%2520subunit%2520composition%252C%2520assembly%252C%2520and%2520pharmacological%2520responses%26jtitle%3DNeuropharmacology%26date%3D2000%26volume%3D39%26spage%3D2570%26epage%3D2590%26doi%3D10.1016%2FS0028-3908%2800%2900144-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talley, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobango, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huidobro
Melo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hararah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of alpha-conotoxin potency for inhibition of human and rat alpha6beta4 nicotinic acetylcholine receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">17838</span>– <span class="NLM_lpage">17852</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.005649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=10.1074%2Fjbc.RA118.005649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=30249616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aqsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=17838-17852&author=A.+J.+Honeauthor=T.+T.+Talleyauthor=J.+Bobangoauthor=C.+Huidobro%0AMeloauthor=F.+Hararahauthor=J.+Gajewiakauthor=S.+Christensenauthor=P.+J.+Harveyauthor=D.+J.+Craikauthor=J.+M.+McIntosh&title=Molecular+determinants+of+alpha-conotoxin+potency+for+inhibition+of+human+and+rat+alpha6beta4+nicotinic+acetylcholine+receptors&doi=10.1074%2Fjbc.RA118.005649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Hone, Arik J.; Talley, Todd T.; Bobango, Janet; Melo, Cesar Huidobro; Hararah, Fuaad; Gajewiak, Joanna; Christensen, Sean; Harvey, Peta J.; Craik, David J.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">17838-17852</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) contg. α6 and β4 subunits are expressed by dorsal root ganglion neurons and have been implicated in neuropathic pain.  Rodent models are often used to evaluate the efficacy of analgesic compds., but species differences may affect the activity of some nAChR ligands.  A previous candidate α-conotoxin-based therapeutic yielded promising results in rodent models, but failed in human clin. trials, emphasizing the importance of understanding species differences in ligand activity.  Human and rat α6/α3β4 nAChRs expressed in Xenopus laevis oocytes exhibit differential sensitivity to α-conotoxins.  Sequence homol. comparisons of human and rat α6β4 nAChR subunits indicated that α6 residues forming the ligand-binding pocket are highly conserved between the two species, but several residues of β4 differed, including a Leu-Gln difference at position 119.  X-ray crystallog. of α-conotoxin PeIA complexed with the Aplysia californica acetylcholine-binding protein (AChBP) revealed that binding of PeIA orients Pro 13 in close proximity to residue 119 of the AChBP complementary subunit.  Site-directed mutagenesis studies revealed that Leu 119 of human β4 contributes to higher sensitivity of human α6/α3β4 nAChRs to α-conotoxins, and structure-activity studies indicated that PeIA Pro 13 is crit. for high potency.  Human and rat α6/α3β4 nAChRs displayed differential sensitivities to perturbations of the interaction between PeIA Pro 13 and residue 119 of the β4 subunit.  These results highlight the potential significance of species differences in α6β4 nAChR pharmacol. that should be taken into consideration when evaluating the activity of candidate human therapeutics in rodent models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpghB2KpjOnOrVg90H21EOLACvtfcHk0ljPvkpPs-_Stg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aqsLfI&md5=10531f0e5744c1b066d62924ee070923</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.005649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.005649%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DTalley%26aufirst%3DT.%2BT.%26aulast%3DBobango%26aufirst%3DJ.%26aulast%3DHuidobro%2BMelo%26aufirst%3DC.%26aulast%3DHararah%26aufirst%3DF.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DMolecular%2520determinants%2520of%2520alpha-conotoxin%2520potency%2520for%2520inhibition%2520of%2520human%2520and%2520rat%2520alpha6beta4%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D17838%26epage%3D17852%26doi%3D10.1074%2Fjbc.RA118.005649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JME" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JME','PDB','5JME'); return false;">PDB: 5JME</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00566">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_43582"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00566">10.1021/acs.jmedchem.9b00566</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">RP-HPLC chromatograms of PeIA-5466 showing the crude linear, purified linear, first- and second-step oxidation products, and the fully folded/purified peptide; RP-HPLC chromatograms of the fully folded peptides (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00566/suppl_file/jm9b00566_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00566/suppl_file/jm9b00566_si_001.pdf">jm9b00566_si_001.pdf (476.44 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00566&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00566%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00566" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679abce1fe8d1955","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
